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Total Synthesis of (−)-Nakadomarin A 
Abstract 
      A  convergent  and  scalable  total  synthesis  of  polycyclic  manzamine  alkaloid  (−)-
nakadomarin A is described. 
      In  the  first  generation  route,  a  cascade  reaction  sequence  with  a  Mannich/Pictet-
Spengler reaction was devised. A Michael adduct resulting from an enal and malonate 
addition was obtained. The adduct was then transformed into a bisamide, a potential 
precursor for the cascade reaction. Attempts of the cascade reaction utilizing the amide 
failed. 
      The  second  generation  route  features  a  cascade  reaction  sequence  of  a  conjugate 
addition /enamine alkylation /Pictet-Spengler reaction. The requisite macrocyclic amine 
and unsaturated iminium fragments were prepared. The conjugate addition product was 
observed  in  the  presence  of  a  base  at  low  temperature.  However,  the  adduct  readily 
underwent  a  more  facile  azetidine  formation,  as  opposed  to  the  desired  enamine 
alkylation, and lead to decomposition of the conjugate addition product. 
      Modifications of both fragments finally lead to a successful cascade reaction (Scheme 
1). Unsaturated bicyclic lactam fragment A was prepared from acrolein in 5 steps, and 
macrolactam  fragment  B  was  prepared  from  3-furfural  in  7  steps.  A  double  Michael 
addition reaction (or cyclization) between A and B provided the desired product C in 
79% yield and 9:1 dr on more than one-gram scale. Completion of the total synthesis of   iv 
(−)-nakadomarin A was then achieved in one or two steps from compound C. Over 500 
mg of (−)-nakadomarin A has been prepared following this route. 
Scheme 1. Total synthesis of (−)-nakadomarin A. 
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Chapter 1  
(−)-Nakadomarin A and the Manzamine Alkaloids 
 
I. Isolation and Biological Activity 
      Since the isolation of manzamine A
1 in 1986, the manzamine family of alkaloids have 
been  enriched  continuously  by  the  discovery  of  new  compounds  with  unprecedented 
molecular  architectures.  Members  of  the  family  include  simple  macrocyclic  3-
alkylpyridinium  salts,  such  as  cyclostellettamine  A  (1),  and  highly  elaborated  and 
complex structures, such as manzamine A (5) and sarain A (7) (Figure 1.1).
2   
 
Figure 1.1. Selected alkaloids from the manzamine family. 
 
 
                                                 
1 Sakai, R.; Higa, T.; Jefford, C. W.; Bernardinelli, G. J. Am. Chem. Soc. 1986, 108, 6404–6405. 
2 Duval, R.; Poupon, E. in Biomimetic Organic Synthesis, Poupon E.; Nay, B. (eds.), Chapter 6, Wiley-
VCH, 2011. 
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2 
      Kobayashi and coworkers reported the isolation of (−)-nakadomarin A (6) from an 
Okinawan marine sponge Amphimedon sp. in 1997.
3 Its novel structure constituting an 
8/5/5/5/15/6 ring system was elucidated by extensive spectroscopic analysis. The relative 
stereochemistry  was  deduced  from  the  NOE  correlation  data  and 
1H  NMR  coupling 
constants. The first total synthesis of nakadomarin A
4 gave the absolute configuration. 
      (−)-Nakadomarin  A  (6)  has  already  been  shown  exhibits  a  range  of  therapeutic 
activities, such as anticancer (murine lymphoma L1210 cells IC50 = 1.3 µg/mL, CDK4 
IC50 = 9.9 mg/mL), antifungal (against Trichophyton mentagrophytes, MIC 23 µg/mL), 
and  antibacterial  (against  Corynebacterium  xerosis,  MIC  11  µg/mL).  No  further 
investigation on the biological activity has been reported since its isolation. 
 
II. Biosynthesis 
      Although  the  exact  biosynthetic  path  to  the  manzamine  alkaloids  was  unclear,
1 
Baldwin devised a biosynthetic proposal of the manzamine alkaloids (Scheme 1.1).
5 A 
transannular  Diels-Alder  reaction  of  3-alkylpyridinium  derivative  8  would  generate 
polycyclic  compound  9,  subsequent  reduction  of  9  would  afford  natural  product 
keramaphidin B 2.
6 Redox reaction of 2 or 9 would afford iminium species 10 and further 
hydrolysis will lead to aminoaldehyde 11. A transannular allylic amination is reasoned to 
                                                 
3  Kobayashi, J.; Watanabe, D.; Kawasaki, N.; Tsuda, M. J. Org. Chem. 1997, 62, 9236–9239.  
4 Nagata, T.; Nakagawa, M.; Nishida, A. J. Am. Chem. Soc. 2003, 125, 7484–7485.  
5 (a) Baldwin, J. E.; Whitehead, R. C. Tetrahedron. Lett. 1992, 33, 2059. (b) Baldwin, J. E.; Claridge, T. D. 
W.; Culshaw, A. J.; Heupel, F. A.; Lee, V.; Spring, D. R.; Whitehead, R. C.; Boughtflower, R. J.; Mutton, 
I. M.; Upton, R. J. Angew. Chem. Int. Ed. 1998, 37, 2661. (c) Baldwin, J. E.; Claridge, T. D. W.; Culshaw, 
A. J.; Heupel, F. A.; Lee, V.; Spring, D. R.; Whitehead, R. C. Chem. Eur. J. 1999, 5, 3154. 
6 (a) Tsuda, M.; Inaba, K.; Kawasaki, N.; Honma, K.; Kobayashi, J. Tetrahedron Lett. 1996, 52, 2319 and 
references cited therein. (b) Kong, F.; Andersen, R. J. Tetrahedron 1995, 51, 2895.  
 
3 
complete the polycyclic skeleton of manzamine alkaloid to generate the natural product 
ircinal 4.  
Scheme 1.1. Proposed biosynthesis of manzamine alkaloids by Baldwin. 
 
 
            To  verify  the  feasibility  of  his  proposed  biosynthesis,  Baldwin  reported  a 
biomimetic synthesis of keramaphidin B 2 (Scheme 1.2).
5 Oxidation of bisamine 12 with 
mCPBA, followed by treatment with trifluoroacetic anhydride generated diiminium 13. 
Tautomerization of 13 under buffered neutral conditions gave 8, which underwent an 
intramolecular Diels-Alder reaction to give iminium 9. Reduction of 9 with NaBH4 gave 
natural product keramaphidin B 2 in low yield. The major product (60-85%) was the 
recyclable bis-tetrahydropyridine 12. 
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Scheme 1.2. Biomimetic synthesis of keramaphidin B 2. 
 
      Marazano later modified Baldwin’s biosynthesis proposal as illustrated in Scheme 
1.3.
7 He argued that Zincke aldehdye 14 could undergo a Diels-Alder reaction (path A or 
B) to give 11 or 16. Subsequent oxidation would generate natural product ircinal 4. 
Scheme 1.3. Modified biosynthetic proposal by Marazano. 
 
                                                 
7 (a) Kaiser, A.; Billot, X.; Gateau-Olesker, A.; Marazano, C.; Das, B. J. Am. Chem. Soc. 1998, 120, 8026–
8034; (b) Wypych, J.; Nguyen, T.; Nuhant, P.; Benechie, M.; Marazano C. Angew. Chem. Int. Ed. 2008, 47, 
5418 –5421. 
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5 
      Kobayashi put forth a biosynthetic proposal for (−)-nakadomarin A 6 from ircinal A 4 
(Scheme  1.4).
8 A  retro-Mannich  reaction  of  4  could  generate  iminium  18.  σ-Bond 
rotation  and  a  subsequent  vinylogous  Mannich  reaction  would  give  20.  A  final 
cyclodehydration reaction would generate (−)-nakadomarin A 6. 
Scheme 1.4. Proposed biosynthesis of (−)-nakadomarin A 6. 
 
 
III. Previous Total Syntheses of (−)-Nakadomarin A 
      The unique and complex structure of (−)-nakadomarin presents a great challenge to 
the synthetic organic chemists. New synthetic methodologies and strategies had been 
developed for its total synthesis. To date, six groups have reported their total syntheses of 
(−)-nakadomarin A and/or its enantiomer (+)-nakadomarin A. 
1. The Nishida Synthesis (I) 
      Nishida and co-workers reported the first total synthesis of (+)-nakadomarin A 30 in 
2003 (Scheme 1.5).
4 The synthesis commenced from chiral carboxylic acid 21, which 
                                                 
8 Kobayashi, J.; Tsuda, M.; Ishibashi, M. Pure. Appl. Chem. 1999, 71, 1123–1126. 
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6 
was  obtained  in  optically  pure  form  by  resolution  with  cinchonine.  Acid  21  was 
transformed  into  the  unsaturated  ester  22  and  an  intramolecular  conjugate  addition 
afforded the bicyclic lactam 23 in modest diastereoselectivity. A Suzuki coupling with 24 
incorporated the furan moiety into the molecule, and a followed hydrogenation reaction 
Scheme 1.5. Nishida’s total synthesis of (+)-nakadomarin A. 
 
Reagents  and  conditions:  (a)  BnNH2,  WSC•HCl,  HOBt,  91%;  (b)  cat.  OsO4,  NMO;  (c)  NaIO4;  (d) 
Ph3PCHCO2Et; (e) DBU, EtOH; (f) 2 N NaOH; (g) AcCl, EtOH, 54% (8 steps); (h) LiBH4, 99%; (i) 70% 
HClO4,  91%;  (j)  DHP,  cat.  CSA,  91%;  (k)  i)  LiN(TMS)2,  THF,  -78°C,  ii)  PhNTf2,  87%;  (l)  24, 
PdCl2(dppf),  K3PO4,  80°C,  95%;  (m)  i)  H2,  10%  Pd-C,  71%,  ii)  PPTS,  EtOH,  iii)  separation  of 
diastereomers, (iv) DHP, cat. CSA, 69%; (n) LiBH4, 99%; (o) Li, liq. NH3; (p) PhSO2Cl, aq NaHCO3, 80% 
(2 steps); (q) (Boc)2O, Et3N, cat. DMAP, 98%; (r) DIBAL-H; (s) Ac2O, pyridine, 80% (2 steps); (t) p-
TsOH; (u) 1 N HCl, 87% (2 steps); (v) 2-nitrophenylselenocyanate, n-Bu3P; (w) mCPBA, aq K2HPO4; (x) 
TFA; (y) 5-hexenoic acid, WSC•HCl, HOBt, 73% (4 steps); (z) Grubbs 2
nd generation catalyst (20 mol %), 
2 mM, 50 °C, 1.5 h; (aa) 2 N NaOH, 64% (2 steps); (bb) Dess-Martin periodinane, 80%; (cc) Ph3PCH2, 
72%;  (dd)  Na,  naphthalene;  (ee)  5-hexenoic  acid,  WSC·HCl,  HOBt,  77%  (2  steps);  (ff)  Grubbs  1
st 
generation catalyst (15 mol %), 0.5 mM, 26%(Z), 44%(E); (gg) Red-Al, 86%. 
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7 
gave  25.  An  intramolecular  cyclization  of  furan  with  the  iminium  generated  the 
tetracyclic compound 26. The macrocycle and the azocine ring were both formed with 
ring closing olefin methathesis reaction. A mixture of Z/E olefins was obtained in the 
macrocyclic RCM reaction of 29 and fortunately the two isomers could be separated from 
each other. A final amide reduction generated 30. The NMR spectra of 30 matched with 
those of the natural product, but a careful comparison of the specific rotation showed that 
it was the enantiomer. The total synthesis of 30 was completed in 38 steps with the 
longest linear sequence, and it proved the structure and absolute configuration of the 
natural product. 
 
2. The Nishida Synthesis (II) 
      Following  their  first  total  synthesis  of  (+)-nakadomarin  A  30,  the  Nishida  group 
reported the first total synthesis of natural enantiomer (−)-nakadomarin A 6 in 2004.
9 
Starting from unsaturated amide 31, which was obtained from L-serine in 10 steps, a 
Diels-Alder  reaction  with  Danishefsky  diene  32  afforded  bicyclic  compound  33  with 
poor diastereoselectivity. Cycloaddition of diene 35 with singlet O2, followed by base and 
acid mediated rearrangement formed the furan ring of tetracyclic compound 36. As in the 
previous synthesis of 30, the remaining macrocycle and azocine rings were both formed 
by ring closing metathesis reactions. Separation of the macrocyclic olefin isomers and 
amide reduction completed natural product (−)-nakadomarin A 6 (Scheme 1.6). 
                                                 
9 Ono. K.; Nakagawa, M.; Nishida, A. Angew. Chem. Int. Ed. 2004, 43, 2020–2023.  
 
8 
Scheme 1.6. Nishida’s total synthesis of (−)-nakadomarin A. 
 
Reagents and conditions: (a) 32 (3.0 equiv), neat, 180 °C, 1 h; then TFA, 52% (diastereomer 35%); (b) 
NaBH4, CeCl3ﾟ7H2O, 98% (d.r.=2:1); (c) HCl, 70%; (d) TBDPSCl, imidazole; (e) Na/anthracene, 74% 
(two  steps);  (f)  O3;  then  Me2S;  (g)  N-methylanilinium  trifluoroacetate,  75%  (two  steps);  (h) 
IPh3PCH2CH2CH2CCTMS, 76%; (i) O2, halogen lamp, Rose Bengal, quant.; (j) t-BuOK; then HCl; (k) 
Dess-Martin periodinane, 90%; (l) TMSCH2MgCl, 83%; (m) BF3ﾟEt2O; (n) K2CO3, MeOH, 81% (two 
steps);  (o)  Boc2O,  DMAP,  Et3N,  93%;  (p)  DIBAL-H;  (q)  Et3SiH,  BF3ﾟEt2O,  84%  (two  steps);  (r) 
Na/naphthalene;  (s)  5-hexenoyl  chloride,  Et3N,  92%  (two  steps);  (t)  Co2(CO)8,  91%;  (u)  Grubbs  2
nd 
generation catalyst (25 mol%), 83%; (v) n-Bu3SnH, 75%; (w) TFA; (x) 5-hexenoyl chloride, Et3N, 92% 
(two steps); (y) Grubbs 1
st generation catalyst (20 mol%), 26% (Z) + 46% (E); (z) Red-Al, 92%. Bs = 
benzenesulfonyl. 
 
 
 
3. The Kerr Synthesis 
      The  Kerr  group  reported  a  total  synthesis  of  (+)-nakadomarin  A  30  in  2007,
 10 
(Scheme 1.7).
 The synthesis featured a three-component dipolar cycloaddition reaction 
                                                 
10 Young, I.; Kerr, M. J. Am. Chem. Soc., 2007, 129, 1465–1469. 
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9 
developed by their group.
 11 Cyclopropane malonate 40, hydroxylamine 41 and aldehyde 
42 underwent a Yb(OTf)3 catalyzed three-component reaction to afford product 43 in 
good yield. An intramolecular Heck reaction generated tricyclic compound 44. Reductive 
cleavage of the weak N-O bond of 44 and an intramolecular SN2 alkylation formed the  
Scheme 1.7. Kerr’s Total synthesis of (+)-nakadomarin A. 
 
Reagents and conditions: (a) 15 mol% Yb(OTf)3, 87%; (b) DIBAL-H, 87%; (c) (MeO)2P(O)CH2CO2Me, t-
BuOK, 93%; (d) Pd(PPh3)4, Ag2SO4, NEt3, 82%; (e) DDQ, 56% after 1 recycle; (f) ClC(O)(CH2)4OBn, 
NEt3, 89%; (g) 0.1 M SmI2 (5:1 ratio of double bond isomers); (h) MsCl, NEt3, DMAP; (i) t-BuOK, 65% 
(three steps); (j) NiCl2ﾟ6H2O, NaBH4, Na2CO3, 67% (14:1 diastereomers); (k) LiAlH4; (l) MsCl, NEt3, 
DMAP, 79% (two steps), 14:1 diastereomers; (m) NH3; (n) ClC(O)(CH2)4OTBDPS, NEt3, 77% (two steps); 
(o) BCl3, 71%; (p) IBX, DMSO; (q) t-BuOK, MePPh3Br, 30-45% (two steps); (r) 20 mol % Grubbs 2
nd 
generation catalyst, 84%; (s) MeOH, AcCl; (t) Dess-Martin periodinane, 70% (two steps); (u) t-BuOK, 
MePPh3Br; (v) 30 mol % Grubbs first generation catalyst, 28% E-isomer (two steps), yield for Z-isomer 
given after reduction; (w) Red-Al, 20% (three steps). 
                                                 
11 (a) Young, I.; Kerr, M. Angew. Chem. Int. Ed. 2003, 42, 3023-3026; (b) Young, I.; Kerr, M. Org. Lett. 
2004, 6, 139-141. (c) Young, I.; Williams, J.; Kerr, M.  Org. Lett. 2005, 7, 953-955.  
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pyrrolidine ring of compound 45. Double alkylation of 46 formed the piperidine ring of 
the tetracyclic compound 47. RCM reaction generated both the macrocyclic and azocine 
rings. Separation of the macrocyclic olefin isomers, followed by amide reduction gave 
(+)-nakadomarin A 30. 
 
4. The Dixon Synthesis 
      The Dixon group reported a convergent total synthesis of (−)-nakadomarin A 6 in 
2009 (Scheme 1.8).
12 The malonate Fragment 51 was prepared from the D-pyroglutamic 
acid derivative 49 in 6 steps and the nitro olefin fragment 54 was prepared in 4 steps from 
the phosphate 52. A Michael reaction of malonate 51 with nitro olefin 54 catalyzed by a 
cinchona-derived  organocatalyst  55  afforded  product  56,  which  underwent  a  three-
component  reaction
13  with  5-hexenyl-1-amine  and  formalin  to  afford  tetracyclic 
compound 57. Functional group manipulation and an acid mediated cyclization reaction 
of the pedant furan with iminium afforded pentacyclic compound 58. Macrocyclization 
via  RCM,  followed  by  separation  of  the  olefin  isomers  by  HPLC,  generated  natural 
product (−)-nakadomarin A 6. A later improvement with the Z selective RCM reaction 
afforded the natural product in higher selectivity.
14 Two additional total syntheses of 6 
with the same fragment coupling strategy were reported from the same group.
15 
                                                 
12 Jakubec, P.; Cockfield, D.; Dixon, D. J. Am. Chem. Soc. 2009, 131, 16632–16633. 
13 Jakubec, P.; Helliwell, M.; Dixon, D. J. Org. Lett., 2008, 10, 4267–4270. 
14 (a) Yu, M.; Wang, C.; Kyle, A. F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, A. H. Nature 
2011, 479, 88−93. (b) Wang, C.; Yu, M.; Kyle, A. F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, 
A. H. Chem. Eur. J. 2013, 19, 2726-2740. 
15 (a) Kyle, A. F.; Jakubec, P.; Cockfield, D. M; Cleator, E.; Skidmore J.; Dixon, D. J. Chem. Comm. 2011, 
47, 10037-10039. (b) Jakubec, P.; Kyle, A.F; Calleja, J.; Dixon, D. J. Tetrahedron Lett. 2011, 52, 6094-
6097.  
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Scheme 1.8. Dixon’s total synthesis of (−)-nakadomarin A. 
 
Reagents  and  conditions:  (a)  1-tert-butyl-1H-tetrazole-5-thiol,  NaH,  96%;  (b)  2-(4-bromobutyl)-1,3-
dioxolane, NaH, Bu4NI (cat.), 71%; (c) m-CPBA, 78%; (d) HCl, 98%; (e) Cs2CO3, 56%; (f) LHMDS, 
dimethylcarbonate, 82%. (g) NaH, BuLi, allylbromide, then 2-oxopropane-1,3-diyl diacetate, 42%; (h) HCl, 
69%; (i) (COCl)2, DMSO, Et3N, 86%; (j) MeNO2, KOH, then MsCl, Et3N, 88%. (k) organocatalyst 55 (15 
mol %), toluene, 30 °C, 8 days, 57%, 91:9 dr; (l) hex-5-enamine, (CH2O)n, 68%; (m) AIBN, Bu3SnH, 70%; 
(n) LiAlH4, then HCO2H, 86%; (o) DIBAL-H, then HCl, 41%; (p) Grubbs first-generation catalyst, (+)-
CSA, 62%, 63:37 Z/E. 
 
5. The Funk Synthesis 
      The Funk group reported a total synthesis of (−)-nakadomarin A 6 in 2010 (Scheme 
1.9).
16 Compound  60  was  obtained  from  the  D-pyroglutamic  acid  derivative  59,  and 
underwent a Knoevenagel condensation with aldehyde 61 to give compound 62. A Lewis 
acid  InCl3  catalyzed  Michael  addition/Pictet-Spengler  cyclization  reaction  sequence
17 
                                                 
16 Nilson, M. G.; Funk, R. L. Org. Lett., 2010, 12, 4912-4915. 
17 Nilson, M. G.; Funk, R. L. Org. Lett., 2006, 8, 3833–3836. 
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produced tetracyclic compound 63. Ring closing alkyne metathesis of 63 followed by 
Lindlar reduction formed macrocycle 64. Generation of the azocine ring by RCM and 
amide reduction finished the natural product 6. 
Scheme 1.9. Funk’s total synthesis of (−)-nakadomarin A. 
 
Reagents and conditions: (a) 5-heptynylamine, NaBH4; (b) methyl malonyl chloride, 66%, 2 steps; (c) 
PhCOOH, piperidine, 87%; (d) InCl3 (10 mol%), 79%; (e) KOH; H3O
+; (f) PhMe, heat, 80%, 2 steps; (g) 
(t-BuO)3WC-t-Bu (25 mol%), 77%; (h) H2, Lindlar catalyst. (i) TBAF, 80%, 2 steps; (j) IBX, DMSO; (k) 
Cp2TiCH2AlClMe2, 68%, 2 steps; (l) TFA; (m) 5-hexenoyl chloride, Et3N, 74%, 2 steps; (n) Grubbs first 
generation catalyst; (o) AlCl3, LiAlH4, 58%, 2 steps. 
 
6. The Mukai Formal Synthesis  
      The Mukai group reported a formal total synthesis of (+)-nakadomarin A 30 in 2010 
(Scheme 1.10).
18 Reductive amination of amine 65 with the D-pyroglutamic acid derived 
aldehyde 66 afforded enyne 67, which underwent a Pauson-Khand cyclization to give 
tricyclic  compound  68.  Furan  formation  and  hydrogenation  generated  tetracyclic 
compound  69.  RCM  reaction  generated  the  azocine  ring,  which  established  the 
                                                 
18 Inagaki, F.; Kinebuchi, M.; Miyakoshi, N.; Mukai, C. Org. Lett. 2010, 12, 1800-1803. 
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13 
pentacyclic  framework  of  compound  70.  70  was  transformed  into  the  diene  29,  a 
intermediate  in  Nishida  and  Kerr’s  total  synthesis  of    (+)-nakadomarin  A,  which 
completed a formal synthesis of (+)-nakadomarin A. 
Scheme 1.10. Mukai’s formal synthesis of (+)-nakadomarin A. 
 
Reagents and conditions: (a) MgSO4, MeOH, then NaBH4; (b) TsCl, pyridine, 69%; (c) Co2(CO)8; then n-
BuSMe, 60%. (d) DDQ; (e) BzCl, pyridine, 90%; (f) OsO4 (4 mol%), NMO; (g) CSA, 80%; (h) FmocCl, 
NaHCO3, 90%; (i) 10 mol% Pd/C, H2, 51%; (j) piperidine, quant.; (k) 5-hexenoyl chloride, Et3N; (l) TBAF, 
55%; (m) Dess-Martin periodinane; (n) CH2=PPh3; (o) Grubbs 2
nd generation catalyst, 84%; (p) NaOH; (q) 
IBX; (r) CH3C(N2)PO(OMe)2, K2CO3, 73%; (s) Na, naphthalene; (t) 5-hexenoic acid, EDCﾟHCl, HOBT, 
69%; (u) Lindlar catalyst, H2, 83%. 
 
7. The Zhai Synthesis 
      The most recent total synthesis of (−)-nakadomarin A 6 came from the Zhai group in 
2011 (Scheme 1.11).
19 Alkyne 72 was obtained from D-pyroglutamic acid derivative 71, 
and  coupled  with  iodide  73  to  give  enyne  74.  A  PtCl2  catalyzed  cascade  reaction 
sequence
20  of  74  afforded  tetracyclic  compound  75.  Olefin  hydroboration  and 
                                                 
19 Cheng, B.; Wu, F.; Yang, X.; Zhou, Y.; Wan, X.; Zhai H. Chem. Eur. J. 2011, 17, 12569-12572. 
20 (a) Deng, H.; Yang, X.; Tong, Z.; Li, Z.; Zhai, H. Org. Lett., 2008, 10, 1791–1793. (b) Harrison, T. J.; 
Patrick, B. O.; Dake, G. R. Org. Lett. 2007, 9, 367. 
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deoxygenation gave the tetracyclic core structure of (−)-nakadomarin A 76. Ring closing 
metathesis of diene 77 and 79 generated the azocine ring and the macrocycle. HPLC 
separation of two olefin isomers, followed by amide reduction gave natural product 6.   
Scheme 1.11. Zhai’s total synthesis of (−)-nakadomarin A. 
 
Reagents and conditions: a) propargylamineﾟHCl, TEA, NaBH4, MeOH; b) BsCl, TEA, 54% (2 steps); c) 
73, [Pd(PPh3)2Cl2], CuI, TEA, 87%; d) PtCl2, 81%; e) BH3ﾟSMe2, H2O2, NaOH, 81%; f) NaH, CS2, MeI; g) 
Bu3SnH, AIBN, 94% (2 steps); h) DIBAL-H; i)	 ﾠMePPh3Br, tBuOK, 74% (2 steps); j) ZnBr2; k) 5-hexenoyl 
chloride, TEA, DMAP; l) TBAF, 70% (3 steps); m) Grubbs second-generation catalyst (20 mol%); n) 
Swern oxidation; o) MePPh3Br, K2CO3, 18-crown-6, 70% (3 steps); p) Na, naphthalene; q) 6-bromo-1-
hexene, K2CO3, 91% (2 steps); r) Grubbs first-generation catalyst (25 mol%), CSA, Z/E about 2:1, 31%; s) 
Red-Al, 85%. 
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IV. A Macrocyclic Approach to Polycyclic Structures 
      It has been a long theme of research in the Evans group to synthesize polycyclic 
natural  products  from  acyclic  precursors,
21 in  concomitant  with  efficient  synthetic 
methodology development for acyclic stereochemical control.
22 
      A  biomimetic  total  synthesis  of  polycyclic  natural  product  (–)-FR182877  was 
reported in 2002 from Evans lab (Scheme 1.12).
21b,21c Two acyclic chiral compounds (80 
and  81),  obtained  from  two  (4R)-4-benzyl-2-oxazolidinone-mediated  boron  aldol 
reactions,
23 were  transformed  into  the  boronic  acid  (82)  and  vinyl  bromide  (83) 
respectively. A Suzuki coupling reaction united the two fragments and an intramolecular 
malonate  allylation  reaction
24 generated  the  macrocycle.  The  key  double  transannular 
Diels-Alder reaction of macrocycle 84 generated pentacyclic product 86. Conformational 
analysis  of  the  macrocycle  revealed  that  an  endo  transition  state  dictated  the  first 
diastereoselective Diels-Alder reaction which gave intermediate 85, followed by a rapid 
hetero-Diels-Alder reaction to the resultant pentacycle 86, which was further elaborated 
to the natural product (–)-FR182877 (87).   
 
 
                                                 
21 (a) (+)-Miyakolide: Evans, D. A.; Ripin, D. H. B.; Halstead, D. P.; Campos, K. R. J. Am. Chem. Soc. 
1999, 121, 6816. (b) (−)-FR182877: Evans, D. A.; Starr, J. T. Angew. Chem., Int. Ed. 2002, 41, 1787-1790. 
(c) Evans, D. A.; Starr, J. T. J. Am. Chem. Soc. 2003, 125, 13531. (d) (+)-Clavolonine: Evans, D. A.; 
Scheerer, J. R. Angew. Chem. Int. Ed. 2005, 44, 6038-6042. (e) Salvinorin A: Scheerer, J. R.; Lawrence, J. 
F.; Wang, G. C.; Evans, D. A. J. Am. Chem. Soc. 2007, 129, 8968. (f) Tetracycline intermediate: Wzorek, J. 
S.; Knöpfel, T. F.; Sapountzis, I.; Evans, D. A. Org. Lett., 2012, 14, 5840–5843. (g) Phorbol intermediate: 
Catino, A. J.; Sherlock, A.; Shieh, P.; Wzorek, J. S.; Evans, D. A. Org. Lett., 2013, 15, 3330–3333. 
22 For examples of synthetic methodologies, see: (a) aldol reaction: Evans, D. A.; Nelson, J. V.; Vogel, E.; 
Taber, T. R. J. Am. Chem. Soc., 1981, 103, 3099-3111. (b) BOX-ligand based reaction: Johnson, J. S.; 
Evans, D. A. Acc. Chem. Res., 2000, 33, 325–335. 
23 Gage, J. R.; Evans, D. A. Org. Synth. 1990, 68, 77; Evans, D. A.; Bartroli, J.; Shih, T. L. J. Am. Chem. 
Soc. 1981, 103, 2127. 
24 Phoenix, S.; Bourque, E.; Deslongchamps, P. Org. Lett. 2000, 2, 4149.  
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Scheme 1.12. Total synthesis of (–)-FR182877. 
 
 
       
      A more recent illustration of the macrocyclic approach came from the total synthesis 
of salvinorin A, a potent and selective κ opioid receptor agonist (Scheme 1.13).
5e The 
chiral  vinyl  iodide  fragment  88,  which  was  prepared  from  the  CBS  reduction,
25 was 
transformed into the vinyl magnesium bromide, and coupled with aldehyde 89 to give 90. 
The  three  chiral  centers  of  89  were  prepared  from  a  Ni(II)-(R)-BINAP  catalyzed 
                                                 
25 Corey, E. J.; Helal, C. J. Angew. Chem., Int. Ed. 1998, 37, 1986-2012 and references therein. 
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orthoester alkylation of thiazolidinethione,
26 a selective aldol addition of acetate-derived 
chiral  auxiliary,
27  and  an  (-)-N-methylephedrine-mediated  zinc  acetylide  addition 
reaction.
28  
Scheme 1.13. Total synthesis of salvinorin A. 
 
Macrolactonization of the seco-acid generated the macrocycle.
29 The key transannular 
cyclization of macrocycle 91 mediated by TBAF gave product 94 in good yield and 
diastereoselectivity. A double Michael addition via 92 was proposed for this process; 
                                                 
26 Evans, D. A.; Thomson, R. J. J. Am. Chem. Soc. 2005, 128, 10506-10507. 
27 Nagao, Y.; Fujita, E. J. Org. Chem. 1986, 51, 2391-2393. 
28 Frantz, D. E.; Fassler, R.; Carreira, E. M. J. Am. Chem. Soc. 2000, 122, 1806-1807. 
29 (a) Shiina, I.; Kubota, M.; Ibuka, R.; Tetrahedron Lett. 2002, 43, 7535-7539. (b) Shiina, I.; Kubota, M.; 
Oshiumi, H.; Hashizume, M. J. Org. Chem. 2004, 69, 1822-1830. 
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however,  an  exo-Diels-Alder  reaction  via  93  was  also  possible.  From  the  cyclization 
product 94, salvinorin A (95) was obtained in a few steps. 
      From the analysis of the two total syntheses presented above, the overall sequence of 
this macrocyclic synthetic strategy can be summarized into the following four general 
steps:  (1)  Building  the  acyclic  precursors  with  appropriate  stereochemistry.    (2) 
Generating the macrocycle. (3) Transforming the macrocycle to the polycyclic skeleton. 
(4) Further functional group manipulation to the final target. The success of this strategy 
would  rely  on  the  well-established  acyclic  stereochemical  control,
30  efficient 
macrocyclization methods,
31 and powerful conformational analysis.
32,33  
      To further extend the scope of this strategy, the Evans group initiated a program 
directed  toward  the  total  synthesis  of  polycyclic  manzamine  alkaloids,  including  (–)-
nakadomarin A
34 and manzamine A.
35 
 
                                                 
30(a)  Comprehensive  Asymmetric  Catalysis,  I-III.  Jacobsen,  E.  N.;  Pfaltz,  A.;  Yamamoto,  H.  (eds.), 
Springer, 1999. (b) Asymmetric Synthesis-the Essentials. Christmann, M.; Bräse, S. (eds), Wiley-VCH, 
2007. 
31 Some reviews on macrocyclization reactions: (a) Roxburgh, C. Tetrahedron 1995, 51, 9767-9822. (b) 
Paterson, I.; Norcross, R. D. Chem. Rev. 1995, 95, 2041-2114. (c) A. Parenty, X. Moreau, Gilles Niel, J.-M. 
Campagne Chem. Rev., 2013, ASAP; (d) A. Parenty, X. Moreau, J.-M. Campagne Chem. Rev., 2006, 106, 
911–939. (e) RCM/RCAM: Ana, G.; Pérez-Castells, J. Angew. Chem. Int. Ed. 2006, 45, 6086-6101. (f) 
Fukuyama-Mitsunobu reaction: Kan, T., Fukuyama, T. Chem. Comm., 2004, 353-359. (g) Prins reaction: 
Crane, E. A.; Scheidt, K. A. Angew. Chem. Int. Ed. 2010, 49, 8316–8326. 
32 (a) Still, W. C.; Galynker, I. Tetrahedron 1981, 37, 3981-3996. (b) Wzorek, J. S. PhD Thesis, Harvard 
University, 2012. 
33 The transannular reaction can also be subjected to catalyst-controlled conditions, e.g. the chiral Lewis 
acid catalyzed transannular Diels-Alder reaction afforded the tricyclic compound in good enantioselectivity. 
Balskus, E. P.; Jacobsen, E. N. Science 2007, 317, 1736–1740. 
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34 Aye, Y. PhD Thesis, Harvard University, 2009. 
35 (a) Weiss, A. Postdoctoral Report, Harvard University, 2011; (b) Fodor, M. Postdoctoral Report, Harvard 
University, 2012.  
Chapter 2 
First Generation Route to the Total Synthesis of (−)-Nakadomarin A 
 
I. Retrosynthetic Analysis  
       Our  first  retrosynthetic  plan  for  (–)-nakadomarin  A  (1)  features  a  cascade 
Mannich/Pictet-Spengler  reaction  sequence  to  form  rings  A  and  B  from  macrocyclic 
intermediate 3 (Scheme 2.1). The assumption behind this strategy is that the Mannich 
reaction of 3 would be reversible,
1 therefore iminium 2 (path a) could be formed and 
further cyclized to generate 1, while the other possible iminium 2’ (path b) could not 
undergo further cyclization and would regenerate 3. Compound 3 can be disassembled 
into two fragments enamine 4 and furan 5, both of similar size and complexity.  
Scheme 2.1. Retrosynthetic analysis of (–)-nakadomarin A. 
 
                                                 
1 (a) Stork, G.; Dolfini, J. E. J. Am. Chem. Soc. 1963, 85, 2872. For general reviews on Mannich reaction, 
see: (b) Comprehensive Organic Synthesis (eds. Trost, B. M.; Fleming, I.), Vol. 2, Chapter 4, Pergamon, 
Oxford, 1991. (c) Overman, L. E. Acc. Chem. Res. 1992, 25, 352-359. (d) Arend, M.; Westermann, B.; 
Risch, N. Angew. Chem., Int. Ed. 1998, 37, 1045-1070. 
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II. Results and Discussion 
1. Furan Fragment 
      The  furan  fragment  was  prepared  from  3-furancarboxaldehyde  6  (Scheme  2.2). 
Regioselective lithiation
2 of 6 and quenching with iodine gave the iodinated product with 
5:1 regioselectivity, favoring the desired product 7. The two regioisomers was separated 
by flash column chromatography and the desired iodide 7 was obtained in 50-60% yield 
on  multi-gram  scale.  Horner-Wadsworth-Emmons  olefination
3  of  7  generated  the 
unsaturated  imide  8.  Heck  cross  coupling  of  8  with  allyl  alcohol  under  Jeffery’s 
condition
4 provided aldehyde 9, which underwent a Wittig olefination reaction
5 to afford 
the desired fragment 5.  
Scheme 2.2. Preparation of furan fragment. 
 
Reagents  and  conditions:  (a)  morpholine,  n-BuLi,  THF;  s-BuLi;  I2;  58%;  (b)  Et3N,  LiCl, 
(MeO)2POCH2COXc, THF, 52%, 2 steps; (c) Pd(OAc)2, NaHCO3, (Bu)4NBr, allyl alcohol, DMF, 62%; (d) 
t-BuONa, N3(CH2)5PPh3Br, THF, 40%.  
 
                                                 
2 Lee, G. C. M.; Holmes, J. M.; Harcourt, D. A.; Garst, M. E. J. Org. Chem. 1992, 57, 3126-3131. Initial 
attempts to trap the organolithium intermediate with homoallylic or homopropargylic halides failed, only 
elimination products from the alkylhalides (diene and enyne) were obtained. 
3 (a) Horner, L.; Hoffmann, H. M. R.; Wippel, H. G. Chem. Ber. 1958, 91, 61-63. (b) Wadsworth, W. S.; 
Emmons, W. D. J. Am. Chem. Soc. 1961, 83, 1733-1738. 
4 Jeffery, T. Tetrahedron Lett. 1991, 32, 2121. 
5 (a) Wittig, G., Schollkopf, U. Chem. Ber. 1954, 97, 1318-1330. (b) Wittig, G., Haag, W. Chem. Ber. 
1955, 88, 1654-1666. (c) Chhen, A.; Vaultier, M.; Carrie, R. Tetrahedron Lett.  1989, 30, 4953–4956. 
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2. Enamine Fragment
6       
      The  enamine  fragment  was  prepared  from  pyroglutamic  acid  10  (Scheme  2.3). 
Protection of amide and carboxylic acid gave ester 11, which was then converted to 
aldehyde 12. A Wittig olefination afforded cis-olefin 13. Both benzyl and silyl protecting 
groups  were  then  removed,  and  the  alcohol  was  transformed  into  iodide  14.  An 
intramolecular N-alkylation of 14 formed the azocine ring and afforded bicyclic lactam 
15 in high yield. Unfortunately, attempted reduction of lactam 15 to enamine 4 failed, 
presumably due to the high sensitivity and over-reduction of enamine.
  
Scheme 2.3. Attepted synthesis of enamine.  
 
Reagents and conditions: (a) SOCl2, MeOH; (b) NaH, BnBr; (c) LiBH4; (d) SO3•py, DMSO, i-Pr2NEt; (e) 
NaHMDS, TBSO(CH2)5PPh3I. 68%, 5 steps; (f) Li, liq. NH3; (g) TBAF, AcOH; (h) polymer-PPh3, I2, 
imidazole, 98%, 3 steps; (i) NaH, 96%. 
 
III. Modified First Generation Route 
      Due to the difficulties in obtaining enamine fragment 4, bicyclic malonate 16 was 
chosen as an enamine surrogate, and enal 5ƹ′ as the Michael acceptor. Iminium 3 could be 
generated from semi-reduction or controlled activation of bisamide 3ƹ′ (Scheme 2.4). 
 
                                                 
6 This fragment was investigated by former graduate student Dr. Yimon Aye. A minimum of 85% ee of the 
bicyclic lactam was estimated by 
1H NMR analysis with chiral shift reagent (+)- and (−)-enantiomers of 
Eu(hfc)3 (0.6 equiv) in CDCl3. Aye, Y. PhD Thesis, Harvard University, 2009.  
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Scheme 2.4. Modified first generation retrosynthetic analysis. 
 
1. Malonate Fragment       
      Preparation of malonate 16 started from 4-vinyl-1,3-dioxolan-2-one 17. A palladium 
catalyzed  dynamic  kinetic  asymmetric  transformation
7 of  17  with  2-nitrobenzene- 
sulfonamide  18  (2-NsNH2)  afforded  key  chiral  building  block  19,  which  was  then 
enantioenriched via recrystallization. N-alkylation of 19 with 1-iodo-5-hexene generated 
20  in  high  yield.  The  primary  alcohol  was  then  transformed  into  the  triflate,
8 and 
substitution by dimethyl malonate afforded compound 21. Removal of Ns group with 
PhSH and in situ lactamization gave diene 22. Ring closing metathesis of diene 22 with 
Grubbs first generation catalyst
9 afforded the desired fragment 16 in high yield (Scheme 
2.5).  
                                                 
7 Trost, B. M.; Bunt, R. C.; Lemoine, R. C.; Calkins, T. L. J. Am. Chem. Soc. 2000, 122, 5968-5976. 
Carbonate 17 was used instead of the more expensive 3,4-epoxy-1-butene and 2-NsNH2 (18) was employed 
as a new nitrogen nucleophile instead of phthalimide to increase the overall efficiency of the route. 2-
NsNH-(CH2)4CHCH2 and 4-NsNH2 were also investigated, but gave lower ee. 
8 The corresponding iodide, tosylate are not reactive enough for this substitution reaction. 
9 RCM of substrates such as 20 and 21 failed with Grubbs first generation catalyst. Use of Grubbs second 
generation catalyst did provide the desired RCM product, however, the yield was lower than that observed 
with 22. 
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Scheme 2.5. Preparation of malonate 16. 
 
Reagents  and  conditions:  (a)  (PdC3H5Cl)2  (1  mol%),  (R,R)-DACH-naphthyl  Trost  ligand  (2.5  mol%), 
Na2CO3 (5 mol%), 83% yield, 80% ee; recrystallized to 60% yield, > 99% ee; (b) 1-iodo-5-hexene, K2CO3, 
DMF, 89%; (c) Tf2O, pyridine; (d) LiCH(CO2Me)2; (e) PhSH, K2CO3, DMF, 77% (3 steps), dr ~1:1;  (f) 
Grubbs first generation catalyst (2 × 1 mol%), DCM (2 mM), 91%, dr ~1:1. Ns = 2-nitrobenzenesulfonyl. 
 
2. Furan Fragment        
      The  enal  fragment  5ƹ′  was  prepared  from  aldehyde  7  in  five  steps.  A  Horner-
Wadsworth-Emmons  olefination  reaction  of  7  with  (MeO)2(O)PCH2CO2Me  gave 
unsaturated ester 23. Heck coupling of 23 with allyl alcohol provided aldehyde 24. Wittig 
olefination of 24 with ylide derived from BocHN(CH2)5PPh3I installed the cis-olefin, and 
subsequent redox chemistry on the ester gave enal 5ƹ′ (Scheme 2.6). 
Scheme 2.6. Preparation of enal. 
 
Reagents  and  conditions:  (a)  NaHMDS,  (MeO)2(O)PCH2CO2Me,  E/Z  >  50:1,  95%;  (b)  Pd(OAc)2, 
NaHCO3, (Bu)4NBr, allyl alcohol, 53%; (c) KHMDS, BocHN(CH2)5PPh3I, Z/E~15;1, 62%; (d) DIBAL-H, 
(80%); (e) BaMnO4, 96%. 
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3. Fragment Coupling 
       Malonate 16 and enal 5ƹ′ underwent a Michael addition reaction in the presence of 
Jørgensen–Hayashi catalyst (25) (Scheme 2.7). 
10 The Michael adduct 26 was obtained in 
good yield and good selectivity at the tertiary center, but quite surprisingly, no selectivity 
at  the  quaternary  center.  Since  the  quaternary  center  will  be  destroyed  as  planned, 
Michael adduct 26 was carried on as a mixture of diastereomers in the synthesis.  
Scheme 2.7. Fragment coupling and attempted cascade precursor synthesis. 
 
Reagents and conditions: (a) 25 (10 mol%), MeOH, 82%, dr 1:1 (C2), 10:1 (C22); (b) HC(OMe)3, HCl, 
MeOH; (c) 1,2-dichloroethane, 60 °C , 60%, (2 steps); (d) NaBH(OAc)3; (e) HCOOAc; (f) DMSO, NaCl, 
190 °C, 64% (3 steps). 
 
                                                 
10 Brandau, S.; Landa, A.; Franzen, J.; Marigo, M.; Jorgensen, K. A. Angew. Chem. Int. Ed. 2006, 45, 4305-
4309. The Michael addition reaction was first studied in a model system with Jørgensen–Hayashi catalyst. 
Good selectivity was obtained in the tertiary center, however, no selectivity was observed in the quaternary 
center. 
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Following  the  removal  of  Boc  protecting  group,  the  macrocycle  27  was  obtained  by 
imine formation; the two major diastereoisomers were separated and characterized at this 
stage. The macrocycle imine 27 was reduced and transformed into a formamide. Krapcho 
decarboxylation of the malonate gave bisamide 28 as a 1:1 mixture of rotamers. The 
transformation  of  28  into  the  cascade  precursor  2  was  investigated  with  a  variety  of 
reducing reagents. No desired product was obtained. 
 
IV. A Formal Total Synthesis of (–)-Nakadomarin A        
      Since the product from the Michael addition reaction possesses the complete carbon 
framework of the natural product, a total synthesis of (–)-nakadomarin A was developed. 
The  enal  fragment  31  with  Ns  protecting  group  on  amine  was  used  as  the  Michael 
acceptor  (Scheme  2.8).  Wittig  olefination  of  aldehyde  7  with  ylide 
Ph3PCHCONMe(OMe)
11 gave unsaturated Weinreb amide 29. Heck coupling reaction of 
29  with  allyl  alcohol  provided  aldehyde  30,  Wittig  olefination  of  the  aldehyde  and 
reduction of Weinreb amide afforded enal 31. 
Scheme 2.8. Preparation of enal 31. 
 
Reagents and conditions: (a) Ph3PCHCONMe(OMe), 88%, E/Z 12:1; (b) Pd(OAc)2, NaHCO3, (Bu)4NBr, 
allyl alcohol, DMF, 86%; (c) KHMDS, NsHN(CH2)5PPh3I, THF, 64%, Z/E~10:1; (d) DIBAL-H, 84%. 
       
      Michael reaction product 32 was obtained as a ~1:1 mixture of diastereoisomers from 
malonate 16 and enal 31 (Scheme 2.9). Aldehyde 32 was reduced to a primary alcohol by 
                                                 
11 Evans, D. A.; Kaldor, S. W.; Jones, T. K.; Clardy, J.; Stout, T. J. J. Am. Chem. Soc.  1990, 112, 7001- 
7031. 
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NaBH(OAc)3,  subsequent  Fukuyama-Mitsunobu  alkylation  with  PPh3  and  diethyl 
azodicarboxylate (DEAD) generated the macrocycle. Reduction of the malonate ester 
with  DIBAL-H  at  low  temperature  stopped  at  the  aldehyde  stage.  The  resultant  two 
diastereoisomers  were  separable  via  preparative  TLC,  and  provided  the  desired 
analytically pure aldehyde 33. The Ns group was then removed with PhSH, and reductive 
amination with NaBH(OAc)3 formed the 6-membered ring of the known compound 34.
12 
Amide activation with Tf2O, and cyclization with the furan ring, followed by NaBH4 
reduction generated the natural product (–)-nakadomarin A.   
Scheme 2.9. Formal total synthesis of (–)-nakadomarin A. 
 
Reagents and conditions: (a) 25 (15 mol%), MeOH, 77%, dr 1:1 (C2), 10:1 (C22); (b) NaBH(OAc)3; (c) 
PPh3,  DEAD; 78%, 2 steps; (d) DIBAL-H, separation of diastereomers, 30%;  (e) PhSH, K2CO3;  then 
NaBH(OAc)3, 87%; (f) see ref 11. Tf2O, 2,6-ditert-butyl-4-methylpyridine, then NaBH4, MeOH. 
 
 
 
                                                 
12 Jakubec, P.; Kyle, A.F; Calleja, J.; Dixon, D. J. Tetrahedron Lett. 2011, 52, 6094-6097. 
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V. Experimental Section 
General Information 
Reactions  in  anhydrous  solvents  were  conducted  under  an  atmosphere  of  nitrogen  or 
argon  in  glassware  that  was  flame-dried  or  oven-dried.  Analytical  thin  layer 
chromatography (TLC) was performed on EMD Reagent 0.25 mm silica gel 60 F254 
plates. Visualization was accomplished with UV light (254 nm) followed by heating after 
staining  the  plate  with  ceric  ammonium  molybdate  solution,  unless  otherwise  noted. 
Extraction and chromatography solvents were reagent grade or HPLC grade, and were 
used without further purification. Product purification was performed by flash column 
chromatography using Sorbent Technologies silica gel (40–63 µm, 230–400 mesh).  
Analytical Information  
 
Unless otherwise stated, all isolated and characterized compounds were >95% pure as 
judged  by 
1H  NMR  spectroscopic  analysis. 
1H  NMR  spectra  were  recorded  at  room 
temperature  on  a  Varian  Inova  600  spectrometer  (600  MHz),  a  Varian  Inova  500 
spectrometer (500 MHz), or a Mercury 400 spectrometer (400 MHz). 
1H NMR data are 
reported  in  the  following  format:  chemical  shift  (multiplicity,  coupling  constants, 
integration). Chemical shifts are reported in ppm with the residual solvent resonance as 
internal  standard  (7.26  ppm  for  CDCl3,  7.16  ppm  for  C6D6,  3.34  ppm  for  CD3OD). 
Multiplicity is abbreviated as follows: m = multiplet, s = singlet, d = doublet, t = triplet, q 
= quartet, quint = quintet, sext = sextet, sept = septet, oct = octet, br = broad, app = 
apparent. Proton assignments were made with the aid of 2D-COSY experiments or homo-
nuclear decoupling experiments. 
13C NMR spectra were recorded at room temperature on 
a Varian Inova 500 spectrometer (125 MHz), or a Mercury 400 spectrometer (100 MHz)  
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with broadband proton decoupling. Chemical shifts are reported in ppm with the solvent 
resonance as internal standard (77.0 ppm for CDCl3, 128.0 ppm for C6D6, 49.9 ppm for 
CD3OD).  Carbon  assignments,  when  made,  were  made  with  the  aid  of  2D-HSQC. 
Infrared spectra were recorded as thin films on NaCl plates using a Perkin Elmer 1600 
series FT-IR spectrometer at a resolution of 4 cm
–1. Optical rotations were measured on a 
Jasco DIP-181 digital polarimeter with a sodium lamp, and are reported as: [α]
T(°
C)
D XX° 
(c (g/100 mL), solvent). Melting points were measured on a MEL-TEMP
 ΙI capillary 
melting point apparatus and are uncorrected. High-resolution mass spectra were obtained 
on Jeol AX-505 or SX-102 spectrometers at the Harvard University Mass Spectrometry 
Laboratory. Analytical high performance liquid chromatography (HPLC) was performed 
on  a  Hewlett-Packard  1100  Series  HPLC  with  a  diode  array  multiple  wavelength 
detector,  or  on  an  Agilent  1100  Series  HPLC  equipped  with  a  variable  wavelength 
detector, using the indicated chiral column and eluent. 
Materials 
Tetrahydrofuran,  diethyl  ether,  toluene  and  dichloromethane  employed  as  reaction 
solvents were dried by passage through a column of activated alumina under an argon 
atmosphere.  Amine  bases  (triethylamine,  pyridine,  morpholine)  were  distilled  from 
calcium  hydride  prior  to  use.  EMD  DriSolv  dimethyl  sulfoxide  and  N,N-
dimethylformamide were used without further purification. Organolithium reagents (e.g. 
n-butyllithium, s-butyllithium, etc.) were purchased from commercial suppliers and were 
titrated prior to use by standard literature methods.  
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Experimental Procedures 
 
 
5-iodofuran-3-carbaldehyde (7).
13 To a solution of morpholine (4.40 mL, 50.5 mmol) in 
THF (375 mL) at –78 °C was slowly added a solution of n-BuLi (20.2 mL, 2.5 M in 
hexanes,  50.5  mmol)  via  syringe.  After  stirring  for  15  min  at  this  temperature,  3-
furancarboxaldehyde (4.30 mL, 49.7 mmol) was added via syringe. After stirring for 
another 15 min, s-BuLi (36.5 mL, 1.4 M in cyclohexane, 51.1 mmol) was added slowly 
via syringe. The resulting solution was stirred for 3 h at this temperature, after which time 
a solution of I2 (13.1 g, 51.6 mmol) in THF (20 mL) was added via cannula until the 
color  persisted.  Na2S2O3  (sat.)  was  added  and  the  mixture  was  warmed  to  room 
temperature.  The  solvent  was  removed  under  reduced  pressure  and  the  residue  was 
extracted with diethyl ether. The extracts were dried over Na2SO4 and concentrated. 
1H 
NMR analysis of the residue showed ~ 5:1 (C5:C2) regioselectivity. Purification by flash 
column chromatography with 2-3% EtOAc in hexanes afforded the product as an off-
white solid (6.17 g, 27.8 mmol, 56%). The product is a crystalline solid and stable for 
months when stored in a –20 °C freezer. It is less stable in solution under air, especially 
in chlorinated solvents. The isolated yield and analytical data are reported for material 
judged >95% pure as determined by 
1H NMR spectroscopy. 
1H NMR (C6D6, 600 MHz) 
δ 9.19 (s, 1H), 6.91 (s, 1H), 6.57 (s, 1H). 
13C NMR (C6D6, 125 MHz) δ 181.8, 154.6, 
131.1, 117.6, 92.1. Mp: 43–45°C. IR (C6D6 film): 3136, 2827, 2729, 1694 cm
-1. 
                                                 
13 Lee, G. C. M.; Holmes, J. M.; Harcourt, D. A.; Garst, M. E. J. Org. Chem. 1992, 57, 3126-3131. 
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(E)-methyl 3-(5-iodofuran-3-yl)acrylate (23). A solution of NaHMDS (1.35 mL, 1.0 M 
solution  in  THF,  1.35  mmol)  was  slowly  added  to  a  solution  of  5-iodo-3-
furancarboxaldehyde (0.253 g, 1.14 mmol) and trimethyl phosphonoacetate (0.28 g, 1.54 
mmol) in THF (5 mL) at –78 °C. The solution was warmed to 0 °C and stirred for 20 
min, then concentrated and extracted with diethyl ether. Filtration through silica gel and 
concentration gave the pure product as a white solid (303 mg, 1.09 mmol, 95%). 
1H 
NMR analysis showed ≥ 50:1 E/Z selectivity. The isolated yield and analytical data are 
reported for material judged >95% pure as determined by 
1H NMR spectroscopy. 
1H 
NMR (CDCl3, 400 MHz) δ 7.70 (s, 1H), 7.48 (d, J = 16.2 Hz, 1H), 6.74 (s, 1H), 6.12 (d, 
J = 16.2 Hz, 1H), 3.78 (s, 3H). 
13C NMR (CDCl3, 125 MHz) δ 167.1, 148.7, 133.3, 
125.4, 118.5, 117.9, 91.0, 51.7. Mp: 58–60 °C. IR (CH2Cl2 film): 3128, 1641 cm
-1. 
 
(E)-methyl 3-(5-(3-oxopropyl)furan-3-yl)acrylate (24).
14 To a stirring mixture of the 
iodide 23 (303 mg, 1.09 mmol), Bu4NBr (354 mg, 1.10 mmol), NaHCO3 (274 mg, 3.26 
mmol)  and  allyl  alcohol  (0.5  mL,  7  mmol,  ~  7  eq.)  in  DMF  (0.5  mL)  was  added 
Pd(OAc)2 (7.0 mg, 0.031 mmol, 2.8 mol%). The mixture was heated in an oil bath at 40 
°C for 24 h and then cooled to room temperature. Water was added and the reaction 
mixture was extracted with Et2O, the combined organic layers were washed with brine 
                                                 
14 Jeffery, T. Tetrahedron Lett. 1991, 32, 2121. 
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and  concentrated.  Purification  by  flash  column  chromatography  with  20%  EtOAc  in 
hexanes gave aldehyde 24 (120 mg, 0.58 mmol, 53%) as oil, which solidifies when stored 
in the freezer. The isolated yield and analytical data are reported for material judged 
>95% pure as determined by 
1H NMR spectroscopy. 
1H NMR (CDCl3, 600 MHz) δ 9.80 
(br s, 1H), 7.49 (s, 1H), 7.47 (d, J = 15.8 Hz, 1H), 6.21 (s, 1H), 6.07 (d, J = 15.8, Hz, 
1H), 3.74 (s, 3H), 2.94 (t, J = 7.2 Hz, 2H), 2.79 (t, J = 7.2 Hz, 2H). 
13C NMR (CDCl3, 
125 MHz) δ 200.3, 167.3, 156.0, 143.4, 134.8, 123.3, 117.1, 103.3, 51.5, 41.4, 20.5. IR 
(CH2Cl2 film): 3056, 2953, 2848, 1715, 1644, 1436 cm
-1. HRMS-ESI: calculated for 
[C11H12O4+H]
+: 209.0808; found 209.0806.  
 
5-(tert-butoxycarbonylamino)pentan-1-triphenylphosphonium  iodide.  A  solution  of 
5-amino-1-pentanol (5.01 g, 48.6 mmol) and di-tert-butyl dicarbonate (10.9 g, 50 mmol) 
in DCM (100 mL) was stirred for 3h at 0 °C to rt. A homogenous solution was obtained. 
The reaction mixture was then cooled to 0 °C, PPh3 (17 g, 64.9 mmol), imidazole (4.80 g, 
70.6 mmol) and I2 (13.6 g, 53.5 mmol) were added. After stirring 3h at 0°C, the solvent 
was removed under vacuum and the residue was extracted with diethyl ether and filtered 
through Celite. The filtrate was concentrated and filtered through silica gel and eluted 
with 50% diethyl ether in hexanes to afford the iodide, which was contaminated with 
some PPh3 and used without further purification.    
      The iodide and PPh3 (13.0 g) was refluxed in toluene (20 mL) in a 120 °C oil bath for 
5h until no iodide left, and the phosphonium salt precipitated from the solution.  The 
reaction mixture was cooled to rt, then 0 °C and filtered, the white solid product was 
washed with diethyl ether and dried under vacuum (24.5 g, 42.6 mmol, 87.7%). 
1H NMR 
H2N OH
1. Boc2O;
2. PPh3, I2, imidazole;
BocHN PPh3I
3. PPh3. 
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(CDCl3, 400 MHz) δ 7.61-7.74 (m, 15H), 4.85 (bs, 2H), 3.50 (bs, 2H), 2.96 (m, 2H), 1.60 
(m, 4H), 1.46 (m, 2H), 1.30 (s, 9H). 
13C NMR (CDCl3, 100 MHz) δ 155.85, 134.90 (d, J 
= 2.3 Hz), 133.33 (d, J = 10 Hz), 130.31 (d, J = 12 Hz), 117.63 (d, J = 85.9 Hz), 78.50, 
39.43, 28.87, 28.12, 27.05 (d, J = 16 Hz), 22.69 (d, J = 50.6 Hz), 21.74. IR (film): 3451, 
3316, 3059, 2979, 2935, 2867, 1698, 1510 cm
-1. HRMS-ESI: calculated for C28H35NO2P 
448.2400, found 448.2419. 
 
(E)-methyl  3-(5-((Z)-8-((tert-butoxycarbonyl)amino)oct-3-en-1-yl)furan-3-
yl)acrylate. To a stirring suspension of (5-((tert-butoxycarbonyl)amino)pentyl)triphenyl-
phosphonium iodide
 (215 mg, 0.374 mmol, 1.3 equiv) in THF (4 mL) at 0 °C was added 
KHMDS  (146  mg,  0.734  mmol,  2.5  equiv),  and  resulted  in  a  homogenous  dark  red 
solution. A solution of aldehyde 24 (60 mg, 0.29 mmol) in THF (4 mL) was added to the 
Wittig reagent solution via cannula. The mixture was stirred for 40 min until TLC (20% 
EtOAc  in  hexanes)  indicated  completion  of  the  reaction.  The  reaction  mixture  was 
quenched with HOAc dropwise until the color turned grey, and then was concentrated. 
The residue was dissolved in a small amount of DCM and loaded on a silica gel column; 
purification by gradient elution with 20–30% EtOAc in hexanes gave the product (67 mg, 
62%) as an oil. 
1H NMR analysis showed ~15:1 Z/E ratio. The minor isomer can be 
further removed by silica gel column impregnated with AgNO3. The isolated yield and 
analytical data are reported for material judged >95% pure as determined by 
1H NMR 
spectroscopy. IR (CH2Cl2 film): 3450, 3055, 2984, 2933, 1714, 1644, 1506 cm
-1. 
1H 
NMR (CDCl3, 600 MHz) δ 7.53 (d, J = 15.1 Hz, 1H), 7.51 (s, 1H), 6.19 (s, 1H), 6.08 (d, 
O
CHO
OMe
O
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O
O
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NHBoc
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BocHN(CH2)5PPh3I 
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J = 16.1 Hz, 1H), 5.38 (m, 2H), 4.51 (bs, 1H), 3.76 (s, 3H), 3.09 (m, 2H), 2.65 (t, J = 7.3 
Hz, 2H), 2.37 (app q, J = 6.5 Hz, 2H), 2.02 (app q, J = 6.9 Hz, 2H), 1.45 (m, 2H), 1.43 (s, 
9H), 1.33 (quint, J = 7.5 Hz, 2H). 
13C NMR (CDCl3, 125 MHz) δ 167.5, 157.9, 155.9, 
143.3, 135.3, 130.7, 128.1, 123.3, 116.8, 102.8, 79.0, 51.5, 40.4, 29.7, 28.4, 28.0, 26.8, 
26.7, 25.5. HRMS-ESI: calculated for [C21H31NO5+Na]
+ 400.2094; found 400.2096. 
 
tert-butyl ((Z)-8-(4-((E)-3-oxoprop-1-en-1-yl)furan-2-yl)oct-5-en-1-yl)carbamate (5ƹ′). 
To a solution of ester (1.48 g, 0.392 mmol) in DCM (20 mL) at –78 °C was added a 
solution of DIBAL-H (1 M in hexane, 10.0 mL, 10.0 mmol, ~ 2.5 eq.) dropwise. The 
solution was warmed to 0 °C and stirred for 30 min. Methanol (1 mL) was added to the 
solution slowly, followed by H2O (1 mL). The mixture was stirred at room temperature 
vigorously  for  30  min  and  filtered  through  Celite®.  The  filter  cake  was  rinsed  with 
excess methanol, and the combined filtrate was concentrated. The residue was purified by 
flash column chromatography with 20–30% EtOAc in hexanes, affording allylic alcohol 
(1.10 g, 0.315 mmol, 80%) as an oil. The isolated yield and analytical data are reported 
for material judged >95% pure as determined by 
1H NMR spectroscopy. IR (CH2Cl2 
film) 3454, 3008, 2980, 2934, 2861,1698, 1506 cm
-1. 
1H NMR (CDCl3, 600 MHz) δ 7.28 
(s, 1H), 6.42 (d, J = 15.6 Hz, 1H), 6.15 (s, 1H), 6.04 (dt, J = 15.6, 6.0 Hz, 1H), 5.38 (m, 
2H), 4.57 (bs, 1H), 4.23 (bs, 2H), 3.08 (bs, 2H), 2.64 (t, J = 6.9 Hz, 2H), 2.36 (m, 2H), 
2.00 (m, 2H), 1.44 (s, 9 H), 1.44 (m, 2H), 1.31 (m, 2H). 
13C NMR (CDCl3, 125 MHz) δ 
156.7, 156.0, 139.0, 130.6, 128.4, 127.8, 124.3, 121.3, 103.1, 79.1, 63.5, 40.5, 29.6, 28.4, 
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28.0, 26.8, 26.8, 25.7. HRMS-ESI: calculated for [C20H31NO4+Na]
+ 372.2145; found 
372.2128. 
      To a solution of allylic alcohol (1.10 g, 3.15 mmol) in DCM (24 mL) was added 
BaMnO4 (4.0 g, 15.6 mmol, ground into fine powder and dried overnight in the oven 
before use). The suspension was stirred at room temperature for 6 h and TLC (30% 
EtOAc/hexanes) showed complete conversion. The reaction mixture was filtered through 
packed Celite® and rinsed with excess EtOAc. The combined filtrate was concentrated 
and  the  residue  was  purified  by  flash  column  chromatography  with  30%  EtOAc  in 
hexanes, affording the enal (1.05 g, 3.02 mmol, 96%) as an oil. The isolated yield and 
analytical data are reported for material judged >95% pure as determined by 
1H NMR 
spectroscopy. IR (CH2Cl2 film): 3446, 3054, 2980, 2933, 2860, 1708, 1678, 1634,1508 
cm
-1. 
1H NMR (CDCl3, 400 MHz) δ 9.60 (d, J = 7.9 Hz, 1H), 7.62 (s, 1H), 7.34 (d, J = 
15.5 Hz, 1H), 6.37 (dd, J = 15.5, 7.9 Hz, 1H), 6.22 (s, 1H), 5.38 (m, 2H), 4.51 (bs, 1H), 
3.09 (app q, J = 6.1 Hz, 2H), 2.67 (t, J = 7.3 Hz, 2H), 2.37 (q, J = 7.2 Hz, 2H), 2.01 (q, J 
= 7.0 Hz, 2H), 1.45 (m, 2H), 1.43 (s, 9H), 1.33 (app quint, J = 7.5 Hz, 2H). 
13C NMR 
(CDCl3, 100 MHz) δ 193.4, 158.4, 155.9, 144.1, 142.9, 130.8, 128.1, 128.0, 123.5, 102.9, 
79.0,  40.4,  29.6,  28.4,  27.9,  26.8,  26.7,  25.4.  HRMS-ESI:  calculated  for 
[C20H29NO4+Na]
+ 370.1989; found 370.1983. 
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(S)-N-(1-hydroxybut-3-en-2-yl)-2-nitrobenzenesulfonamide  (19).
15  2-Nitrobenzene-
sulfonamide (2.02 g, 10 mmol), [Pd(C3H5)Cl]2 (36.5 mg, 0.1 mmol, 1.0 mol%), N,N'-
bis(2-diphenylphosphino-1-naphthoyl)-(1R,2R)-(-)-1,2-diaminocyclohexane  (202  mg, 
0.255 mmol, 2.55 mol%) and Na2CO3 (53 mg, 0.5 mmol, 5 mol%) were mixed in a round 
bottom flask and evacuated/backfilled with nitrogen for three cycles. DCM (100 mL) was 
added via syringe and the suspension was stirred for 10 min. 4-Vinyl-1,3-dioxolan-2-one 
(1.20 mL, 12.4 mmol, 1.24 eq.) was added via syringe and the mixture was stirred for 3 h, 
by which time the reaction mixture became clear and TLC (30% EtOAc in hexanes) 
showed  complete  consumption  of  2-NsNH2.  The  solution  was  loaded  on  a  silica  gel 
column, and eluted with 0–50% EtOAc in hexanes to give the product (2.27 g, 8.34 mmol, 
83%, 80% ee) as a white solid. The enantiomeric excess of the product was determined 
by HPLC: ODH column, 85:15 i-PrOH/hexanes, 1.0 mL/min, 254 nm, τ(minor) = 17.9 
min,  τ(major)  =  20.0  min.  The  optical  purity  of  the  product  was  increased  by 
recrystallization from toluene (1.70 g, 62%, >99% ee). The isolated yield and analytical 
data are reported for material judged >95% pure as determined by 
1H NMR spectroscopy. 
Mp: 95–97 °C. [α]
23
D = 79.8 (c 1.10, EtOAc). IR (CH2Cl2 film): 3361, 3054, 2987, 1543, 
1422, 1360 cm
-1. 
1H NMR (CDCl3, 600 MHz) δ 8.11 (m, 1H), 7.87 (m, 1H), 7.73 (m, 
2H), 5.81(bs, 1H), 5.67 (dddd, J = 17.0, 10.5, 6.4, 2.3 Hz, 1H), 5.17 (app d, J = 17 Hz, 
1H), 5.09 (app d, J = 10.5 Hz, 1H), 4.10 (m, 1H), 3.70 (dddd, J = 11.0, 7.0, 4.4, 2.3 Hz, 
1H), 3.63 (app dtd, J = 10.8, 5.6, 2.3 Hz, 1H), 2.00 (t, J = 6.0 Hz , 1H). 
13C NMR 
(CDCl3, 125 MHz) δ 147.8, 134.5, 133.8, 133.6, 132.8, 131.0, 125.3, 118.3, 64.9, 58.7. 
HRMS-ESI: calculated for [C10H12N2O5S+Na]
+ 295.0359; found 295.0352. 
                                                 
15 Trost, B. M.; Bunt, R. C.; Lemoine, R. C.; Calkins, T. L. J. Am. Chem. Soc. 2000, 122, 5968-5976.  
 
36 
 
(S)-N-(hex-5-en-1-yl)-N-(1-hydroxybut-3-en-2-yl)-2-nitrobenzenesulfonamide (20). A 
mixture of the nosylamide 19 (1.54 g, 5.66 mmol), 1-iodo-5-hexene (1.51 g, 7.19 mmol) 
and K2CO3 (1.58 g, 11.4 mmol) in DMF (5 mL) was heated in an oil bath at 60 °C. 
Additional  5-hexenyl-1-iodide  (0.30  g)  was  added  after  12  h.  TLC  (50%  EtOAc  in 
hexanes) and 
1H NMR analysis showed completed consumption of starting material after 
24 h. The solvent was removed under vacuum in a 60 °C oil bath, and the resulting solid 
residue was cooled and extracted with EtOAc, and then filtered through Celite®. The 
filtrate was concentrated and the residue was purified by flash column chromatography 
with 30% EtOAc in hexanes, affording the product (1.77 g, 5.00 mmol, 88%) as light 
yellow oil. The isolated yield and analytical data are reported for material judged >95% 
pure as determined by 
1H NMR spectroscopy. [α]
23
D = 38.7 (c 1.58, CHCl3). IR (CH2Cl2 
film): 3543, 3078, 2935, 1539, 1372, 1344 cm
-1. 
1H NMR (CDCl3, 500 MHz) δ 8.09 (m, 
1H), 7.69 (m, 2H), 7.62 (m, 1H), 5.74 (m, 2H), 5.25 (app d, J = 10.7 Hz, 1H), 5.19 (app 
d, J = 17.6 Hz, 1H), 5.00 (app d, J = 17.0 Hz, 1H), 4.95 (app d, J = 10.2 Hz, 1H), 4.46 
(m, 1H), 3.78 (m, 2H), 3.33 (ddd, J = 15.5, 10.5, 5.3 Hz, 1H), 3.25 (ddd, J = 15.5, 10.8, 
5.6 Hz, 1H), 2.04 (q, J = 7.0 Hz, 2H), 1.66 (m, 2H), 1.37 (quint, J = 7.6 Hz, 2H). 
13C 
NMR (CDCl3, 125 MHz) δ 147.8, 138.0, 133.5, 133.3, 132.7, 131.6, 130.6, 123.9, 119.3, 
114.6, 62.1, 61.2, 44.9, 32.9, 30.2, 25.8. HRMS-ESI: calculated for [C16H22N2O5S+Na]
+ 
377.1141; found 370.1143. 
H
N
HO
Ns
N
HO Ns
19 20
CH2CH(CH2)4-I,
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(5R)-methyl  1-(hex-5-en-1-yl)-2-oxo-5-vinylpyrrolidine-3-carboxylate  (22).  To  a 
solution of the alcohol 20 (1.77 g, 5.00 mmol) and pyridine (0.66 g, 8.35 mmol) in DCM 
(20 mL) at –78 °C was added Tf2O (1.04 mL, 6.16 mmol) dropwise via syringe. The 
solution was warmed to 0 °C and stirred for 2 h, at which time TLC (30% EtOAc in 
hexanes) showed complete consumption of starting material. The reaction mixture was 
loaded on a silica gel column and washed with DCM to give the triflate intermediate, 
which was carried to the next step without further purification or storage.  
In  a  separate  flask,  n-BuLi  (2.87  M  in  hexanes,  3.0  mL,  8.61  mmol)  was  added 
dropwise to a solution of dimethyl malonate (2.1 g, 16 mmol) in THF (10 mL) at −78 °C. 
The solution was warmed to 0 °C and transferred via cannula to a solution of the triflate 
in THF (3 mL) at 0 °C. The reaction mixture was stirred at room temperature for 30 h and 
concentrated,  filtered  through  silica  gel  and  eluted  with  EtOAc  to  give  the  malonate 
product (contained dimethyl malonate) and used without further purification. A small 
amount of malonate was purified for analytical purpose. The analytical data are reported 
for material judged >95% pure as determined by 
1H NMR spectroscopy. [α]
23
D = 49.9 (c 
1.08, CHCl3). IR (CH2Cl2 film): 3055, 2987, 1754, 1736, 1547 cm
-1. 
1H NMR (CDCl3, 
500 MHz) δ 7.94 (m, 1H), 7.66 (m, 2H), 7.57 (m, 1H), 5.72 (m, 1H), 5.60 (ddd, J = 17.0, 
10.3, 5.9 Hz, 1H), 5.14 (app d, J = 10.7 Hz, 1H), 5.10 (app d, J = 17.0 Hz, 1H), 4.98 (app 
dq, J = 17.1, 2.0 Hz, 1H), 4.93 (app d, J = 10.3 Hz, 1H), 4.41 (m, 1H), 3.73 (s, 3H), 3.72 
(s, 3H), 3.62 (app q, J = 4.9 Hz, 1H), 3.33 (ddd, J = 15.1, 11.2, 5.4 Hz, 1H), 3.10 (ddd, J 
N
HO Ns
20
N
O
O
OMe
22
1. Tf2O, pyridine; 
2. LiCH(CO2Me)2; 
3. PhSH, K2CO3. 
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= 15.1, 10.7, 4.9 Hz, 1H), 2.35 (ddd, J = 14.2, 9.3, 5.9 Hz, 1H), 2.05 (ddd, J = 14.2, 9.3, 
4.9 Hz, 1H), 2.01 (m, 2H), 1.72 (m, 1H), 1.57 (m, 1H), 1.37 (m, 2H). 
13C NMR (CDCl3, 
125 MHz) δ 169.5, 169.0, 147.9, 138.0, 134.6, 133.6, 133.1, 131.5, 130.8, 123.9, 118.8, 
114.7, 57.5, 52.6, 52.5, 47.9, 44.7, 33.0, 31.1, 30.7, 26.0. HRMS-ESI: calculated for 
[C21H28N2O8S+K]
+ 507.1198; found 507.1217. 
A mixture of malonate (from previous step), K2CO3 (2.00 g, 14.5 mmol), and PhSH (0.80 
mL, 8.0 mmol) was stirred in DMF (5 mL) at room temperature for 24 h.
16 The volatiles 
were removed by distillation at 60 °C under vacuum (~1 torr), the residue was extracted 
with EtOAc and filtered through Celite®. The filtrate was concentrated and purified by 
flash  column  chromatography  with  20–30%  EtOAc  in  hexanes,  affording  the  lactam 
product 22 (0.99 g, 79% from alcohol) as an inseparable 1:1 mixture of diastereoisomers. 
[α]
23
D −53.7 (c 2.04, CHCl3); IR (CH2Cl2 film): 3055, 2985, 1742, 1686 cm
-1. 
1H NMR 
(CDCl3, 600 MHz) δ 5.78-5.69 (m, 3H), 5.60 (app quint, J = 8.5 Hz, 1H), 5.30-5.23 (m, 
4H), 4.99-4.91 (m, 4H), 4.18 (app q, J = 7.0 Hz, 1H), 3.97 (app q, J = 7.6 Hz, 1H), 3.76 
(s, 3H), 3.75 (s, 3H), 3.56 (1H), 3.56 (dt, J = 13.5, 6.7 Hz, 1H), 3.51 (dt, J = 13.8, 7.0 Hz 
1H), 3.44 (m, 2H), 2.93-2.88 (m, 2H), 2.54 (m, 1H), 2.44 (m, 1H), 2.16 (m, 1H), 2.03 (m, 
4H), 1.94 (m, 1H), 1.44 (m, 2H), 1.34 (4H). 
13C NMR (CDCl3, 100 MHz) δ 170.7, 170.6, 
169.5,  169.3,  138.33,  138.27,  137.7,  137.2,  119.1,  118.7,  114.73,  114.67,  60.1,  59.9, 
52.61,  52.59,  47.9,  47.7,  40.8,  40.7,  33.18,  33.16,  29.8,  29.2,  26.4,  26.3,  25.9,  25.8. 
HRMS-ESI: calculated for [C14H21NO3+Na]
+ 274.1414; found 274.1424. 
                                                 
16 Kan, T., Fukuyama, T. Chem. Comm., 2004, 353-359.  
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(10aR,Z)-methyl  3-oxo-1,2,3,5,6,7,8,10a-octahydropyrrolo[1,2-a]azocine-2-
carboxylate (16). A solution of diene 22 (0.99 g, 3.94 mmol) in DCM (2.0 L, from a 
newly opened bottle, reagent grade) was gently refluxed; Grubbs 1
st generation catalyst 
(2 × 32 mg, 0.078 mmol, 2.0 mol%) was added in two portions over 5 h. The reaction 
mixture was refluxed for 20 h. 
1H NMR analysis of an aliquot showed completed reaction. 
The solution was cooled to room temperature and concentrated. The residue was purified 
by flash column chromatography with 30–50% EtOAc in hexanes, affording the known 
bicyclic product
17 (0.81 g, 92%) as a 1:1 mixture of diastereoisomers. [α]
23
D −94.1 (c 
1.22, CHCl3); IR (CH2Cl2 film): 3020, 2935, 2859, 1740, 1682, 1456, 1435 cm
-1.
1H 
NMR (CDCl3, 600 MHz) δ 5.94 (dd, J = 10.8, 8.5 Hz , 1H), 5.84 (dd, J = 10.8, 8.2 Hz, 
1H), 5.46 (dd, J = 10.8, 7.0 Hz , 1H), 5.84 (dd, J = 10.8, 6.1 Hz, 1H),, 4.45 (app q, J = 6.7 
Hz, 1H), 4.30 (app q, J = 7.3 Hz, 1H), 3.78 (s, 3H), 3.77 (s, 3H), 3.65 (dd, J = 14.0, 8.2 
Hz, 1H), 3.48 (m, 4H), 3.22 (dd, dd, J = 14.3, 8.2 Hz, 1H), 2.62 (ddd, J = 14.3, 7.6, 6.7 
Hz, 1H), 2.52 (ddd, J = 12.9, 9.0, 7.3 Hz, 1H), 2.36-2.25 (m, 2H), 2.21 (ddd, J = 12.9, 
9.0, 7.6 Hz, 1H), 2.16 (m, 2H), 2.01 (ddd, J = 12.9, 8.8, 4.9 Hz, 1H), 1.94 (m,1H), 1.84 
(m, 1H), 1.66 (m, 3H), 1.51 (m, 3H). 
13C NMR (CDCl3, 100 MHz) δ 170.2 (2C), 168.7, 
168.5, 134.0,131.8, 129.5, 128.5, 54.9, 53.9, 52.1, 48.4, 47.8, 41.1, 40.8, 30.1, 29.7, 26.9, 
26.5, 25.6, 25.0, 24.6.  
                                                 
17 Jakubec. P.; Cockfield, D.; Dixon, D.; J. Am. Chem. Soc., 2009, 131, 16632. 
N
O
O
OMe
22
N
O
O
OMe
16
Grubbs first
generation catalyst 
 
40 
 
(10aR,Z)-methyl  2-((S)-1-(5-((Z)-8-((tert-butoxycarbonyl)amino)oct-3-en-1-yl)furan-
3-yl)-3-oxopropyl)-3-oxo-1,2,3,5,6,7,8,10a-octahydropyrrolo[1,2-a]azocine-2-
carboxylate (26). A solution of malonate 16 (23 mg, 0.10 mmol), enal 5ƹ′ (41 mg, 0.12 
mmol) and (S)-(–)-α,α-diphenyl-2-pyrrolidinemethanol trimethylsilyl ether (25) (3.1 mg, 
0.010 mmol, 0.10 mol%) in MeOH (0.15 mL) was stirred at room temperature for 3 days. 
The  solution  was  concentrated  and  the  residue  was  purified  by  flash  column 
chromatography with 30–40% EtOAc in hexanes gave the product (50 mg, 88%) as an 
inseparable 1:1 mixture of diastereoisomers. IR (CDCl3 film): 3444, 3054, 2986, 2931, 
2858, 1728, 1714, 1694, 1682 cm
-1. 
1H NMR (CDCl3, 500 MHz) δ 9.56 (m, C24H, 2H), 
7.18 (s, ArH, 1H), 7.13 (s, ArH, 1H), 5.96 (s, ArH, 1H), 5.88 (s, ArH, 1H), 5.77 (m, C6H, 
2H), 5.32 (m, 1C5H, 2C15H, 2C16H, 5H), 5.18 (m, 1C5, 1H), 4.58 (br, NH, 2H), 4.26 (m, 
1C4H, 1C22H, 2H), 3.89 (dd, J = 13, 3.2 Hz, C22H, 1H). 3.75 (s, CH3O, 3H), 3.73 (s, 
CH3O, 3H), 3.69 (m, C4H, 1H), 3.45(m, 2H), 3.30 (m, 2H), 3.22 (m, 1H), 3.09 (m, 5H), 
3.02 (m, 1H), 2.81 (dd, J = 20, 3.0 Hz, 1H), 2.63 (dd, dd, J = 15.6, 8.4 Hz, 1H), 2.59-2.49 
(m, 7H), 2.35 (dd, J = 16.8, 10 Hz, 1H), 2.28 (m, 6H), 2.18 (dd, J = 16, 7.2 Hz, 1H), 2.00 
(m, 4H), 1.87 (m, 3H), 1.76 (dd, J = 16, 10 Hz, 1H), 1.68 (m, 1H), 1.58 (m, 1H), 1.50-
1.45 (m), 1.42 (s, 9H), 1.32 (m, 4H). 
13C NMR (CDCl3, 125 MHz) δ 201.02, 200.97, 
172.4, 171.0, 170.3, 169.7, 156.8, 156.2, 140.1, 139.3, 134.6, 133.0, 130.8, 130.6, 129.8, 
128.6, 128.5, 123.2, 122.9, 107.4, 105.9, 79.1, 61.1, 59.1, 54.0, 53.2, 52.9, 45.7, 44.2, 
N
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42.2, 42.0, 40.7, 35.9, 35.2, 34.2, 29.9, 28.6, 28.3, 28.2, 27.5, 27.2, 27.00, 26.95, 25.7, 
25.7, 25.5. HRMS-ESI: calculated for [C32H46N2O7+H]
+ 571.3378; found 571.3399. 
 
Macrocyclic imine 27. To a solution of Michael product 26 (25 mg, 0.044 mmol) in 
HC(OMe)3 (0.10 g, 0.9 mmol) and MeOH (0.20 g, 6.3 mmol) at 0 °C, was added AcCl 
(0.12  mL,  1.7  mmol)  dropwise.  The  solution  was  warmed  to  room  temperature  and 
stirred for 3 h, at which time TLC (50% EtOAc in hexanes) showed complete conversion 
of the starting material. The solution was then cooled to −78 °C, and excess HCl was 
removed by high vacuum over 2 h with a liquid nitrogen trap. The solvent was then 
removed under vacuum by slowly warming the cooling bath to room temperature. The 
residue was dried under high vacuum overnight and dissolved in 1,2-dichloroethane (5 
mL). The solution was heated in an oil bath at 60 °C for 8 h under nitrogen and at the end 
was concentrated to about half volume by distillation under slight vacuum at the same 
temperature. Saturated NaHCO3 was added and the solution was extracted with DCM. 
The organic phase was dried over Na2SO4 and concentrated under vacuum. Purification 
by flash column chromatography with 60−100% EtOAc in hexanes afforded two major 
macrocyclic imine products. Stereochemistry of the quaternary center is not determined. 
The isolated yield and analytical data are reported for material judged ~90% pure as 
determined by 
1H NMR spectroscopy. 
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Less polar one (6.0 mg, 31%) [α]
23
D −34.9 (c 0.68, CHCl3); IR (CHCl3 film): 3020, 
2932, 2857, 1733, 1674 cm
-1. 
1H NMR (CDCl3, 600 MHz) δ 7.32 (d, J = 8.3 Hz, C24H, 
1H), 7.16 (s, ArH, 1H), 5.92 (s, ArH, 1H), 5.75 (app q, J = 9.2 Hz, C6H, 1H), 5.37 (app q, 
J = 9.0 Hz, C15H, 1H), 5.22 (m, C5H, C16H, 2H), 4.24 (app q, J = 7.2 Hz, C4H, 1H), 4.02 
(dd, J = 12.7, 2.9 Hz, C23H, 1H), 3.79 (s, CH3O, 3H), 3.76 (m, C11H, 1H), 3.24 (bs, C10H, 
2H), 2.82 (m, C11H, 1H), 2.67 (dd, J = 12.7, 6.8 Hz, C3H, 1H) 2.64 (m, C18H, 1H), 2.49-
2.39 (m, C17H, C18H, C22H, 3H), 2.32 (td, J = 12.7, 8.3 Hz, C23H, 1H), 2.09 (m, C17H, 
1H), 1.86 (dd, J = 12.9, 8.8 Hz, C3H, 1H), 1.81-1.42 (m, C7H, C8H, C9H, C12H, C14H, 
10H), 0.65 (m, C13H, 1H), 0.12 (m, C13H, 1H). 
13C NMR (CDCl3, 125 MHz) δ 171.1, 
169.5, 162.8, 154.6, 141.1, 134.4, 131.2, 128.5, 127.4, 121.2, 109.4, 61.4, 61.0, 54.8, 
52.9,  42.0,  37.0,  36.3,  31.5,  29.4,  27.6,  27.3,  27.0,  26.9,  26.3,  24.9.  HRMS-ESI: 
calculated for [C27H36N2O4+Na]
+ 475.2567; found 475.2584. 
More polar one  (5.3 mg, 28%) [α]
23
D −75.9 (c 0.56, CHCl3); IR (CHCl3 film): 3054, 
2929, 1732, 1674 cm
-1. 
1H NMR (CDCl3, 600 MHz) δ 7.29 (d, J = 7.8 Hz, C24H, 1H), 
7.13 (s, ArH, 1H), 5.85 (s, ArH, 1H), 5.79 (“q”, J = 9.2 Hz, C6H, 1H), 5.44 (“q”, J = 9.0 
Hz, C15H, 1H), 5.39 (dd, J = 10.8, 6.8 Hz, C5H, 1H), 5.30 (td, J = 10.2, 6.6 Hz, C16H, 
1H), 3.99 (“q”, J = 6.6 Hz, C4H, 1H), 3.84 (dd, J = 12.6, 3.0 Hz, C23H, 1H), 3.72 (s, 
CH3O, 3H), 3.64 (m, C11H, 1H), 3.55 (dd, J = 13.8, 8.4 Hz, C10H, 1H), 3.30 (dd, J = 13.8, 
9.0 Hz, C10H, 1H), 2.88 (td, J = 10.8, 2.4 Hz, C11H, 1H), 2.66 (m, C23H, 1H), 2.64 (m, 
C18H, 1H), 2.53 (ddd, J = 13.8, 10.8, 2.4 Hz, C18H, 1H), 2.47 (m, C22H, 1H), 2.41 (dd, J 
= 13.6, 8.3 Hz, C3H, 1H), 2.36 (m, C17H, 1H), 2.34 (dd, J = 13.6, 5.4 Hz, C3H, 1H), 2.24 
(m, C17H, C7H, 2H), 2.05 (ddd, J = 18.0, 9.6, 2.4 Hz, C7H, 1H), 1.89-1.35 (m, C8H, C9H, 
C12H, C14H, 8H), 0.64 (m, C13H, 1H), 0.15 (m, C13H, 1H). 
13C NMR (CDCl3, 125 MHz)  
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δ 171.5, 169.8, 162.8, 155.9, 139.7, 132.7, 130.9, 129.9, 128.0, 122.3, 107.1, 61.1, 60.5, 
53.4, 52.7, 41.7, 37.9, 36.4, 32.8, 29.2, 27.9, 27.5, 27.4, 27.1, 26.7, 25.8, 25.4. HRMS-
ESI: calculated for [C27H36N2O4+Na]
+ 475.2567; found 475.2585. 
 
(Z)-2-((10aR,Z)-3-oxo-1,2,3,5,6,7,8,10a-octahydropyrrolo[1,2-a]azocin-2-yl)-15-oxa-
5-azabicyclo[12.2.1]heptadeca-1(16),10,14(17)-triene-5-carbaldehyde (28). A mixture 
of 27 (43 mg, ~1:1 mixture of diastereoisomers) and NaBH(OAc)3 (30 mg) in DCM (1 
mL) was stirred at room temperature for 30 min, then quenched with saturated K2CO3 
solution, and stirred for another 10 min. The reaction mixture was extracted with DCM, 
dried over K2CO3 and concentrated under vacuum gave the amine product (42 mg, 97% 
crude yield), which was used in next step without further purification.  
A stock solution of formic acid–acetic anhydride mixture (FAM) was made by heating a 
mixture of HCOOH (5.15 g, 112 mmol) and Ac2O (7.20 g, 70.0 mmol) at 60 °C for 2 h. 
0.25 g of this solution was added to a solution of macrocyclic amine (18.4 mg) in DCM 
(0.3 mL). The reaction mixture was stirred for 20 min at room temperature and carefully 
quenched with saturated K2CO3. The aqueous layer was extracted with DCM, organic 
fraction was dried over solid K2CO3 and concentrated under vacuum, affording the N-
formamide (18.0 mg, 92%) as a 1:1 mixture of rotamers.  
The N-formamide (18.0 mg) was mixed with NaCl (68 mg), DMSO (0.45 mL) and H2O 
(80 mg). The mixture was sealed in a vial and refluxed in a sand bath for 5 h. The solvent 
N
O
N
O
CHO
N
O CO2Me
N
O
27 28
1. NaBH(OAc)3;
2. HCOOAc; 
3.DMSO, NaCl. 
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was removed by distillation in a 100 °C oil bath under vacuum. The residue was purified 
by flash column, eluting with 1%-10% isopropanol/EtOAc, gave bisamide 28 (12.4 mg, 
72%, dr ~5:1) as a 1:1 mixture of rotamers on the N-formamide. IR (CH2Cl2 film): 2936, 
2866, 1664 cm
-1;
 1H NMR (CDCl3, 600M Hz, some diagnostic peaks) δ 8.06 (s) & 8.02 
(s), 7.12 (s) & 7.10 (s), 5.95 (s) & 5.94 (s), 5.79 (m, 1H), 5.32 (m, 1H), 5.25 (m, 1H), 
5.21 (m, 1H), 4.08 (m, 1H).
 HRMS (ESI): calculated for [C26H36N2O3+Na]
+ 447.2618; 
found 447.2615. 
 
(E)-3-(5-iodofuran-3-yl)-N-methoxy-N-methylacrylamide (29). A mixture of aldehyde 
7  (573  mg,  2.58  mmol)  and  N-methoxy-N-methyl-2-(triphenylphosphoranylidene)-
acetamide
18 (1.12 g, 3.09 mmol) in DCM (10 mL) was stirred at room temperature for 4h. 
The solution was loaded onto silica gel column directly and eluted with 30-50% EtOAc 
in hexanes to obtain the product (695 mg, 2.26 mmol, 88%). 
1H NMR (CDCl3, 400 MHz) 
δ 7.59 (s, 1H), 7.35 (d, J= 15.7 Hz, 1H), 6.67 (s, 1H), 6.57 (d, J = 15.7 Hz, 1H), 3.58 (s, 
3H), 3.12 (s, 3H). 
13C NMR (CDCl3, 100 MHz) δ 165.97, 148.27, 131.33, 125.51, 117.62, 
116.05,  90.50,  61.44,  32.04.  IR  (film):  3018,  1660,  1614,  1416,  1384,  1215  cm
-1. 
HRMS-ESI: calculated for C9H10INO3+Na 329.9598, found 329.9610. 
 
 
                                                 
18 Evans, D. A.; Kaldor, S. W.; Jones, T. K.; Clardy, J.; Stout, T. J. J. Am. Chem. Soc.  1990, 112, 7001- 
7031. 
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(E)-N-methoxy-N-methyl-3-(5-(3-oxopropyl)furan-3-yl)acrylamide (30). To a mixture 
of iodide 29 (695 mg, 2.26 mmol), Pd(OAc)2 (28 mg, 0.12 mmol), NaHCO3 (381 mg, 
4.54 mmol) under nitrogen was added allyl alcohol (0.80 mL, 11.7 mmol) and DMF (6.0 
mL). The mixture was stirred at 40 °C oil bath for 15h and no starting material was left as 
monitored by 
1H NMR analysis of an aliquot. The reaction mixture was diluted with half 
saturated brine and extracted with EtOAc. The organic extracts were combined and dried 
over Na2SO4 and concentrated. Purification by flash column chromatography with 50% 
EtOAc in hexanes afforded the product (460 mg, 1.94 mmol, 86%). 
1H NMR (CDCl3, 
400 MHz) δ 9.63 (bs, 1H), 7.36 (s, 1H), 7.35 (d, J =15.7 Hz, 1H), 6.52 (d, J = 15.7 Hz, 
1H), 6.13 (s, 1H), 3.56 (s, 3H), 3.09 (s, 3H), 2.78 (t, J = 7.0 Hz, 2H), 2.64 (t, J = 7.0 Hz, 
2H). 
13C  NMR  (CDCl3,  100  MHz)  δ  200.17,  166.5,  155.5,  142.96,  132.93,  123.42, 
114.75, 103.05, 61.33, 40.99, 31.93, 20.11. IR (film): 2968, 2938, 2901, 2826, 2730, 
1728,  1660,  1614,  1462,  1416,  1384,  1132  cm
-1.  HRMS-ESI:  calculated  for 
C12H15NOS4+H 238.1074, found 238.1098. 
 
(E)-N-methoxy-N-methyl-3-(5-((Z)-8-(2-nitrophenylsulfonamido)oct-3-en-1-
yl)furan-3-yl)acrylamide.  To  (5-(2-nitrophenylsulfonamido)pentyl)triphenyl-
phosphonium  iodide
19 (645  mg,  0.98  mmol)  at  -78  °C  was  added  THF  (7.0  mL). 
KHMDS (3.80 mL, 0.5 M in toluene) was added via syringe while keeping the reaction 
mixture with good stirring. A clear solution was obtained after 1h. Aldehyde 30 (197 mg, 
0.83 mmol) was added via cannula (1.5 mL THF + 1.5 mL THF rinse). After 1h at -78 °C, 
                                                 
19 Prepared from 5-amino-1-pentanol. (1) NsCl, Et3N, DCM; (2) PPh3, I2, DCM; (3) PPh3, CH3CN. 
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the reaction mixture was warmed to 0 °C and after 30 min was quenched with dropwise 
addition  of  HOAc  until  the  color  faded.  The  reaction  mixture  was  concentrated  and 
filtered through silica gel and washed with EtOAc. The filtrate was concentrated and 
purified by flash column chromatography with 30-50% EtOAc in hexanes to obtain the 
product (250 mg, 0.51 mmol, 64%). 
1H NMR (CDCl3, 500 MHz) δ 8.11 (m, 1H), 7.83 
(m, 1H), 7.72 (m, 2H), 7.55 (d, 1H), 7.50 (s, 1H), 6.67 (d, 1H), 6.24 (s, 1H), 5.32 (m, 3H), 
3.73 (s, 3H), 3.27 (s, 3H), 3.06 (q, J = 6.5 Hz, 2H), 2.62 (t, J = 7.3 Hz, 2H), 2.32 (q, J = 7 
Hz, 2H), 1.96 (q, J =7 Hz, 2H), 1.50 (quint, J = 7 Hz, 2H), 1.32 (quint, J = 7 Hz, 2H). 
13C 
NMR  (CDCl3,  125  MHz)  δ  167.03,  157.42,  147.92,  143.04,  133.64,  133.54,  133.43, 
132.65,  130.88,  130.09,  128.41,  125.17,  123.69,  114.77,  102.97,  61.69,  43.54,  32.34, 
28.98, 27.9, 26.36, 26.19, 25.43. IR (film): 3366, 3009, 2939, 2863, 1655, 1610, 1542, 
1418, 1363, 1170 cm
-1. HRMS-ESI: calculated for (C23H29N3O7S+H) 492.1804, found 
492.1761. 
 
2-nitro-N-((Z)-8-(4-((E)-3-oxoprop-1-en-1-yl)furan-2-yl)oct-5-en-1-yl)benzenesulfon-
amide (31). To a DCM (15 mL) solution of the Weinreb amide (113 mg, 0.23 mmol) at -
78  °C  was  added  DIBAL-H  (0.40  mmol,  1M  in  toluene).  Excess  DIBAL-H  was 
quenched with EtOAc, MeOH and H2O was added later and the solution was warmed to 
room  temperature.  The  prepicipitate  was  filtered  through  silica  gel  and  washed  with 
EtOAc. The filtrate was concentrated and purified by flash column chromatrography with 
30%  EtOAc  in  hexanes  to  obtain  the  product  (83  mg,  0.19  mmol,  84%). 
1H  NMR 
(CDCl3, 500 MHz) δ 9.59 (d, J = 8.3 Hz, 1H), 8.12 (m, 1H), 7.85 (m, 1H), 7.73 (m, 2H), 
H
N
O
Ns
CHO H
N
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O
N
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7.63 (s, 1H), 7.35 (d, J = 16 Hz, 1H), 6.37 (dd, J = 15.6, 7.8 Hz, 1H), 6.22 (s, 1H), 5.34 
(m, 2H), 5.26 (t, J = 6 Hz, 1H), 3.06 (q, J = 6.5 Hz, 2H), 2.66 (t, J = 7.3 Hz, 2H), 2.35 (q, 
J = 7 Hz, 2H), 1.98 (q, J = 7 Hz, 2H), 1.50 (quint, J = 7 Hz, 2H), 1.33 (quint, J= 7 Hz, 
2H). 
13C NMR (CDCl3, 125 MHz) δ 193.51, 158.32, 148.04, 144.2, 142.97, 133.66, 
133.5,  132.74,  131.04,  130.32,  128.36,  128.15,  125.33,  123.51,  102.97,  43.66,  29.12, 
27.89, 26.51, 26.3, 25.42. IR (film): 3349, 3008, 2935, 2860, 2734, 1673, 1634, 1596, 
1541,  1415,  1363,  1343,  1167,  1125  cm
-1.  HRMS-ESI:  calculated  for  C21H25N2O6S 
433.1428, found 433.1434. 
 
(2R,10aR,Z)-2-((S,Z)-5-((2-nitrophenyl)sulfonyl)-15-oxa-5-
azabicyclo[12.2.1]heptadeca-1(16),10,14(17)-trien-2-yl)-3-oxo-1,2,3,5,6,7,8,10a-
octahydropyrrolo[1,2-a]azocine-2-carbaldehyde (33). A mixture of malonate 16 (64 
mg, 0.29 mmol), aldehyde 31 (150 mg, 0.35 mmol) and catalyst 25 (12.3 mg, 0.038 
mmol) in MeOH (0.25 mL) was stirred at rt for 48h and was concentrated. Flash column 
chromatography with 30-50% EtOAc in hexanes gave recovered aldehyde (27 mg) and 
Michael adduct (145 mg, 0.22 mmol, 77%) as a mixture of diastereoisomers.  
      The product was dissolved in DCM (2.5 mL) and stirred with NaBH(OAc)3 (250 mg) 
overnight. The reaction mixture was filtered through silica gel and washed immediately 
with EtOAc to obtain the alcohol (150 mg).  
N
O
O
OMe
H
N
O
Ns
CHO +
N
O CHO
N
Ns
O
1. 25;
2. NaBH(OAc)3;
3. PPh3, DEAD;
4. DIBAL.
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      The alcohol was stirred with PPh3 (119 mg) in toluene (48 mL), DEAD (0.060 mL) 
was added dropwise via syringe over 10 min. After stirring another 10 min at rt, the 
reaction mixture was loaded on silica gel and flash column chromatography with 0-30-
40-50% EtOAc in hexanes to afford the macrocycle as off-white foam (111 mg, 0.173 
mmol, 78%, 2 steps).  
      To a toluene solution (1.0 mL) of macrocyclic malonate (45 mg, 0.070 mmol) at -78 
°C was added DIBAL-H (0.15 mL, 1 M in toluene) dropwise. After 50 min, the reaction 
was quenched with EtOAc. MeOH and H2O was added later and warmed to rt. After 
stirring  30  min,  the  precipitate  was  filtered  through  Celite  and  concentrated.  Flash 
column chromatography with diethyl ether afforded the product (38 mg, 0.062 mmol, 
89%). Separation of the diastereoisomers by preparative TLC with diethyl ether afforded 
the desired product 33 (13 mg, 0.021 mmol, 30%). 
1H NMR (CDCl3, 500 MHz) δ 9.52 (s, 
1H), 7.95 (m, 1H), 7.67 (m, 2H), 7.58 (m, 1H), 7.12 (s, 1H), 5.86 (s, 1H), 5.82 (app q, J = 
Hz, 1H), 5.34 (app q, J = Hz, 1H), 5.30 (m, 1H), 5.20 (m, 1H), 4.08 (app q, J = Hz, 1H), 
3.58 (q, J = Hz, 1H), 3.40 (ddd, J = Hz, 1H), 3.30 (dd, J = Hz, 2H), 3.20 (dd, J = Hz, 1H), 
3.08 (m, 2H), 2.81 (ddd, J = Hz, 1H), 2.69 (ddd, J = Hz, 1H), 2.62 (ddd, J = Hz, 1H), 2.28 
(m, 4H), 2.16 (m, 1H), 2.10 (m, 1H), 1.77-1.95 (m, 5H), 1.67 (m, 1H), 1.54 (m, 1H), 1.44 
(m, 1H), 1.22 (m, 3H), 1.08 (m, 1H). 
13C NMR (CDCl3, 125 MHz) δ 198.98, 169.73, 
157.45, 148.15, 138.51, 133.34, 132.83, 131.58, 130.9, 130.62, 129.78, 129.45, 123.99, 
123.09, 105.05, 64.29, 53.21, 48.21, 45.45, 41.32, 36.68, 29.67, 28.65, 27.6, 27.47, 26.85, 
26.71, 25.99, 25.97, 25.73, 25.47. [α]
23
D = −61.6 (c 0.81, CHCl3). IR (film): 3055, 2986, 
2934,  2868,  1730,  1676,  1546,  1422,  1374,  1265  cm
-1.  HRMS-ESI:  calculated  for 
(M+H)+ C32H40N3O7S 610.2581, found 610. 2590.   
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Lactam 34. A mixture of the aldehyde 33 (12.6 mg, 0.021 mmol), K2CO3 (20 mg, 0.14 
mmol) and PhSH (19 mg, 0.17 mmol) in CH3CN (0.20 mL) was stirred in a 50 °C oil 
bath for 30 min. the mixture was then cooled to rt and NaBH(OAc)3 (33 mg, 0.16 mmol) 
was added and stirred for 2h. The reaction was quenched with Na2CO3 (aq) and extracted 
with  DCM,  dried  over  Na2SO4  and  concentrated.  Purification  by  flash  column 
chromatography with 10% MeOH in EtOAc obtained the product (7.3 mg, 0.018 mmol, 
87%). For characterization data see compound 63 in Chapter 3. 
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Chapter 3 
Second Generation Route to the Total Synthesis of (−)-Nakadomarin A 
 
I. Retrosynthetic Analysis 
      The second generation route to (−)-nakadomarin A (1) is presented in Scheme 3.1. 
Like the first generation route, it takes advantage of Pictet-Spengler reaction of iminium 
2 to form (−)-nakadomarin A (1). However, iminium 2 would be generated by a stereo-
reinforcing alkylation of enamine 4,
1instead of Mannich reaction of iminium 3. Enamine 
4 could be formed by a conjugate addition reaction of two fragments, macrocyclic amine 
6 and α,β-unsaturated iminium 5, both of similar size and complexity.
2 
Scheme 3.1. The second-generation retrosynthetic analysis of 1. 
 
                                                 
1 Stork, G.; Brizzolara, A.; Landesman, H.; Szmuszkovicz, J.; Terrell, R. J. Am. Chem. Soc. 1963, 85, 207. 
2 Conjugate addition of nitrogen nucleophiles to unsaturated iminium: Erkkilä, A.; Majander, I.; Pihko, P. 
M. Chem. Rev. 2007, 107, 5416. 
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II. Results and Discussion 
1. Macrocyclic Amine Fragment       
      A macrolactamization approach was investigated first to prepare macrocyclic amine 
6.
 3  Aldehyde 7 was protected as dimethyl acetal, and a Heck coupling reaction with allyl 
alcohol  gave  aldehyde  8.  Wittig  olefination  of  8  with  ylide  derived  from 
BocNH(CH2)5PPh3I and acidic workup generated aldehyde 9. An acetate aldol reaction of 
9 with chiral auxiliary 10 gave alcohol 11 in high yield and diastereoselectivity.
4 The Boc 
group was removed with TFA and macrolactamization under basic conditions generated 
macrolactam 12. Unfortunately, attempted reduction of the secondary amide to amine 
failed (Scheme 3.2).  
Scheme 3.2. Macrolactamization route to macrocyclic amine fragment. 
 
Reagents and conditions: (a) Amberlyst 15, HC(OMe)3; (b) Bu4NCl, NaHCO3, allyl alcohol, Pd(OAc)2 (5 
mol%),  65%  over  2  steps;  (c)  BocNH(CH2)5PPh3I,  KHMDS,  then  HCl  (1  M),  86%,  Z/E  >15:1;  (d) 
Sn(OTf)2, N-ethylpiperidine, 10, quant., single diastereoisomer; (e) TMSOTf, Et3N then K2CO3 (aq), 74%. 
 
 
                                                 
3 Macrolactam route was developed by Dr. Simone Bonazzi. 
4 Nagao, Y.; Hagiwara, Y.; Kumagai, T.; Ochiai, M.; Inoue, T.; Hashimoto, K.; Fujita, E. J. Org. Chem. 
1986, 51, 2391-2393. 
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      On the other hand, acetate aldol reaction of 7 with 10 gave alcohol 14 in high yield 
and diastereoselectivity (Scheme 3.3).
 5 Reductive cleavage of the auxiliary provided the 
diol, which was protected as bis-silyl ether 15. Heck coupling of 15 with allyl alcohol 
gave aldehyde 16. Wittig olefination with ylide derived from NsNH(CH2)5PPh3I gave 
compound 17. Selective deprotection
6 of the primary alcohol with PPTS and Fukuyama-
Mitsunobu  alkylation
7 with  PPh3  and  DEAD  gave  macrocycle  19  in  good  yield.
8 
Structure determination of 19 was confirmed by X-ray crystallographic analysis (Figure 
3.1). Removal of Ns group with PhSH gave macrocyclic amine 6. 
Scheme 3.3. Preparation of macrocyclic amine 6. 
 
Reagents  and  conditions:  (a)  Sn(OTf)2,  N-ethylpiperidine,  10,  DCM,  97%,  dr  >  99:1;  (b)  LiBH4;  (c) 
TBSOTf, 2,6-lutidine, > 90%, 2 steps; (d) Bu4NBr, NaHCO3, allyl alcohol, Pd(OAc)2 (5 mol%), DMF, 
85%; (e) NsNH(CH2)5PPh3I, KHMDS, THF, 81%, Z/E~10:1; (f) PPTS, MeOH, 81%, one recycle; (g) 
PPh3, DEAD, toluene (5 mM), rt, 87%; (h) PhSH, K2CO3, DMF, 90%. 
 
 
                                                 
5 A combination of TiCl4/Et3N also worked for this reaction and gave aldol product 14 in 85% yield with 
30:1 dr. 
6 Crouch, R. D. Tetrahedron, 2013, 69, 2383–2417. 
7 Kan, T., Fukuyama, T. Chem. Comm., 2004, 353-359. 
8 An intermolecular double Fukuyama-Mitsunobu alkylation to generate 19 resulted in low yield (20%). 
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Figure 3.1. X-ray structure of macrocycle 19. 
 
2. Iminium Fragment
9 
      The α,β-unsaturated iminium 5
 was prepared from commercially available 4-pentyn-
1-ol 20 (Scheme 3.4). Alkyne 20 was transformed into allylic alcohol 21 in three steps 
following a literature method.
10 Alcohol 21 was then converted to trichloroacetimidate 22 
with  trichloroacetonitrile  and  DBU,  and  a  paladium  catalyzed  asymmetric  catalytic 
Overman rearrangement
11 generated chiral allylic amide 23 in 93% yield and 94% ee. 
Amide 23 was hydrolyzed to give free amine 24, and reductive amination with 5-hexenal 
provided diene 25. Ring closing metathesis of 25 with Grubbs 2
nd generation catalyst 
formed azocine 26. Removal of silyl group, oxidation of the alcohol and α-methylenation 
                                                 
9 Route was developed by Dr. Andrew Weiss and Dr. Simone Bonazzi. 
10 Marshall, J. A.; DeHoff, B. S. J. Org. Chem. 1986, 51, 863-872. 
11 Anderson, C. E.; Overman, L. E.; Watson, M. P. Org. Synth. 2005, 82, 134.  
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of aldehyde gave enal 27.
12  Removal of the Boc group with trifluoroacetic acid and in 
situ cyclization generated unsaturated iminium 5. 
Scheme 3.4. Preparation of unsaturated iminium 5. 
 
Reagents and conditions: (a) TBSCl, imidazole, 99%; (b) nBuLi, (CH2O)n, 79%; (c) Red-Al, 77%; (d) 
DBU, CH3CN, 96%; (e) (R)-COP-Cl (5 mol%), K2CO3, 93%, 94% ee; (f) NaOH, EtOH, 82%; (g) 5-
hexenal, MeOH, then NaBH4; (h) Boc2O, 70%, 2 steps; (i) Grubbs 2nd generation catatalyst, DCM, 35 °C 
75%; (j) Dess-Martin periodinane; (k) pyrrolidine, 4-(dimethylamino)benzoic acid, (CH2O)n, 85%, 2 steps; 
(l) TFA, quant.. 
 
3. Fragment Coupling
13       
      With  both  fragments  in  hand,  conjugate  addition  of  macrocyclic  amine  6  to  α,β-
unsaturated iminium 5 was then investigated (Scheme 3.5). In the presense of 1,2,2,6,6-
pentamethylpiperidine, the conjugate addition product enamine 28 was generated at low 
temperature,  however  was  unstable  to  isolation,  and  only  observed  by  the 
1H  NMR 
spectroscopy. The presence of 1,2,2,6,6-pentamethylpiperidine was crucial for the first 
conjugate  addition  reaction.  It  quenched  the  trifluoroacetic  acid  generated  from  the 
conjugate  addition,  and  prevented  the  decomposition  of  enamine  28.  No  conjugate 
                                                 
12 Erkkila, A.; Pihko, P. M. J. Org. Chem. 2006, 71, 2538-2541. 
13 This work was performed in collaboration with Dr. Simone Bonazzi. 
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addition was observed without base or with bases of weaker strength or smaller size 
(Et3N, iPr2NEt, etc.).  
Scheme 3.5. Fragment coupling and attempted enamine alkylation reaction. 
 
Reagents and conditions: (a) 5, 1,2,2,6,6-pentamethylpiperidine, CD3CN or CD2Cl2, -40 °C; (b) HOAc, HX 
(X = Cl, Br), quant.; (c) Et3N, CDCl3; (d) 0 °C (X = Cl) or -40 °C (X = Br). 
 
       
      We  then  directed  our  efforts  to  installation  of  the  leaving  group  for  the  enamine 
alkylation reaction. Macrocyclic compound 29 with a leaving group (X= Cl, Br) could be 
generated by treating 6 with HX (X= Cl, Br) in acetic acid. Under the same conditions as 
28, the conjugate addition product 30 was generated at low temperature. Unfortunately, 
when the solution was warmed up, no desired enamine alkylation product was observed. 
Instead,  N-alkylation  was  more  facile  and  formation  of  azetidine  32,  presumably  via 
intermediate 31, was observed. 32 was stable in solution, however, attempted isolation 
resulted in decomposition.  
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III. Modification of Bicyclic Iminium Fragment 
      To  avoid  formation  of  the  azetidine  32,  it  was  necessary  to  either  increase  the 
nucleophilicity  of  enamine  or  decrease  the  nucleophilicity  of  macrocyclic  nitrogen. 
Modification of the bicyclic iminium fragment was investigated first.  
    The first variant to be derived was unsaturated lactam 35, since an amide enolate is 
predicated to be a better nucleophile than the corresponding enamine. The lactam was 
prepared  from  methyl  malonate  33  in  two  steps.  Reduction  of  ester  33  with  NaBH4 
generated  primary  alcohol  34,  and  subsequent  dehydration  with  bis[α,α-
bis(trifluoromethyl)benzyloxy]diphenylsulfur (Martin’s sulfurane)
14 provided unsaturated 
lactm 35. Unfortunately, this lactam was a poor Michael acceptor, as attempted addition 
of macrocyclic amine 6 was not successful (Scheme 3.6).
15 
Scheme 3.6. Attempted addition of 6 to unsaturated lactam 35. 
 
Reagents and conditions: (a) NaBH4, MeOH; (b) Martin's sulfurane, DCM, 60%, 2 steps; (c) 6, heat or 
Lewis acid. 
 
      The  second  variant  to  our  system  was  modification  of  the  macrocyclic  nitrogen, 
specifically, the incorporation of an electron-withdrawing carbonyl group adjacent to the 
nitrogen atom, such as that shown in 39, to reduce its nucleophilicity (Scheme 3.7).       
                                                 
14 Martin, J. C.; Arhart, R. J. J. Am. Chem. Soc.1971, 93, 4327. 
15 The desired Michael adduct 36 was later prepared via reductive amination of the macrocyclic amine 6 
with the aldehyde by Dr. Simone Bonazzi. Attempted alkylation also failed in this case.  
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Scheme 3.7. Attempted enamide alkylation. 
 
Reagents and conditions: (a) LiOH, THF/H2O; (b) CF3CO2C6F5, pyridine, DMF, 99%, 2 steps;  (c) MeOTf, 
DCM; then LiEt3BH, 50-70%; (d) DMAP, DMF, 6; (e) TBAF, THF, 50%, 2 steps; (f) NaHMDS, TsCl, 
THF, 79%. 
       
      The modified enamine fragment 38 was prepared from 33 in three steps. The methyl 
ester of 33 was hydrolyzed and the resultant carboxylic acid was transformed into the 
activated  ester  37.  In  this  case  the  pentafluorophenol  ester
16 was  chosen.  Selective 
activation of the amide with MeOTf and reduction with Super-hydride
® afforded enamide 
38.
17 Coupling of 38 with macrocyclic amine 6 afforded the amide and removal of the 
silyl protecting group generated alcohol 39, a precursor for the cascade reaction. The 
alcohol of 39 was converted into a tosylate, and set the stage for nucleophilic substitution. 
Surprisingly, only the O-alkylation product 40 was obtained. The structure of 40 was 
elucidated by 1D and 2D NMR analysis and further confirmed by X-ray crystallographic 
analysis of a single crystal (Figure 3.2). 
                                                 
16 Green, M.; Berman, J. Tetrahedron Lett. 1990, 31, 5851–5852. 
17 Tsay, S.; Robl, J. A.; Hwu, J. J. Chem. Soc. Perkin. Trans. 1, 1990, 757. 
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Figure 3.2. X-ray structure of compound 40. 
 
IV. Modification of the Macrocyclic Fragment
18       
      Since modifications on the bicyclic iminium fragment did not lead to desired product, 
we decided to modify the macrocyclic fragment. Macrolactam 43 was envisioned as a 
viable  fragment,  and  either  lactam  35  or  iminium  5  could  act  as  a  suitable  Michael 
acceptor  for  43.  Further,  we  also  substituted  the  original  enamine  alkylation  with  a 
second conjugate addition (Scheme 3.8).  
                                                 
18 Part of the results from this section has been published, see: Bonazzi, S.; Cheng, B.; Wzorek, J. S.; 
Evans, D. A. J. Am. Chem. Soc. 2013, 135, 9338–9341.  
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Scheme 3.8. Retrosynthetic analysis based on modification on the macrocyclic fragment.
    
 
1. Macrolactam Fragment
19       
      Macrolactam fragment 43 was prepared from aldehyde 7. The sequence commenced 
with Z-olefination of 7, which afforded cis-unsaturated ester 44.
20 Heck coupling of 44 
with allyl alcohol under Jeffrey’s condition gave aldehyde 45. Wittig olefination of 45 
generated cis olefin 46.
21 The methyl ester of 46 was then hydrolyzed to the carboxylic 
acid  and  subsequent  removal  of  the  Boc  group  with  TFA  provided  47. 
Macrolactamization of 47 with HBTU under dilute conditions afforded macrolactam 43. 
Overall, the synthesis of 43 is 7 steps beginning from 3-furanaldehyde, and the fragment 
has been obtained on gram-scale (Scheme 3.9). 
 
 
                                                 
19 The last 3 steps were developed by Dr. Simone Bonazzi. 
20 (a) Still, W. C.; Gennari, C. Tetrahedron Lett. 1983, 24, 4405–4408. (b) Sub-stoichiometric amount of 
18-crown-6 could be used. Fürstner, A.; Nevado, C.; Waser, M.; Tremblay, M.; Chevrier, C.; Teply, F.; 
Aïssa, C.; Moulin, E.; Müller, O. J. Am. Chem. Soc. 2007, 129, 9150-9161. 
21 The reaction was run under dilute conditions (40 mM) to avoid isomerization of the cis-unsaturated ester, 
which was observed in reactions conducted at higher concentrations. 
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Scheme 3.9. Synthesis of macrolactam 43. 
 
Reagents  and  conditions:  (a)  (CF3CH2O)2POCH2CO2Me,  KHMDS,  18-crown-6,  96%,  Z/E  >  20:1;  (b) 
Bu4NCl,  NaHCO3,  Pd(OAc)2,  allyl  alcohol,  61%;  (c)  BocNH(CH2)5PPh3I,  KHMDS,  80%;  (d)  NaOH, 
MeOH, H2O; (e) TFA; (f) HBTU, Et3N, CH3CN, (2 mM), 74%, 3 steps. 
 
2. Bicyclic Lactam Fragment  
      Bicyclic lactam fragment 35 was first synthesized from corresponding malonate 33, 
however,  an  improved  synthesis  of  this  fragment  was  later  developed  as  shown  in 
Scheme  3.10.  Condensation  of  acrolein  with  (R)-tert-butyl  sulfinamide
22  gave 
unsaturated imine 49 in high yield. Allylation of 49 with commercially available ethyl 2-
(bromomethyl)acrylate  under  Barbier  conditions  afforded  homoallylic  amine  product 
50.
23 The chiral auxialiary of 50 was then removed with HCl in methanol, and basic work 
up with NaOH provided lactam 51 in good yield. Deprotonation of 51 and in situ quench 
                                                 
22 (a) Raghavan, S.; Krishnaiah, V.; Sridhar, B. J. Org. Chem. 2010, 75, 498; (b) Liu, G.; Cogan, D. A.; 
Owens, T. D.; Tang, T. P.; Ellman, J. A. J. Org. Chem. 1999, 64, 1278. 
23 Shen, A.; Liu, M.; Jia, Z.-S.; Xu, M.-H.; Lin, G.-Q. Org. Lett. 2010, 12, 5154. H2O is critical for this 
reaction.  In  the  absence  of  water,  a  mixture  of  two  products,  the  lactam  and  the  double  allylation 
production, was obtained. 
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with 1-iodo-5-hexene afforded diene 52.
24   Ring closing metathesis of 52 with Grubbs 
first generation catalyst gave desired bicyclic lactam 35, 3.5 g of which has been obtained 
by this route.  
Scheme 3.10. Improved synthesis of bicyclic lactam 35. 
 
Reagents and conditions: (a) Ti(Oi-Pr)4, 97%; (b) ethyl 2-(bromomethyl)acrylate, Zn, LiCl, H2O, DMF, 
82%, dr > 95:5; (c) HCl, MeOH; then NaOH (s), 86%; (d) NaH, 1-iodo-5-hexene, 85%; (e) Grubbs first 
generation catalyst, DCM, (2 mM), 83%. 
 
3. Fragment Coupling
25   
      With fragments 35 and 43 prepared, fragment coupling was then investigated. After 
various screening and optimization efforts, it was found that slow addition of 35 to a 
solution of pre-activated 43 (TBSOTf, iPr2NEt) in dichloroethane afforded the desired 
fragment coupling product in 79% yield and 9:1 diastereoselectivity (Scheme 3.11).
26 
Only two of the four possible product diastereomers were observed by 
1H NMR analysis 
                                                 
24 The diene 52 could also be obtained from allylation product 50 directly (NaH or KHMDS, then 1-iodo-5-
hexene), but in lower yield (40%). 
25 This fragment coupling reaction was developed by Dr. Simone Bonazzi. 
26 For double Michael addition reaction with TBSOTf/amine base, see (a) Takasu, K.; Nishida, N.; Ihara, 
M. Tetrahedron Lett. 2003, 44, 7429. (b) Takasu, K.; Nishida, N.; Tomimura, A.; Ihara, M. J. Org. Chem. 
2005, 70, 3957. (c) Ihara, M.; Takino, Y.; Tomotake, M.; Fukumoto, K. J. Chem. Soc., Perkin Trans. 1 
1990, 2287. (d) Ihara, M.; Kirihara, T.; Kawaguchi, A.; Tsuruta, M.; Fukumoto, K.; Kametan, T. J. Chem. 
Soc., Perkin Trans. 1 1987, 1719. (e) Takasu, K.; Nishida, N.; Ihara, M. Synthesis 2004, 2222. 
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of the crude reaction mixture. The two diastereomers (57 and 58) were readily separable 
via silica gel flash column chromatography.     
Scheme 3.11. Fragment coupling of 35 and 43. 
 
Reagents and conditions: (a) TBSOTf, iPr2NEt, 1,2-dichloroethane; then slow addition of 35, 79%, dr 9:1. 
 
      Both diastereomers 57 and 58 were characterized by 1D and 2D NMR spectroscopic 
analysis and their structures were further confirmed by X-ray crystallographic analysis 
(Figure  3.3).  The  structure  of  major  product  57  has  the  desired  stereochemistry 
corresponding  to  final  target  (−)-nakadomarin  A  (1),  and  addition  of  the  achiral 
unsaturated macrolactam to the less hindered convex face of the bicyclic lactam (53→55) 
generated the quaternary center. The stereochemistry of the minor diastereomer 58 was 
quite surprising. It was unexpectedly derived from the addition of the opposite face of 
achiral  unsaturated  macrolactam  to  the  more  congested  concave  face  of  the  bicyclic 
lactam (54→56).        
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                                        57                                                                        58 
Figure 3.3. X-ray structures of 57 and 58. 
 
      The  computed  energies  (B3LYP/6-31G*)  of  the  four  possible  silicon-alkylated 
product diastereomers 59–62TMS are provided in Figure 3.4.
 27  The centro-symmetric 
trimethylsilyl moiety was used in place of the analogous TBS analogue to simplify the 
computations. As with any compromise, the relative energies of 59–62TMS might under-
represent the actual energy differences between 60TBS and 61TBS, as the TBS moiety is 
more sterically demanding than its TMS counterpart. Nevertheless, the energies of these 
structures substantiate that the most stable silylated structure is 59TMS, an observation 
that is consistent with the structure of the major product diastereomer 57. It is evident that 
both of the isolated product diastereomers (57 and 58) have their respective C═O dipoles 
disposed in an anti orientation, as predicted by the computations. 
                                                 
27 Calculations were conducted by Dr. Joseph S. Wzorek.  
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Figure 3.4. Computed energies (B3LYP/6-31G*) of silylated vs. protonated products. 
 
      Calculations for the protonated product diastereomers 59−62H were also performed 
for comparison to probe the potential steric effects of the silicon substituent. The stability 
order of 59−62H is quite different than that of 59−62TMS. In this set of structures, 61H 
is the most stable diastereomer. Hence, for structures 59−62H, the computed product 
energies suggest that C−O dipole effects alone are not a major factor in determining the 
diastereomer stability, and possibly the kinetic selectivities. We thus conclude that the 
structure of the reaction promoter (TMSOTf or TBSOTf) seems to play a role in the 
observed reaction diastereoselectivity. It also appears that this reaction, first reported by 
Ihara, could well be a concerted rather than stepwise transformation. 
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4. Total synthesis of (−)-nakadomarin A
28       
      With an efficient route to pentacyclic compound 57 established, completion of the 
total  synthesis  of  our  targeted  natural  product  (−)-nakadomarin  A  (1)  was  then 
investigated (Scheme 3.12).  
Scheme 3.12. Total synthesis of (−)-nakadomarin A (1). 
 
Reagents and conditions: (a) Me3OBF4, 4 Å MS, DCM, rt, 2 h, then NaBH4, MeOH, 0 °C to rt, 76%; (b) 
Tf2O, 2,6-di-tert-butyl-4-methylpyridine, DCM, rt, 30 min, then NaBH3CN, MeOH, rt, 52%; (c) Tf2O, 2,6-
di-tert-butyl-4-methylpyridine, DCM, rt, 2 h; (d) Na2CO3 (aq); e) Red-Al, −78 to 60 °C, 3 h, 69%. 
       
      When  compound  57  was  treated  with  electrophiles  such  as  Meerwein’s  salt 
(Me3OBF4), selective reactivity at the less hindered δ-lactam was observed. Treatment of 
the activated amide intermediate with NaBH4 in methanol gave known lactam 63.
29 To 
complete the synthesis, treatment of lactam 63 using modified conditions similar to those 
reported  by  Dixon  and  co-workers  (Tf2O  and  2,6-di-tert-butyl-4-methylpyridine), 
                                                 
28 The two-step procedure was developed by Dr. Simone Bonazzi. 
29 Jakubec, P.; Kyle, A.F; Calleja, J.; Dixon, D. J. Tetrahedron Lett. 2011, 52, 6094-6097. Also compound 
34 in Chapter 2. 
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facilitated the activation of the γ-lactam, and cyclized with the furan to afford iminium 
intermediate.  Subsequent  reduction  using  NaBH3CN  afforded  (−)-nakadomarin  A  (1). 
The spectra data for synthetic (−)-nakadomarin A matched with the reported literature 
data  (
1H  and 
13C  NMR,  HRMS,  IR,  and  optical  rotation).
30 A  single  crystal  of  the 
hydrochloride salt of (−)-nakadomarin A was obtained by slow diffusion of diethyl ether 
vapor  to  its  2-propanol  solution  (mp  >  260  °C),  and  X-ray  crystallographic  analysis 
confirmed the structure (Figure 3.5). 
      A one-pot procedure to convert 57 to (−)-nakadomarin A was later developed. When 
57 was activated with the stronger electrophile Tf2O, in the presence of 2,6-di-tert-butyl-
4-methylpyridine,
31 a  complete  and  clean  cyclization  reaction  took  place  rapidly  as 
observed by 
1H NMR. The disappearance of the furan 2-H peak (δ 7 ppm) indicated 
cyclization  of  the  furan  with  the  activated  amide.  Aqueous  work-up  of  the  reaction 
mixture with Na2CO3 (aq) gave iminium 65. Alternatively, addition of a reducing reagent 
to the reaction mixture would afford  (−)-nakadomarin A directly. After screening of a 
variety  of  reducing  agents,  Red-Al  was  found  to  give  the  best  results  and  (−)-
nakadomarin A (1) was obtained in 70% yield from 57.  
 
      In conclusion, total synthesis of (−)-nakadomarin A was completed in 9 steps (longest 
linear sequence, 14 steps in total) from 3-furaldehyde with 10% overall yield. More than 
500 mg  (−)-nakadomarin A has been prepared following this route. 
                                                 
30 See the experiment section for the full characterization of synthetic (−)-nakadomarin A, and Appendix II 
for spectra comparison with the literature data. 
31 In the absence of base, the reaction was very slow and the reaction was not clean.  
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Figure 3.5. X-ray structure of (−)-nakadomarin A•2HCl. 
 
V. Fragment Coupling with Iminium 
      With the success of bicyclic lactam fragment 35 in the cascade reaction leading to 
(−)-nakadomarin A, iminium fragment 5 was also investigated as a means to access the 
natural product. Iminium 5 was originally prepared in 12 steps, however, a more step-
economical synthesis was developed, in a way similar to that of bicyclic lactam 35. 
 
1. Iminium Fragment 
      The allylation reagent 68 was prepared in accordance with literature precedent from 
commercially available 2-bromopropenal diethylacetal 66.
32 A lithium-halogen exchange 
reaction  of  66  with  n-BuLi,  followed  by  transmetalation  with  CuBrﾟSMe2  generated 
                                                 
32 Kolodney, G.; Sklute, G.; Perrone, S.; Knochel, P.; Marek, I. Angew. Chem., Int. Ed. 2007, 46, 9291.  
 
68 
vinyl  cuprate  67.  Homologation  of  vinyl  cuprate  with  zinc  carbenoid  Zn(CH2I)2
33 
generated allylzinc reagent 68 (Scheme 3.13).   
Scheme 3.13. Preparation of allylzinc reagent. 
 
Reagents and conditions: (a) n-BuLi; (b) CuBr•SMe2; (c) Zn(CH2I)2. 
 
      Treatment of the in situ derived allylzinc 68 with imine 49 generated homoallylic 
amine derivative 69 (Scheme 3.14).
34 N-alkylation furnished diene 70, and treatment with 
TsOH gave iminium 71. Attempted ring closing metathesis of iminium 71 only resulted  
Scheme 3.14. Synthesis of iminium 5. 
   
Reagents and conditions: (a) 68; (b) NaH, 1-iodo-5-hexene, DMF, 52%, 2 steps, dr > 10:1; (c) TsOH, 
MeOH, quant.; (d) oxalic acid (aq), THF, 94%; (e) Hoveyda-Grubbs 2
nd generation catalyst (20 mol%), 
toluene, 110 °C, 66%; (f) TsOH, MeOH, quant.. 
 
                                                 
33 Sidduri, A. R.; Rozema, M. J.; Knochel, P. J. Org. Chem. 1993, 58, 2694. Generated from CH2I2 and 
Et2Zn in a separated flask and then transferred into the vinyl cuprate solution.  
34 In the absence of other electrophiles, the allylzinc will further react with Zn(CH2I)2 to give the double 
methylene insertion product. Marek, I. Tetrahedron 2002, 58, 9463. 
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in decomposition. On the other hand, hydrolysis of acetal 70 with oxalic acid
35 provided 
the  corresponding  unsaturated  aldehyde.  Subsequent  ring  closing  metathesis  with  the 
second generation Grubbs-Hoveyda catalyst afforded desired product 72. The targeted 
iminium 5 was obtained by treating compound 72 with TsOH in methanol.  
      Slow addition of iminium 5 to a solution of pre-activated macrolactam 43 provided 
the fragment coupling products 73 and 74.
36  The reaction is highly dependent on the 
counteranion of iminium 5. BARF gave good yield, but poor selectivity, while TFA gave 
enhanced  selectivity,  but  with  lower  yield.  The  reaction  with  tosylate  anion  is  under 
investigation. Reduction of 73 with LiAlH4 afforded (−)-nakadomarin A.  Reduction of 
74 gave epi-nakadomarin 75, which is the same as that obtained from 58 (Scheme 3.15). 
Sheme 3.15. Cascade reaction with iminium 5. 
 
Reagents  and  conditions:  (a)  TBSOTf,  N-methyl  morpholine,  1,2-dichloroethane,  then  5,  50  °C;  (b) 
LiAlH4, THF. 
                                                 
35 Caine, D.; Venkataramu, S. D.; Kois, A. J. Org. Chem. 1992, 57, 2960-2963. 
36 Experiments were performed by Dr. Simone Bonazzi. 
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VI. Experimental Section 
 
(R)-3-hydroxy-3-(5-iodofuran-3-yl)-1-((S)-4-isopropyl-2-thioxothiazolidin-3-
yl)propan-1-one  (14).  N-ethylpiperidine  (1.75  mL,  12.7  mmol)  was  added  to  a 
suspension of Sn(OTf)2 (5.25 g, 12.6 mmol) in DCM (20 mL) at –45 °C with a dry 
ice/acetone cooling bath. The mixture was stirred for 15 min, then a solution of 3-acetyl-
4-(S)-isopropyl-1,3-thiazolidine-2-thione
37 (2.24  g,  11.0  mmol)  in  DCM  (5  mL)  was 
added via syringe, with a DCM (5 mL) rinse. The mixture was stirred for 3 h at –30 to –
20 °C to form the tin(ΙΙ) enolate, then cooled to –78 °C. 5-Iodo-3-furancarboxaldehyde 
(1.87 g, 8.42 mmol) in DCM (5 mL) was added via syringe, with a DCM (3 mL) rinse. 
The reaction mixture was stirred for 4 h, quenched with pH=7 phosphate buffer solution, 
and extracted with DCM. The organic extracts were dried over Na2SO4 and concentrated. 
The  residue  was  purified  by  flash  column  chromatography  with  0–30%  EtOAc  in 
hexanes  to  afford  the  acetate  aldol  product  (3.46  g,  8.14  mmol,  97%)  as  a  single 
diastereoisomer. The isolated yield and analytical data are reported for material judged 
>95% pure as determined by 
1H NMR spectroscopy. 
1H NMR (CDCl3, 500 MHz) δ 7.47 
(s, 1H), 6.54 (s, 1H), 5.11 (m, 2H), 3.72 (m, 1H), 3.48 (m, 2H), 3.36 (br s, 1H), 3.01 (d, J 
= 11.7 Hz, 1H), 2.31 (m, 1H), 1.03 (d, J = 6.8 Hz, 3H), 0.95 (d, J = 7.3 Hz, 3H). 
13C 
NMR (CDCl3, 125 MHz) δ 202.9, 171.8, 143.9, 130.4, 118.9, 88.9, 71.2, 62.8, 45.5, 
30.64, 30.59, 18.9, 17.7. [α]
23
D = 222.3 (c 0.98, CHCl3). IR (CDCl3 film): 3447, 3132, 
                                                 
37 Nagao, Y.; Hagiwara, Y.; Kumagai, T.; Ochiai, M.; Inoue, T.; Hashimoto, K.; Fujita, E. J. Org. Chem. 
1986, 51, 2391-2393. 
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2963, 2874, 1694, 1472 cm
-1. HRMS-ESI: calculated for [C13H16INO3S2+Na]
+ 447.9508; 
found 447.9506. 
 
To a solution of acetate aldol product (3.46 g, 8.14 mmol) in DCM (50 mL) at –78 °C 
was added 2,6-lutidine (2.0 mL, 17 mmol) and TBSOTf (3.0 mL, 13 mmol) sequentially. 
The mixture was stirred for 1.5 h and TLC (20% EtOAc in hexanes) showed completion 
of the reaction. The mixture was warmed to 0 °C, quenched with pH=7 phosphate buffer 
solution, extracted with DCM and dried over Na2SO4. Flash column chromatography 
with 0–20% EtOAc in hexanes provided the silyl ether as a light yellow solid (4.20 g, 
7.78 mmol, 95%). The isolated yield and analytical data are reported for material judged 
>95% pure as determined by 
1H NMR spectroscopy. Mp: 69–71 °C. [α]
23
D = 227.3 (c 
1.07, CHCl3). IR (CDCl3 film): 2956, 2855, 1694, 1470 cm
-1. 
1H NMR (CDCl3, 500 
MHz) δ 7.43 (s, 1H), 6.54 (s, 1H), 5.25 (dd, J = 8.5, 4.1 Hz, 1H), 5.04 (ddd, J = 7.3, 6.1, 
0.9 Hz, 1H), 3.82 (dd, J = 17.0, 8.5 Hz, 1H), 3.48 (dd, J = 11.4, 7.9 Hz, 1H ), 3.28 (dd, J 
= 16.7, 4.1 Hz, 1H), 3.03 (dd, J = 11.4, 1.2 Hz, 1H), 2.34 (m, 1H), 1.04 (d, J = 7.0 Hz, 
3H), 0.96 (d, J = 6.7 Hz, 3H), 0.83 (s, 9H), 0.04 (s, 3H), -0.05 (s, 3H). 
13C NMR (CDCl3, 
125 MHz) δ 202.8, 170.8, 143.9, 131.9, 119.3, 88.4, 71.6, 64.1, 47.5, 30.9, 30.7, 25.7, 
19.1, 18.0, 17.8, -4.6, -5.1. HRMS-ESI: calculated for [C19H30INO3S2Si+Na]
+ 562.0373; 
found 562.0346. 
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A solution of LiBH4 (5 ml, 2.0 M solution in THF, 10 mmol) was added to a stirred 
solution of TBS ether (1.38 g, 2.56 mmol) in DCM/MeOH (11 mL, 10:1) at 0 °C. The 
reaction was quenched with saturated NaHCO3 after 1 h. The aqueous layer was extracted 
with DCM and the combined organic layers were dried over Na2SO4. The solution was 
concentrated and the crude product was used without further purification. The isolated 
yield and analytical data are reported for material judged >95% pure as determined by 
1H 
NMR spectroscopy. [α]
23
D = 51.1 (c 1.01, CHCl3). IR (neat): 3364, 3134, 2953, 2885, 
2858, 1472 cm
-1. 
1H NMR (CDCl3, 500 MHz) δ 7.40 (s, 1H), 6.47 (s, 1H), 4.91 (dd, J = 
6.4, 4.4 Hz, 1H), 3.75 (ddd, J = 11.2, 7.8, 4.4 Hz, 1H), 3.65 (m, 1H), 2.14 (bs, 1H), 1.95-
1.81 (m, 2H), 0.88 (s, 9H), 0.07 (s, 3H), -0.04 (s, 3H). 
13C NMR (CDCl3, 125 MHz) δ 
143.8, 132.1, 119.0, 88.4, 66.5, 59.7, 40.7, 25.7, 18.0, -4.8, -5.2. HRMS-ESI: calculated 
for [C13H23IO3Si+Na]
+ 405.0353; found 405.0354. 
 
(R)-5-(5-iodofuran-3-yl)-2,2,3,3,9,9,10,10-octamethyl-4,8-dioxa-3,9-disilaundecane  
(15). To a solution of the above product in DCM (10 mL) at 0 °C was added 2,6-lutidine  
(1.0 mL) and TBSOTf (0.78 mL). The reaction mixture was stirred at room temperature 
for 2 h and concentrated. The residue was loaded onto a silica gel column and eluted with 
0- 10% EtOAc in hexanes to give the TBS ether (1.25 g, 98% over 2 steps). The isolated 
yield and analytical data are reported for material judged >95% pure as determined by 
1H 
NMR spectroscopy 
1H NMR (CDCl3, 500 MHz) δ 7.37 (s, 1H), 6.50 (s, 1H), 4.81 (dd, J 
= 7.3, 5.4 Hz, 1H), 3.70 (ddd, J = 10.3, 6.8, 5.9 Hz, 1H), 3.57 (app dt, J = 10.2, 5.9 Hz, 
1H), 1.88 (m, 1H), ), 1.75 (m, 1H), 0.89 (s, 9H), 0.88 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H), 
O
I
TBSO OTBS
O
I
TBSO OH
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 2,6-lutidine 
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0.03 (s, 3H), -0.04 (s, 3H). 
13C NMR (CDCl3, 125 MHz) δ 143.7, 133.0, 119.3, 87.9, 
64.0, 59.2, 42.5, 25.9, 25.8, 18.2, 18.1, -4.7, -5.1, -5.31, -5.33. [α]
23
D = 22.2 (c 1.26, 
CHCl3). IR (neat): 3135, 2929, 2858, 1472 cm
-1. 
 
(R)-3-(4-(2,2,3,3,9,9,10,10-octamethyl-4,8-dioxa-3,9-disilaundecan-5-yl)furan-2-
yl)propanal (16). A mixture of iodide 15 (6.39 g, 12.9 mmol), Bu4NBr (5.51 g, 17.1 
mmol),  NaHCO3  (3.30  g,  39.3  mmol),  Pd(OAc)2  (145  mg,  0.646  mmol,  5.0  mol%), 
allylic alcohol (9.0 mL, 127 mmol) in DMF (20 mL) was stirred in a 40 °C oil bath for 48 
h. The reaction mixture was cooled to room temperature, diluted with diethyl ether and 
filtered through Celite. The combined organic layer was washed with brine, dried over 
Na2SO4  and  concentrated.  The  crude  product  was  purified  by  flash  column 
chromatography with 2-4% EtOAc in hexanes to give aldehyde 16 (4.65 g, 10.9 mmol, 
85%) as light yellow oil. The isolated yield and analytical data are reported for material 
judged >95% pure as determined by 
1H NMR spectroscopy. 
1H NMR (CDCl3, 500 MHz) 
δ 9.82 (1H), 7.14 (s, 1H), 5.98 (s, 1H), 4.76 (dd, J = 7.5, 5.5 Hz, 1H), 3.70 (dt, J = 10.3, 
6.5 Hz, 1H), 3.58 (dt, J = 10.3, 6.3 Hz, 1H), 2.94 (t, J = 7.0 Hz, 2H), 2.77 (t, J = 7.0 Hz, 
2H), 1.88 (m, 1H), ), 1.76 (m, 1H), 0.89 (s, 9H), 0.87 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H), 
0.03 (s, 3H), -0.06 (s, 3H). 
13C NMR (CDCl3, 125 MHz) δ 201.2, 154.3, 137.5, 130.7, 
105.1, 64.6, 59.7, 42.7, 42.1, 26.1, 26.0, 21.1, 18.5, 18.4, -4.4, -4.8, -5.1, -5.1. [α]
23
D = 
27.3 (c 1.12, CHCl3). IR (neat): 3113, 2956, 2929, 2885, 2856, 2719, 1731, 1472 cm
-1. 
HRMS-ESI: calculated for [C22H42O4Si2+Na]
+ 449.2514; found 449.2505. 
O
I
TBSO OTBS
Bu4NBr, NaHCO3, 
allyl alcohol, Pd(OAc)2
15
O
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16 
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(R,Z)-2-nitro-N-(8-(4-(2,2,3,3,9,9,10,10-octamethyl-4,8-dioxa-3,9-disilaundecan-5-
yl)furan-2-yl)oct-5-en-1-yl)benzenesulfonamide (17). A solution of KHMDS (0.68 mL, 
0.9  M  solution  in  THF,  0.61  mmol)  was  added  to  a  suspension  of  5-(2-
nitrobenzenesulfonylamido)pentyl triphenylphosphonium iodide
38 (203 mg, 0.307 mmol) 
in THF (2 mL) at –78 °C. The mixture was stirred for 30 min, until a clear dark red 
solution was obtained. The aldehyde (103 mg, 0.242 mmol) in THF (0.5 mL) was added 
via cannula, followed by a THF (0.5 mL) rinse. The mixture was stirred for 1 h at –78 °C 
and  then  30  min  at  0  °C.  A  deep  purple  solution  was  obtained.  The  reaction  was 
quenched by the dropwise addition of acetic acid until the color faded. The mixture was 
diluted with EtOAc, filtered through silica gel, and washed with EtOAc. The filtrate was 
concentrated and the residue was purified by flash column chromatography with 0–20% 
EtOAc in hexanes to give the product (134 mg, 0.197 mmol, 81%), 
1H NMR analysis 
showed ~ 10:1 Z/E ratio. The minor isomer was further removed by silica gel column 
impregnated with AgNO3. The isolated yield and analytical data are reported for material 
judged >95% pure as determined by 
1H NMR spectroscopy. 
1H NMR (CDCl3, 600 MHz) 
δ 8.14-7.70 (m, 4H), 7.13 (s, 1H), 5.94 (s, 1H), 5.38-5.24 (m, 3H), 4.76 (dd, J = 7.3, 5.3 
Hz, 1H), 3.70 (dt, J = 10.0, 6.7 Hz, 1H), 3.59 (dt, J = 10.3, 6.3 Hz, 1H), 3.10 (q, J = 7.0 
Hz, 2H), 2.58 (t, J = 7.8 Hz, 2H), 2.28 (q, J = 7.3 Hz, 2H), 1.98 (, J = 7.3 Hz, 2H), 1.90 
(m, 1H), 1.77 (m, 1H), 1.52 (m, 2H), 1.35 (m, 2H), 0.89 (s, 9H), 0.87 (s, 9H), 0.04 (s, 
3H), 0.03 (s, 3H), 0.03 (s, 3H), -0.06 (s, 3H). 
13C NMR (CDCl3, 125 MHz) δ 155.8, 
                                                 
38 Prepared in 3 steps from 5-amino-1-pentanol: a, NsCl, Et3N, DMAP; b, PPh3, I2, imidazole; c, PPh3. 
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148.1, 136.8, 133.8, 133.5, 132.7, 131.1, 130.3, 129.7, 129.0, 125.3, 104.4, 64.5, 59.5, 
43.7, 42.5, 29.1, 28.2, 26.5, 26.4, 25.9, 25.8, 25.7, 18.22, 18.18, -4.6, -5.0, -5.3. [α]
23
D = 
18.0 (c 1.47, CHCl3). IR (neat): 3353, 3098, 2954, 2928, 2886, 2857, 1594, 1543, 1472, 
1361,  1256,  1170,  1094  cm
-1.    HRMS-ESI:  calculated  for  [C33H56N2O7SSi2+Na]
+ 
703.3239; found 703.3233. 
 
(R,Z)-N-(8-(4-(1-((tert-butyldimethylsilyl)oxy)-3-hydroxypropyl)furan-2-yl)oct-5-en-
1-yl)-2-nitrobenzenesulfonamide (18). A solution of TBS ether (235 mg, 0.346 mmol) 
and PPTS (8.9 mg, 0.0355 mmol, 10 mol%) in ethanol (3.5 mL) was stirred at room 
temperature for 3 h. The reaction was quenched with saturated NaHCO3 solution and 
extracted with DCM. The organic layer was dried over Na2SO4 and concentrated. The 
residue was purified by flash column chromatography with 0–100% EtOAc in hexanes. 
Desired mono-deprotected product (120 mg) was obtained. Recovered starting material 
(74 mg) was treated with PPTS (2.4 mg) in ethanol (1 mL) for 5 h and worked up as 
above. Starting material (15 mg, 6%) and additional product (38 mg) were obtained, 
resulting in a combined yield of 81% (158 mg, 0.279 mmol). The isolated yield and 
analytical data are reported for material judged >95% pure as determined by 
1H NMR 
spectroscopy. 
1H NMR (CDCl3, 600 MHz) δ 8.14-7.70 (m, 4H), 7.17 (s, 1H), 5.93 (s, 
1H), 5.37-5.25 (m, 3H), 4.90 (dd, J = 6.4, 4.6 Hz, 1H), 3.77 (dd, J = 11.0, 7.8, 4.1 Hz, 
1H), 3.69 (ddd, J = 10.8, 6.0, 4.7 Hz, 1H), 3.08 (q, J = 6.9 Hz, 2H), 2.59 (t, J = 7.5 Hz, 
2H), 2.30 (q, J = 7.3 Hz, 2H), 1.97 (q, J = 7.3 Hz, 2H), 1.94 (m, 2H), 1.51 (m, 2H), 1.34 
(m, 2H), 0.88 (s, 9H), 0.07 (s, 3H), -0.05 (s, 3H). 
13C NMR (CDCl3, 125 MHz) δ 156.1, 
O
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148.1, 137.0, 133.7, 133.5, 132.7, 131.0, 129.8, 129.4, 128.9, 125.3, 104.3, 67.5, 60.2, 
43.7,  40.6,  29.1,  28.1,  26.5,  26.3,  25.7,  25.6,  18.0,  -4.7,  -5.2.  [α]
23
D  =  27.3  (c  0.40, 
CHCl3). IR (neat): 3521, 3354, 3098, 3007, 2931, 2857, 1594, 1540, 1538, 1472, 1361, 
1256,  1170  cm
-1.  HRMS-ESI:  calculated  for  [C27H42N2O7SSi+Na]
+  589.2374;  found 
589.2365.  
 
(R,Z)-2-((tert-butyldimethylsilyl)oxy)-5-((2-nitrophenyl)sulfonyl)-15-oxa-5-
azabicyclo[12.2.1]heptadeca-1(16),10,14(17)-triene  (19).  To  a  stirred  solution  of 
alcohol (210 mg, 0.371 mmol) and PPh3 (220 mg, 0.840 mmol) in toluene (70 mL) was 
added a solution of diethyl azodicarboxylate (130 mg, 0.747 mmol) in toluene (4 mL) 
dropwise. The solution was stirred at room temperature for 8 h, and then loaded onto a 
silica gel column and eluted with 0–10% EtOAc in hexanes to afford the macrocycle (176 
mg, 87%). A single crystal suitable for X-ray crystallography analysis was obtained by 
slow  cooling  of  a  hot  and  concentrated  2-propanol  solution  of  the  macrocycle.  The 
isolated  yield  and  analytical  data  are  reported  for  material  judged  >95%  pure  as 
determined by 
1H NMR spectroscopy. 
1H NMR (CDCl3, 600 MHz) δ 7.99-7.59 (m, 4H), 
7.11 (s, 1H), 5.90 (s, 1H), 5.34 (m, 1H), 5.21 (m, 1H), 4.73 (dd, J = 7.0, 1.8 Hz, 1H), 3.24 
(ddd, J = 16.7, 11.4, 5.6 Hz, 1H), 3.14-3.05 (m, 3H), 2.70 (m, 2H), 2.31 (d, J = 11.4, 6.2 
Hz, 2H), 2.05  (m, 1H), 1.90 (m, 2H), 1.77 (m, 1H), 1.23 (m, 2H), 1.16 (m, 2H), 0.86 (s, 
9H), 0.03 (s, 3H), -0.03 (s, 3H). 
13C NMR (CDCl3, 125 MHz) δ 156.7, 148.1, 137.1, 
133.3, 133.2, 131.4, 130.8, 130.7, 129.6, 129.2, 124.0, 104.2, 66.0, 47.2, 41.7, 36.1, 27.6, 
27.0, 26.5, 26.1, 25.7, 25.6, 18.1, -5.0, -5.1. [α]
23
D = 10.9 (c 1.69, CHCl3). IR (DCM): 
O
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3058, 3004, 2954, 2857, 1592, 1548, 1471, 1373, 1265 cm
-1. HRMS-ESI: calculated for 
[C27H40N2O6SSi+Na]
+ 571.2269; found 571.2250. 
 
(R,Z)-2-((tert-butyldimethylsilyl)oxy)-15-oxa-5-azabicyclo[12.2.1]heptadeca-
1(16),10,14(17)-triene (6). A mixture of macrocycle 19 (113 mg, 0.206 mmol), K2CO3 
(60.8 mg, 0.44 mmol) and PhSH (41.5 mg, 0.38 mmol) in DMF (0.40 mL) was stirred at 
rt overnight. The reaction mixture was diluted with diethyl ether. The organic layer was 
washed  with  K2CO3  (aq),  brine,  dried  over  K2CO3  (s),  and  concentrated  to  give 
macrocyclic amine 6 (71.6 mg, 0.197 mmol, 96%). 
1H NMR (CDCl3, 600 MHz) δ 7.16 
(bs, 1H), 5.99 (s, 1H), 5.46 (m, 1H), 5.38 (m, 1H), 4.81 (dd, J = 6.7, 3.8 Hz, 1H), 2.70 
(m, 3H), 2.50-2.56 (m, 3H), 2.36 (m, 2H), 1.87- 1.99 (m, 4H), 1.25-1.33 (m, 2H), 1.25 
(bs, H), 0.97 (m, 2H), 0.88 (s, 9H), 0.06 (s, 3H), -0.01 (s, 3H). 
13C NMR (CDCl3, 125 
MHz) δ 156.7, 137.1, 130.6, 129.4, 129.1, 105.1, 66.9, 47.9, 43.4, 36.8, 27.7, 26.9, 26.5, 
26.4, 25.8, 18.1, -4.96. [α]
23
D = +17.2 (c 0.37, CHCl3). IR (CDCl3 film): 3345, 3156, 
3007, 2930, 2857, 1472, 1257, 1094 cm
-1. HRMS-ESI: calculated for [C21H37NO2Si+H]
+ 
364.2666; found 364.2669. 
 
(Z)-2-chloro-15-oxa-5-azabicyclo[12.2.1]heptadeca-1(16),10,14(17)-trien-5-ium 
chloride (29). A HCl solution in HOAc (~ 1.5 M) was prepared by mixing AcCl (0.42 
mL) and H2O (0.10g) in HOAc (3.6 g). Macrocyclic amine 6 (15 mg, 0.041 mmol) was 
H
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dissolved in this HCl solution in HOAc (0.10 mL) and stirred for 3h at rt. The reaction 
mixture was concentrated by bubbling N2 through, then concentrated under high vacuum 
to give the salt (13 mg, 0.04 mmol). 
1H NMR (CDCl3, 600 MHz) δ 9.76 (br s, 1H), 8.81 
(br s, 1H), 7.56 (s, 1H), 6.13 (s, 1H), 5.41–5.30 (m, 3H), 3.00 (m, 1H), 2.87 (m, 2H), 
2.81-2.75 (m, 3H), 2.67-2.74 (m, 1H), 2.42-2.50 (m, 2H), 2.29 (m, 1H), 2.02 (m, 1H), 
1.90 (m, 1H), 1.42 (m, 1H), 1.37 (m, 1H), 1.23 (m, 1H), 1.09 (m, 1H). 
13C NMR (CDCl3, 
125 MHz) δ 158.0, 140.1, 130.0, 129.8, 124.4, 104.3, 50.6, 45.2, 41.2, 34.3, 27.6, 26.7, 
26.2, 25.7, 22.8. IR (CDCl3 film): 3392, 2954, 2784, 1589, 1549, 1456 cm
-1. HRMS-
ESI: calculated for [C15H23ClNO]
+ 268.14627; found 268.14634. 
 
(R,Z)-perfluorophenyl  1,5,6,7,8,10a-hexahydropyrrolo[1,2-a]azocine-2-carboxylate 
(38). A mixture of malonate 33 (128 mg, 0.57 mmol) and LiOH (43 mg) was stirred in 
THF/H2O (2.0/0.4 mL) at 0 °C for 1h. The reaction was quenched with 1 M NaHSO4 (aq), 
extracted with DCM, dried over Na2SO4 and filtered through silica gel, further elution 
with EtOAc afforded the analytically pure carboxylic acid (120 mg, quant.). 
      To a solution of the carboxylic acid from above and pyridine (0.13 mL) in DMF (1.6 
mL) at 0 °C was added pentafluorophenyl trifluoroacetate (0.16 mL, 0.91 mmol). After 2 
h,  the  reaction  mixture  was  diluted  with  EtOAc  and  washed  successively  with  1  M 
NaHSO4, pH=7 phosphate buffer and brine, dried over Na2SO4 and concentrated under 
high vacuum to give the activated ester (214 mg, 99%).  
N
O
OCH3
O
33
N
O
OC6F5
38
1. LiOH;
2. CF3CO2C6F5, pyridine;  
3. MeOTf; then LiEt3BH. 
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      A CD2Cl2 (0.40 mL) solution of the ester (52 mg, 0.139 mmol) in a NMR tube was 
cooled to -78 °C, evacuated under vacuum, and refilled with N2. MeOTf (0.0185 mL, 
0.164 mmol) was added via syringe. The mixture was heated in a 40 °C oil bath for 2d, 
and cooled to  -78 °C. LiEt3BH (0.165 mL, 1 M in THF, 0.165 mmol) was added and the 
mixture was kept at -78 °C for 2h, warmed to rt and quenched with 2 drops NaHCO3(sat.). 
The mixture was dried over Na2SO4 and filtered through neutral alumina, eluted with  20% 
EtOAc in hexanes to give product (35 mg, 0.097 mmol, 70%). 
1H NMR (CDCl3, 400 
MHz) δ 7.36 (s, 1H), 5.85 (app q, J =9.0 Hz, 1H), 5.56 (dd, J = 11.0, 7.0 Hz, 1H), 3.41 (m, 
2H), 3.21 (dd, J = 13.9, 11.7 Hz, 1H), 2.74 (dd, J = 14.3, 9.2 Hz, 1H), 2.43 (m, 1H), 2.20 
(m, 1H), 1.82 (m, 1H), 1.73 (m, 2H), 1.53 (m, 1H), 0.89 (m, 1H). 
13C NMR (CDCl3, 100 
MHz) δ 154.6, 132.3, 130.0, 93.1, 60.7, 49.0, 34.8, 27.0, 26.9, 25.7. [α]
23
D = −154 (c 0.53, 
CHCl3). IR (film): 3006, 2979, 2935, 2873, 1713, 1580, 1520, 1446, 1384, 1216 cm
-1. 
HRMS-ESI: calculated for (C17H14F5NO2+H) 360.1017, found 360.1034. 
 
((R,Z)-1,5,6,7,8,10a-hexahydropyrrolo[1,2-a]azocin-2-yl)((R,Z)-2-hydroxy-15-oxa-5-
azabicyclo[12.2.1]heptadeca-1(16),10,14(17)-trien-5-yl)methanone (39). A mixture of 
38 (52 mg, 0.15 mmol), macrocyclic amine 6 (58 mg, 0.16 mmol), DMAP (6.0 mg, 0.049 
mmol) and BHT (3.5 mg, 0.016 mmol) was stirred in DMF (0.050 mL) for 2 d. The 
reaction mixture was then concentrated under high vacuum. The residue was stirred with 
TBAF (0.40 mL, 1 M in THF, 0.40 mmol) for 1h at rt. The mixture was concentrated via 
N
O
N
O
OH
39
N
O
OC6F5
38
1. DMAP, 6;
2. TBAF.
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rotavapor  and  the  residue  was  purified  by  flash  column  chromatography  with  0-5% 
CH3OH in EtOAc to give product 39 (25 mg, 0.059 mmol, 40%, 2 steps). 
1H NMR 
(CDCl3, 600 MHz) δ 7.11 (s, 1H), 6.68 (s, 1H), 5.88 (s, 1H), 5.71 (m, 1H), 5.56 (m, 1H), 
5.36 (m, 1H), 5.22 (m, 1H), 4.76 (m, 1H), 4.27 (m, 1H), 3.94 (m, 1H), 3.25 (m, 2H), 3.18 
(m, 1H), 3.06 (m, 1H), 2.87 (m, 2H), 2.69 (m, 3H), 2.56 (m, 1H), 2.33 (m, 3H), 2.15 (m, 
2H), 1.95-2.06 (m, 5H), 1.72 (m, 2H), 1.64 (m, 1H), 1.53 (m, 1H), 1.21 (m, 2H), 0.97 (m, 
1H). 
13C NMR (CDCl3, 125 MHz) δ 168.1, 156.1, 149.6, 136.6, 131.2, 130.6, 130.2, 
130.1, 129.9, 104.7, 102.1, 65.0, 61.4, 49.8, 49.1, 44.3, 38.8, 35.3, 28.3, 27.7, 27.4, 27.0, 
26.2, 26.1, 25.8, 25.2. [α]
23
D = 7.5 (c 0.62, CHCl3). IR (film): 3327, 3016, 2932, 2858, 
1589, 1549, 1444, 1370 cm
-1. HRMS-ESI: calculated for (C26H36N2O3+H) 425.2799, 
found 425.2809. 
 
O-alkylation product 40. To a solution of the alcohol (25 mg, 0.059 mmol) in THF 
(0.20 mL) in an ice bath was added NaHMDS (0.080 mL, 1 M in THF, 0.080 mmol) 
dropwise via syringe. After 5 min, TsCl (16.5 mg, 0.087 mmol) in THF (0.20 mL+0.10 
mL rinse) was added via cannula. After 30 min, the reaction mixture was warmed to rt 
and stirred overnight. The volatiles were removed under vacuum and the residue was 
extracted  with  CHCl3,  filtered  through  Celite  and  the  filtrate  was  concentrated.  The 
residue  was  washes  with  diethyl  ether  and  the  remaining  residue  was  extracted  with 
EtOAc and CHCl3, and filtered through Celite. The filtrate was concentrated to give the 
N
O
N
O
OH
N
O
N
O
TsO NaHMDS
 TsCl
39 40 
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product (27.3 mg, 0.047 mmol, 79%). A single crystal was obtained by slow diffusion of 
diethyl ether vapor to a CHCl3 solution. 
1H NMR (CDCl3, 500 MHz) δ 8.24 (bs, 1H), 
7.79 (d, J = 8.0 Hz, 2H), 7.25 (s, 1H), 7.10 (d, J = 8.0 Hz, 2H), 5.99 (app q, J = 9.0 Hz, 
1H), 5.93 (s, 1H), 5.49 (s, 1H), 5.32-5.45 (m, 3H), 4.75 (app q, J = 9.9 Hz, 1H), 3.82 (m, 
2H), 3.59 (m, 1H), 3.47 (dd, J = 14.3, 8.8 hz, 1H), 3.35 (m, 2H), 3.25 (m, 1H), 2.68 (m, 
4H), 2.49 (m, 1H), 2.40 (m, 1H), 2.31 (s, 3H), 2.19 (m, 2H), 1.94 (m, 2H), 1.75 (m, 4H), 
1.62 (m, 2H), 1.44-1.30 (m, 6H), 0.61 (m, 1H), 0.43 (m, 1H). 
13C NMR (CDCl3, 125 
MHz) δ 162.4, 159.7, 157.6, 143.8, 138.8, 137.5, 135.5, 130.1, 129.3, 128.6, 128.3, 128.2, 
126.2, 125.9, 122.6, 104.4, 91.6, 70.1, 60.4, 52.7, 48.9, 43.8, 35.6, 27.6, 27.5, 27.04, 
27.01, 26.7, 26.6, 26.4, 26.1, 24.4, 21.2. [α]
23
D = −271 (c 0.38, CHCl3). IR (film): 3018, 
2938, 2860, 1600, 1556, 1433, 1216, 1122, 1034, 1011 cm
-1. HRMS-ESI: calculated for 
(C26H34N2O2) 407.2693, found 407.2699. 
 
(Z)-methyl  3-(5-iodofuran-3-yl)acrylate  (44).  To  a  solution  of 
(CF3CH2O)2POCH2CO2CH3 (2.23 g, 7.01 mmol) and 18-crown-6 (1.48 g, 5.61 mmol) in 
THF (30 mL) at -40 °C was added KHMDS (14.1 mL, 0.5 M in toluene, 7.05 mmol). 
After 30 min at this temperature, the solution was cooled to -78 °C and aldehyde 7 (1.54 
g,  0.694  mmol)  in  THF  (6  mL+4  mL  rinse)  was  added  via  cannula.  After  1h,  TLC 
(hexanes/EtOAc  10:1)  showed  complete  reaction.  The  reaction  was  quenched  with 
NaHCO3  (sat.)  and  extracted  with  diethyl  ether.  The  organic  layers  were  dried  and 
concentrated.  The  residue  was  purified  by  flash  column  chromatography  with  10% 
EtOAc in hexanes to give the product (1.85 g, 0.665 mmol, 96%). 
1H NMR (CDCl3, 500 
O
I
O
H
(CF3CH2O)2POCH2CO2Me
KHMDS, 18-C-6
7
O
I
44
CO2Me 
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MHz) δ 8.08 (s, 1H), 7.08 (s, 1H), 6.52 (d, J = 12.2 Hz, 1H), 5.72 (d, J = 12.2 Hz, 1H), 
3.66 (s, 3H). 
13C NMR (CDCl3, 100 MHz) δ 165.9, 151.1, 132.1, 123.8, 122.1, 116.8, 
89.1, 51.1. IR (film): 3020, 1720, 1638, 1439, 1216 cm
-1.  
 
(Z)-methyl 3-(5-(3-oxopropyl)furan-3-yl)acrylate (45). A mixture of iodide 44 (1.85 g, 
0.665 mmol), NaHCO3 (1.44 g, 17.1 mmol), Bu4NCl (1.94 g, 6.98 mmol), Pd(OAc)2 (76 
mg, 0.34 mmol) and allyl alcohol (0.80 mL, 12 mmol) in DMF (7.0 mL) was stirred at rt 
for  24h.  The  reaction  mixture  was  diluted  with  diethyl  ether  (100  mL)  and  filtered 
through  Celite.  The  filtrate  was  concentrated  and  the  residue  was  purified  by  flash 
column chromatography with 10-15% EtOAc in hexanes to give aldehyde 45 as light 
yellow oil (0.84 g, 0.40 mmol, 61%). 
1H NMR (CDCl3, 500 MHz) δ 9.77 (bs, 1H), 7.90 
(s, 1H), 6.60 (d, J = 12.7 Hz, 1H), 5.72 (d, J = 12.2 Hz, 1H), 3.70 (s, 3H), 2.92 (t, J = 7.0 
Hz, 2H), 2.77 (m, 2H).
 13C NMR (CDCl3, 125 MHz) δ 200.5, 166.5, 154.4, 146.0, 133.9, 
122.0, 115.7, 51.1, 41.5, 20.4. IR (film): 3146, 2951, 2833, 2730, 1728, 1714, 1634, 1600, 
1538,  1445,  1416  cm
-1.  HRMS-ESI:  calculated  for  (C11H12O4+H)  209.0808,  found 
209.0838. 
 
(Z)-methyl 3-(5-((Z)-8-((tert-butoxycarbonyl)amino)oct-3-en-1-yl)furan-3-yl)acrylate 
(46). To a cold (0 °C) suspension of BocNH(CH2)5PPh3I  (4.02 g, 6.99 mmol) in THF 
(170 mL) was added dropwise KHMDS (13.5 mL, 0.5 M in toluene, 6.75 mmol). After 
20 min, aldehyde 45 (1.30 g, 6.25 mmol) in THF (10 mL+5 mL rinse) was added via 
O
45
CO2Me
OHC
O
I
44
CO2Me Bu4NCl, NaHCO3,
Pd(OAc)2, allyl alcohol
PPh3 BocHN I
MeO
O
O
BocHN 46
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syringe. After 10 min, no starting material was left as monitored by TLC (20% EtOAc in 
hexanes). The reaction was then quenched by addition of silica gel. The mixture was 
filtered through a glass frit and washed with diethyl ether. The filtrate was concentrated 
and  the  residue  was  purified  by  flash  column  chromatography  with  5-8%  EtOAc  in 
hexans to give product 46 (1.88 g, 0.50 mmol, 80%). 
1H NMR (500 MHz, CDCl3) δ 7.91 
(s, 1H), 6.64 (d, J = 12.5 Hz, 1H), 6.60 (s, 1H), 5.72 (d, J = 12.5 Hz, 1H), 5.41 – 5.32 (m, 
2H), 4.55 (bs, 1H), 3.72 (s, 3H), 3.07 (q, J = 6.8 Hz, 2H), 2.63 (t, J = 7.5 Hz, 2H), 2.35 (q, 
J = 7.5 Hz, 2H), 2.00 (q, J = 6.7 Hz, 2H), 1.48 – 1.42 (m, 2H), 1.42 (s, 9H), 1.36 – 1.27 
(m, 2H); 
13C NMR (125 MHz, CDCl3) δ 166.6, 156.3, 155.9, 145.8, 134.3, 130.5, 128.3, 
122.0, 115.3, 107.5, 78.9, 51.1, 40.4, 29.6, 28.4, 27.9, 26.75, 26.70, 25.6; IR (film) 3360, 
2933, 2860, 1728, 1714, 1682, 1634, 1600, 1537, 1520, 1446, 1392, 1366, 1249, 1172, 
1007, 921, 843, 780, 603 cm-1; HRMS-ESI: Exact mass calcd for C21H31NO5 [M+Na]+: 
378.2275; found: 378.2283. 
 
(2Z,10Z)-15-oxa-5-azabicyclo[12.2.1]heptadeca-1(16),2,10,14(17)-tetraen-4-one 
(43).
39 To a cooled (0 °C) solution of ester 46 (7.76 g, 20.6 mmol, 1.00 equiv.) in a 
mixture of MeOH/H2O (340 mL/60 mL) was added NaOH (3 M) (68.5 mL, 206 mmol, 
10.0  equiv.).  After  addition  the  ice-bath  was  removed  and  the  reaction  stirred  at  rt 
overnight. The reaction was cooled to 0 °C, quenched by addition of HCl (1 M) and the 
pH was adjusted to 1. The mixture was stirred at rt for 30 min, then the volatiles removed 
under reduced pressure and the aqueous phase extracted with EtOAc (3x). The combined 
                                                 
39 This 3-step procedure was developed by Dr. Simone Bonazzi. 
MeO
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O
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layers were dried (Na2SO4) and concentrated in vacuo. The residue was dissolved in 
mixture of hexanes/EtOAc (1:1) and purified by filtration through a SiO2 plug. The cake 
was  washed  with  a  mixture  of  hexanes/EtOAc  (1:1)  and  concentrated  to  afford  the 
corresponding  carboxylic  acid  (7.44  g,  20.4  mmol,  99%)  as  colorless  oil.  Rf =  0.63 
(hexanes/EtOAc 6:4); 
1H NMR (500 MHz, CD3OD) δ 7.99 (s, 1H), 6.74 (d, J = 12.5 Hz, 
1H), 6.65 (s, 1H), 5.76 (d, J = 12.6 Hz, 1H), 5.46 – 5.36 (m, 2H), 4.96 (s, 1H), 3.04 (t, J = 
7.2 Hz, 2H), 2.67 (t, J = 7.3 Hz, 2H), 2.40 (q, J = 7.1 Hz, 2H), 2.06 (q, J = 6.9 Hz, 2H), 
1.52 – 1.45 (m, 2H), 1.45 (s, 9H), 1.39 – 1.29 (m, 2H); 
13C NMR (125 MHz, CD3OD) δ 
170.4, 159.4, 158.3, 147.9, 135.9, 132.6, 130.3, 124.6, 117.9, 109.5, 80.6, 42.1, 31.4, 
29.7, 29.7, 28.7, 28.7, 27.5; IR (film) 3323, 2932, 2855, 1694, 1651, 1633, 1531, 1514, 
1454, 1392, 1367, 1247, 1169, 918, 835, 779 cm-1; HRMS-ESI: Exact mass calcd for 
C20H29NO5 [M+Na]+: 364.2118; found: 364.2122. 
      To a cooled (0 °C) solution of the previously obtained carboxylic acid (1.89 g, 5.20 
mmol, 1.00 equiv.) in DCM (15 mL) was added TFA (5.00 mL, 65.3 mmol, 12.6 equiv.). 
After addition the ice-bath was removed, the reaction stirred at rt for 45 min and then 
concentrated in vacuo. The residue was dissolved in MeOH, concentrated in vacuo and 
dried under high vacuum (3x cycle). The residue was dissolved in CH3CN (2.60 L) and 
the solution heated to 50 °C. NEt3 (3.30 mL, 23.4 mmol, 4.50 equiv.) and HBTU (5.90 g, 
15.6 mmol, 3.00 equiv.) were sequentially added and the resulting mixture stirred at 50 
°C for 24 h. The reaction was quenched by addition of saturated NH4Cl, the volatiles 
removed under reduced pressure and the resulting mixture extracted with EtOAc (3x). 
The combined organic layers were washed with saturated NH4Cl (1x), saturated Na2CO3 
(1x), dried (Na2SO4) and concentrated in vacuo. The product was purified on a Teledyne  
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Isco  CombiFlash®  instrument  (RediSepRf  Gold  High  Performance  column  80  g, 
hexane/EtOAc 6.5:3.5 to 2:8) to give macrolactam 43 (944 mg, 3.85 mmol, 74%) as a 
pale yellow solid. An analytical sample was recrystallized from MeOH and submitted to 
X-ray diffraction. Rf = 0.48 (EtOAc 100%); mp = 125 – 126 ºC; 
1H NMR (600 MHz, 
CD3OD) δ 7.42 (s, 1H), 6.49 (d, J = 12.0 Hz, 1H), 6.17 (d, J = 0.7 Hz, 1H), 5.95 (d, J = 
12.1 Hz, 1H), 5.51 – 5.43 (m, 1H), 5.37 – 5.29 (m, 1H), 3.31 – 3.26 (m, 2H), 2.76 – 2.72 
(m, 2H), 2.51 – 2.44 (m, 2H), 2.04 (q, J = 7.8 Hz, 2H), 1.66 – 1.57 (m, 2H), 1.25 – 1.18 
(m, 2H); 
13C NMR (125 MHz, CDCl3) δ 168.5, 157.5, 140.8, 131.0, 129.0, 125.8, 125.3, 
122.0, 105.3, 38.8, 28.1, 27.9, 27.4, 26.6, 25.5; IR (neat) 3283, 2929, 2858, 1634, 1597, 
1549, 1452, 1279, 1213, 1126, 960, 911, 800, 727 cm
-1; HRMS-ESI: Exact mass calcd 
for C15H19NO2 [M+H]+: 246.1489; found: 246.1494. 
 
(R)-N-allylidene-2-methylpropane-2-sulfinamide (49). To a solution of acrolein (7.0 
mL, 105 mmol) and (R)-tert-butyl sulfinamide (10.20 g, 84.3 mmol) in DCM (60 mL) 
was added Ti(i-PrO)4 (74 mL, 237 mmol). The mixture was stirred at room temperature 
overnight and poured into ice/water. After standing for 30 min with occasionally shaking, 
the white suspension was filtered through Celite and rinsed with DCM. The filtrate was 
collected and the two layers were separated, the aqueous layer was extracted with DCM. 
The combined organic layer was dried over Na2SO4 and concentrated under vacuum. 
Purification by flash column chromatography with DCM gave the product as light yellow 
oil (13.0 g, 81.8 mmol, 97%). Rf = 0.16 (DCM). 
1H NMR (CDCl3, 500 MHz) δ 8.19 (d, 
J = 9.3 Hz, 1H), 6.66 (dt, J = 17.6, 9.5 Hz, 1H), 5.98 (d, J = 11 Hz, 1H), 5.97 (d, J = 17 
N
S
O
O
H
H
48 49
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Hz, 1H), 1.18 (s, 9H). 
13C NMR (CDCl3, 100 MHz) δ 163.93, 134.38, 131.24, 57.07, 
22.19. [α]
23
D = −583 (c 1.89, CHCl3). IR (film): 2961, 2868, 1624, 1577, 1474, 1457 cm
-
1. HRMS-ESI: calculated for C7H13NOS+H 160.0791, found 160.0790. 
 
(R)-ethyl  4-((R)-1,1-dimethylethylsulfinamido)-2-methylenehex-5-enoate  (50).  To  a 
suspension of zinc (2.57 g, 39.5 mmol) and LiCl (2.57 g, 60.6 mmol) in DMF (50 mL) 
was added a solution of bromide (8.13 g, 43.0 mmol), imine (3.18 g, 20.0 mmol) and 
H2O (0.37 g, 20.6 mmol) in DMF (25 mL) via cannula, followed by a DMF rinse (25 
mL). The reaction is exothermic and a water cooling bath was used. After stirring for 6h 
at room temperature, 
1H NMR analysis of an aliquot showed consumption of the imine. 
The reaction was quenched with water and extracted with EtOAc. The organic phase was 
dried over Na2SO4 and concentrated. DMF was removed under high vacuum. The residue 
was  purified  by  flash  column  chromatography  with  30%-50%  EtOAc  in  hexanes  as 
eluent. The product was obtained as light yellow oil (4.50 g, 1.65 mmol, 82%). Rf = 0.54 
(EtOAc). 
1H NMR (CDCl3, 500 MHz) δ 6.21 (s, 1H), 5.84 (ddd, J = 17.1, 10.3, 6.8 Hz, 
1H), 5.57 (s, 1H), 5.23 (d, J= 17.1 Hz, 1H), 5.12 (d, J = 10.7 Hz, 1H), 4.16 (q, J = 7.0 Hz, 
2H), 3.91 (pent, J = 7.1 Hz), 3.27 (d, J = 7.3 Hz), 2.60 (dd, J = 13.7, 7.8 Hz, 1H), 2.51 (dd, 
J = 13.7, 6.3 Hz, 1H), 1.26 (t, J = 7.3 Hz, 3H), 1.13 (s, 9H).
 13C NMR (CDCl3, 100 MHz) 
δ 166.81, 139.15, 136.98, 127.82, 116.51, 60.74, 58.56, 55.95, 38.20, 22.44, 14.08. [α]
23
D 
= −42.5 (c 2.33, CHCl3). IR (film): 3214, 3080, 2981, 2870, 1712, 1631 cm
-1. HRMS-
ESI: calculated for (C13H23NO3S+Na) 296.1291, found 296.1282. 
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(R)-3-methylene-5-vinylpyrrolidin-2-one (51). A solution of HCl in CH3OH (60 mL, 
1.25 M, 75.0 mmol) was added to the sulfinamide (5.81 g, 21.3 mmol) and the resulting 
mixture was stirred at room temperature for 2h. When the reaction was complete, NaOH 
(5.0 g, 125 mmol) was added to the reaction mixture and stirring was continued for 1h. 
The reaction was quenched with H2O and extracted with EtOAc, dried over Na2SO4 and 
concentrated. Purification by flash column chromatography with 50% EtOAc in hexanes 
afforded the product (2.26 g, 1.84 mmol, 86%). Rf = 0.38 (Et2O); mp = 44 – 46 °C. 
1H 
NMR (CDCl3, 600 MHz) δ 7.86 (bs, 1H), 5.92 (s, 1H), 5.75 (m, 1H), 5.29 (s, 1H), 5.20 
(d, J = 17 Hz, 1H), 5.07 (d, J = 10 Hz, 1H), 4.13 (app q, J = 6.5 Hz, 1H), 3.01 (dd, J= 17, 
8 Hz, 1Hz), 2.48 (app d, J = 17 Hz, 1H). 
13C NMR (CDCl3, 100 MHz) δ 170.93, 138.93, 
138.59, 115.87, 115.73, 53.51, 33.52. [α]
23
D = −55.1 (c 2.96, CHCl3). IR (film): 3434, 
3215, 3089, 2988, 1698, 1662 cm
-1. HRMS-ESI: calculated for (C7H9NO+Na) 146.0576, 
found 146.0550. 
 
(R)-1-(hex-5-en-1-yl)-3-methylene-5-vinylpyrrolidin-2-one  (52).  A  solution  of  the 
lactam (2.26 g, 18.4 mmol) and 1-iodo-5-hexene (4.80 g, 22.8 mmol) in DMF (36 mL) 
was cooled in an ice bath. NaH (1.60g, 60% suspension in oil, 40 mmol) was added 
slowly in one portion. 
1HNMR analysis of an aliquot showed the reaction was completed 
in 30 min. The reaction was quenched with H2O and extracted with Et2O, dried over 
H
N
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O
EtO
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Na2SO4 and concentrated under vacuum. Purification by flash column chromatrography 
with 30% EtOAc in hexanes afforded the diene as liquid (3.22 g, 15.7 mmol, 85%). Rf = 
0.42 (hexanes/EtOAc 7:3). 
1H NMR (CDCl3, 600 MHz) δ 5.98 (s, 1H), 5.77 (m, 1H), 
5.61 (m, 1H), 5.30 (s, 1H), 5.26 (d, J = 17 Hz, 1H), 5.22 (d, J= 10 Hz, 1H), 4.99 (dt, J= 
17, 1.7 Hz, 1H), 4.94 (d, J = 10Hz, 1H), 4.03 (td, J = 8.2, 4.1 Hz, 1H), 3.64 (app quint, J 
= 7 Hz, 1H), 2.98 (m, 2H ), 2.46 (m, 1H), 2.06 (m, 2H), 1.55 (m, 1H), 1.49 (m, 1H), 1.38 
(quint, J = 7.6 Hz, 2H). 
13C NMR (CDCl3, 100 MHz) δ 167.50, 138.71, 138.13, 137.66, 
118.06, 114.87, 114.51, 58.17, 40.52, 33.07, 31.77, 26.29, 25.87. [α]
23
D = −87.4 (c 1.30, 
CHCl3). IR (film): 3079, 2978, 2931, 1738, 1682, 1661, 1441, 1422 cm
-1. HRMS-ESI: 
calculated for (C13H29NO+Na) 228.1359, found 228.1361. 
 
(R,Z)-2-methylene-1,5,6,7,8,10a-hexahydropyrrolo[1,2-a]azocin-3(2H)-one  (35).  A 
solution of the diene (1.60 g, 7.80 mmol) in DCM (4.0 L, ACS grade, new bottle) was 
deoxygenated by refluxing under N2 for 30 min. Grubbs first generation catalyst (3×30 
mg, 0.11 mmol, 1.5 mol%) in DCM was added via syringe in three equal portions every 3 
hours. The reaction mixture was then refluxed overnight and concentrated under vacuum. 
The crude product was combined with the products from the other two batches (1.60 g 
and  1.25  g)  and  the  desired  product  (3.19  g,  18  mmol,  83%)  was  obtained  by  flash 
column chromatography with 20-30% EtOAc in hexanes. Rf = 0.65 (EtOAc 100%). 
1H 
NMR (CDCl3, 500 MHz) δ 5.92 (bs, 1H), 5.79 (app q, J = 9 Hz, 1H), 5.37 (dd, J = 10, 
6.5 Hz, 1H), 5.26 (bs, 1H), 4.29 (app q, J = 6.5 Hz, 1H), 3.57 (dd, J = 14, 7.8 Hz, 1H), 
3.42 (dd, J = 14, 9.6 Hz, 1H), 2.97 (m, 1H), 2.45 (m, 1H), 2.23 (m, 1H), 2.11 (m, 1H), 
N
O
N
O
Grubbs first 
generation catalyst
52 35 
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1.86 (m, 1H), 1.62 (m, 2H), 1.50 (m, 1H). 
13C NMR (CDCl3, 100 MHz) δ 167.37, 139.73, 
132.38, 130.06, 114.90, 53.30, 41.53, 32.64, 27.27, 25.79, 25.36. [α]
23
D = −139 (c 2.30, 
CHCl3). IR (film): 3013, 2928, 2857, 1682, 1660, 1417 cm
-1. HRMS-ESI: calculated for 
(C11H15NO+Na) 228.1359, found 228.1361. 
 
Bisamide 57.
40 To a cooled (0 °C) suspension of macrolactam (43) (1.12 g, 4.60 mmol, 
1.05 equiv.) in DCE (14 mL) were sequentially added i-Pr2NEt (1.36 mL, 7.80 mmol, 
1.80 equiv.) and TBSOTf (2.00 mL, 8.70 mmol, 2.00 equiv.). The suspension turned in to 
a clear yellow solution. The ice-bath was removed and a solution of bicyclic lactam (35) 
(0.76 g, 4.30 mmol, 1.00 equiv.) in DCE (1.5 mL, final reaction concentration 0.28 M vs 
35) was added via syringe pump at the rate of 500 µL/h. After addition the reaction was 
stirred at rt for 14 h, then quenched by addition of diluted HCl (0.5 M) and the mixture 
extracted with DCM (3x). The combined layers were washed with saturated NaHCO3 
(1x), dried (Na2SO4) and concentrated in vacuo. Two diastereoisomers were observed 
and a diastereomeric ratio of 9:1 was determined by 
1H-NMR (C12 proton signal) prior to 
purification.  The  product  was  purified  on  a  Teledyne  Isco  CombiFlash® instrument 
(RediSepRf Gold High Performance column 40 g, hexane/EtOAc 5:5 to 0:10) to give 
bislactam 57 (1.43 g, 3.38 mmol, 79%) and the minor diastereoisomer 58 (130 mg, 0.31 
mmol, 7%) as white solids. An analytical sample of bis-lactam 57 and diastereoisomer 58 
                                                 
40 This procedure was developed by Dr. Simone Bonazzi. 
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were recrystallized from Et2O and submitted to X-ray diffraction.  
Bislactam 57: Rf = 0.32 (EtOAc/MeOH 9:1); mp = 99 – 102 ºC; 
1H NMR (600 MHz, 
CD3OD) δ 7.10 (s, 1H), 6.07 – 6.03 (m, 1H), 6.06 (d, J = 1.4 Hz, 1H), 5.63 – 5.56 (m, 
1H), 5.46 (dd, J = 10.8, 7.0 Hz, 1H), 5.36 (dt, J = 11.0, 7.1 Hz, 1H), 4.66 – 4.61 (m, 1H), 
4.44 (ddd, J = 13.1, 9.6, 3.1 Hz, 1H), 4.13 (d, J = 12.9 Hz, 1H), 3.71 (dd, J = 14.1, 8.8 
Hz, 1H), 3.24 (d, J = 7.2 Hz, 1H), 3.12 (dd, J = 14.2, 8.4 Hz, 1H), 3.07 – 3.03 (m, 1H), 
3.04 (d, J = 13.0 Hz, 1H), 2.79 – 2.76 (m, 2H), 2.72 (dd, J = 12.8, 6.4 Hz, 1H), 2.67 (ddd, 
J = 13.5, 6.1, 3.0 Hz, 1H), 2.53 – 2.47 (m, 2H), 2.41 (dd, J = 18.4, 1.2 Hz, 1H), 2.37 – 
2.26 (m, 2H), 2.26 – 2.17 (m, 1H), 2.16 – 2.07 (m, 1H), 2.04 – 1.96 (m, 1H), 1.91 (dd, J 
= 12.9, 8.5 Hz, 1H), 1.86 – 1.70 (m, 3H), 1.65 – 1.43 (m, 4H); 
13C NMR (125 MHz, 
CD3OD) δ 175.4, 171.7, 159.0, 140.5, 137.2, 132.7, 131.0, 130.8, 126.6, 106.6, 55.2, 
54.0, 50.7, 50.0, 42.6, 41.4, 38.0, 34.6, 29.6, 29.4, 29.3, 28.9, 28.5, 28.3, 27.9, 25.8; IR 
(neat) 2994, 2931, 2860, 1682, 1634, 1494, 1454, 1422, 1360, 1237, 1180, 1106, 964, 
936,  903,  751,  665  cm-1;  HRMS-ESI:  Exact  mass  calcd  for  C26H34N2O3  [M+H]+: 
423.2642; found: 426.2650; [α]
 21.9 
D = –138.6 (c = 1.18, MeOH).  
Diastereoisomer 58: Rf = 0.25 (EtOAc/MeOH 9:1); mp = 95 – 97 ºC; 
1H NMR (600 
MHz, CD3OD) δ 7.14 (s, 1H), 6.10 (d, J = 0.9 Hz, 1H), 5.90 – 5.84 (m, 1H), 5.71 (dd, J = 
11.3, 4.9 Hz, 1H), 5.64 – 5.58 (m, 1H), 5.37 (dt, J = 11.0, 7.1 Hz, 1H), 4.46 (ddd, J = 
13.2, 9.6, 3.3 Hz, 1H), 4.43 – 4.38 (m, 1H), 4.02 (d, J = 12.9 Hz, 1H), 3.64 (ddd, J = 13.5, 
10.5, 2.6 Hz, 1H), 3.33 – 3.28 (m, 2H), 3.02 (dd, J = 12.7, 1.5 Hz, 1H), 3.01 – 2.97 (m, 
1H), 2.82 – 2.78 (m, 2H), 2.69 (ddd, J = 13.5, 6.1, 3.1 Hz, 1H), 2.54 – 2.49 (m, 3H), 2.46 
(dd, J = 13.1, 8.7 Hz, 1H), 2.39 (dd, J = 18.4, 1.2 Hz, 1H), 2.27 – 2.18 (m, 3H), 2.14 – 
2.07 (m, 1H), 1.91 – 1.73 (m, 4H), 1.73– 1.67 (m, 2H), 1.62 – 1.53 (m, 1H), 1.50 – 1.41  
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(m, 1H); 
13C NMR (125 MHz, CD3OD) δ 175.9, 171.7, 158.9, 140.8, 133.8, 132.6, 131.9, 
131.0, 126.7, 106.8, 56.7, 54.7, 50.1, 49.5, 44.3, 40.3, 38.1, 36.7, 29.6, 28.9, 28.9, 28.5, 
27.9, 26.5, 26.3, 25.9; IR (film) 3007, 2932, 2860, 1682, 1644, 1548, 1494, 1434, 1349, 
1285, 1235, 965, 935, 904, 752, 665 cm-1; HRMS-ESI: Exact mass calcd for C26H34N2O3 
[M+H]+: 423.2642; found: 423.2644; [α]D 
21.5 = +23.2 (c = 1.00, MeOH). 
 
Lactam 63. To a suspension of Me3OBF4 (315 mg, 2.13 mmol, 3.00 equiv.) in DCM (7.1 
mL) were sequentially added 4Å sieves (3.00 g) and bis-lactam 57 (300 mg, 0.71 mmol, 
1.00 equiv.). The mixture was stirred at rt for 2 h, then filtered under N2 and the sieves 
washed with dry DCM (10 mL). The solution was cooled to 0 °C and dry MeOH (20 mL) 
was added. NaBH4 (537 mg, 14.2 mmol, 20.0 equiv.) was added in two portions and the 
resulting mixture was stirred for 10 min at 0 °C and then for 1 h at rt. The reaction was 
quenched by addition of saturated NH4Cl, stirred at rt for 15 min and then the volatiles 
removed  under  reduced  pressure.  The  mixture  was  poured  into  a  saturated  Na2CO3 
solution,  extracted  with  EtOAc  (4x)  and  the  combined  layers  dried  (Na2SO4)  and 
concentrated in vacuo. The product was recrystallized from EtOH, the solid collected by 
filtration and washed with a small amount of cold (0 °C) EtOH to give compound 2 (200 
mg, 0.48 mmol) as a white crystalline solid. The filtrate was concentrated and purified by 
column chromatography on SiO2 (hexane/EtOAc 4:6 to 0:10, then EtOAc/MeOH 10:0 to 
96:4) to give an additional portion of product 63 (21.8 mg, 0.05 mmol, 76% overall 
N
O
N
O
O
N
O
N
O
57 63
Me3OBF4; then 
NaBH4, MeOH 
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yield).  An  analytical  sample  was  recrystallized  from  MeOH  and  submitted  to  X-ray 
diffraction. Rf = 0.39 (EtOAc/MeOH 7.5:2.5); mp = 159 – 161 ºC; 
1H NMR (600 MHz, 
CD3OD) δ 7.05 (s, 1H), 6.69 (d, J = 1.3 Hz, 1H), 6.04 (dt, J = 10.7, 8.4 Hz, 1H), 5.55 – 
5.49 (m, 1H), 5.40 (dd, J = 10.8, 7.3 Hz, 1H), 5.38 – 5.33 (m, 1H), 4.57 – 4.52 (m, 1H), 
3.69 (dd, J = 11.7, 1.1 Hz, 1H), 3.68 – 3.65 (m, 1H), 3.23 – 3.17 (m, 1H), 2.98 (dd, J = 
6.0, 2.3 Hz, 1H), 2.97 – 2.94 (m, 1H), 2.78 – 2.58 (m, 6H), 2.47 – 2.41 (m, 1H), 2.36 – 
2.26 (m, 3H), 2.26 – 2.19 (m, 1H), 2.17 (d, J = 11.7 Hz, 1H), 2.15 – 2.07 (m, 1H), 2.01 – 
1.94 (m, 1H), 1.91 – 1.83 (m, 1H), 1.82 – 1.70 (m, 4H), 1.74 (dd, J = 12.7, 9.2 Hz, 2H), 
1.69 – 1.62 (m, 1H), 1.53 – 1.42 (m, 2H); 
13C NMR (125 MHz, CD3OD) δ 178.1, 157.3, 
139.5, 137.5, 132.0, 131.8, 130.7, 129.5, 110.9, 57.3, 56.7, 53.8, 51.6, 46.9, 43.7, 42.3, 
33.8, 30.6, 30.0, 29.9, 29.4, 28.9, 28.6, 28.5, 26.9, 25.9; IR (film) 3004, 2923, 2857, 
2791, 1558, 1444, 1386, 1357, 1330, 1277, 1238, 1132, 1081, 953, 936, 850, 794, 756, 
726 cm-1; HRMS-ESI: Exact mass calcd for C26H36N2O2 [M+H]+: 409.2850; found: 
409.2859; [α]D 
22.2 = –86.9 (c = 0.88, MeOH). 
 
(–)-Nakadomarin A (1).
41 To a solution of lactam 63 (210 mg, 0.51 mmol, 1.00 equiv.) 
and 2,6-di-tert-butyl-4-methylpyridine (423 mg, 2.06 mmol, 4.00 equiv.) in DCM (10 
mL) was added Tf2O (259 µL, 1.54 mmol, 3.00 equiv.) via syringe pump over a 30 min 
period. After addition the reaction was stirred at rt for an additional 30 min, then dry 
                                                 
41 This 2-steps procedure was developed by Dr. Simone Bonazzi. 
N
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93 
MeOH  (10  mL)  and  NaCNBH3  (641  mg,  10.2  mmol,  20.0  equiv.)  were  added.  The 
resulting  solution  was  stirred  at  rt  overnight,  then  quenched  by  addition  of  saturated 
Na2CO3. The volatiles were removed under reduced pressure and the mixture extracted 
with EtOAc (3x). The combined layers were dried (Na2SO4) and concentrated in vacuo. 
The crude was dissolved in Et2O, the precipitate removed by filtration and the filtrate 
concentrated.  The  product  was  purified  on  a  Teledyne  Isco  CombiFlash®  instrument 
(RediSepRf Gold C18 column (15.5 g, 20 – 40 µm), H2O/MeOH 2:8 to 1:9) to give (–)-
nakadomarin A (1) (105 mg, 0.27 mmol, 52%) as a colorless solid. 
 
 
      To a solution of amide 57 (84 mg, 0.20 mmol) and 2,6-di-tert-butyl-4-methyl pyridine 
(167  mg,  0.82  mmol)  in  DCM  (4.0  mL)  was  added  Tf2O  (0.125  mL,  0.74  mmol) 
dropwise. The reaction mixture was stirred at room temperature for 2h. Vitride
® (2.0 mL, 
65% in toluene) was then added dropwise at −78 °C. The reaction mixture was warmed 
to rt and stirred for 1h and then 60 °C for 2h, and cooled to −78 °C. The reaction was 
quenched by adding acetic acid (0.80 mL) dropwise, and then stirred for 10 min at rt. 
DCM was added, followed by saturated Rochelle’s salt and Na2CO3 (aq). The mixture 
was stirred for 30 min until clear solution was obtained. The aqueous layer was extracted 
with  DCM  and  organic  layer  was  dried  over  Na2SO4,  concentrated  under  vacuum. 
Purification by flash column chromatography with DCM to EtOAc to 30% MeOH in 
EtOAc afforded the natural product (58 mg, 0.15 mmol, 74%). On a larger scale (500 mg, 
N
O
N
O
O
N
O
N
H
2,6-di-tert-butyl-4-methyl pyridine,
Tf2O;
then Red-Al
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1.18 mmol bisamide 57), (−)-nakadomarin A was obtained in 69% yield (317 mg, 0.81 
mmol). Rf = 0.15 (EtOAc/MeOH 7.5:2.5); 
1H NMR (600 MHz, CD3OD) δ 5.89 (s, 1H), 
5.85 – 5.80 (m, 1H), 5.56 – 5.50 (m, 1H), 5.50 – 5.45 (m, 1H), 5.33 – 5.26 (m, 1H), 3.95 
(s, 1H), 3.77 – 3.71 (m, 1H), 3.08 – 3.01 (m, 1H), 3.07 (d, J = 12.1 Hz, 1H), 2.86 (br s, 
1H), 2.84 – 2.78 (m, 1H), 2.75 (ddd, J = 14.2, 7.1, 2.3 Hz, 1H), 2.69 – 2.62 (m, 2H), 2.56 
– 2.49 (m, 1H), 2.44 (dt, J = 11.8, 3.7 Hz, 1H), 2.39 – 2.33 (m, 2H), 2.34 (d, J = 12.3 Hz, 
1H), 2.23 – 2.14 (m, 2H), 2.14 – 2.08 (m, 1H), 2.08 – 2.00 (m, 1H), 1.98 – 1.91 (m, 1H), 
1.93 (dd, J = 12.3, 4.7 Hz, 1H), 1.85 (ddd, J = 14.2, 7.2, 2.8 Hz, 1H), 1.78 – 1.59 (m, 
4H), 1.51 (dd, J = 12.2, 10.1 Hz, 1H), 1.47 – 1.39 (m, 1H), 1.39 – 1.33 (m, 1H), 1.15 – 
1.05 (m, 2H), 0.97 – 0.86 (m, 1H); 
13C NMR (125 MHz, CD3OD) δ 163.1, 157.6, 135.8, 
135.2, 133.1, 132.6, 130.1, 105.6, 75.5, 64.5, 61.5, 60.1, 59.0, 51.8, 46.9, 44.4, 44.0, 30.4, 
30.1, 30.1, 29.7, 28.1, 28.0, 26.8, 26.8, 23.9; IR (film) 3005, 2923, 2857, 2792, 1694, 
1556, 1444, 1386, 1354, 1330, 1280, 1239, 1133, 1081, 1063, 953, 936, 850, 793, 756, 
726  cm
-1;  HRMS-ESI:  Exact  mass  calcd  for  C26H36N2O  [M+H]+:  393.2900;  found: 
393.2906; [α]D
21.5 = –64.3 (c = 0.31, MeOH). Lit.
42 [α]D
25 = –65.6 (c = 0.66, MeOH); 
HPLC-MS: Column: Phenomenex Kinetex 2.6 µm, C-18, 100 Å, 100 x 2.1 mm. Solvent 
system: A: 95% water, 5% CH3CN, 0.1% HCO2H, 2 mM NH4OAc. B: 95% CH3CN, 5% 
water, 0.1% HCO2H, 2 mM NH4OAc. Flow rate: 0.400 mL/min. Gradient: 1% B (t = 0 
min), 30% B (t = 0.5 min), 100% B (t = 4.0 min), 100% B (t = 5.0 min), 1% B (t = 6.1 
min), 1% B (t = 8.1 min). (–)-nakadomarin A (1): tr 2.38 min (254 nm). ESI-MS for 
[M+H]+: 393 m/z. 
 
 
                                                 
42 Jakubec, P.; Cockfield, D.; Dixon, D. J. Am. Chem. Soc. 2009, 131, 16632–16633.  
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Comparison of observed 
13C NMR signals for synthetic (–)-nakadomarin A. 
Nishida 
(Angew. Chem. Int. Ed. 2004, 
42, 2020) 
Funk 
(Org. Lett. 2010, 12, 4912) 
Dixon 
(J. Am. Chem. Soc. 2009, 131, 
16632) 
Evans 
(49.0 ppm for CHD2OD) 
23.0 
25.8 
25.9 
27.1 
27.2 
28.8 
29.1 
29.2 
29.5 
43.1 
43.4 
46.1 
50.9 
58.4 
59.3 
60.6 
63.6 
74.8 
104.8 
129.3 
131.3 
132.2 
134.8 
135.4 
156.3 
162.6 
 
23.0 
25.8 
25.9 
27.1 
27.2 
28.8 
29.1 
29.2 
29.5 
43.1 
43.4 
46.1 
50.9 
58.3 
59.3 
60.6 
63.6 
74.7 
104.7 
129.3 
131.4 
132.2 
134.7 
135.3 
156.4 
162.5 
23.0 
25.9 
26.0 
27.1 
27.2 
28.8 
29.2 
29.2 
29.5 
43.1 
43.4 
46.1 
50.9 
58.3 
59.3 
60.6 
63.6 
74.7 
104.8 
129.3 
131.5 
132.3 
134.7 
135.3 
156.4 
162.5 
22.9 
25.6 
25.9 
27.1 
27.2 
28.8 
29.0 
29.2 
29.5 
42.9 
43.2 
46.1 
51.0 
58.7 
59.2 
60.5 
63.6 
74.8 
104.8 
129.2 
131.0 
132.2 
135.1 
135.8 
155.7 
162.7 
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      To a solution of bisamide 57 (20 mg) and 2,6-di-tert-butyl-4-methyl pyridine (32 mg,  
mmol) in DCM (1.6 mL) was added Tf2O (0.022 mL) dropwise. The mixture was stirred 
at rt for 2h, and then quenched with Na2CO3 (aq) and extracted with DCM, dried over 
Na2SO4,  concentrated  and  filtered  through  silica  gel,  eluted  with  DCM,  then 
DCM/MeOH (20:1) to obtain the product (25 mg, 95%). 
1H NMR (CDCl3, 500 MHz) δ 
6.39 (s, 1H), 5.88 (app q, J = 9.0 Hz, 1H), 5.76(dd, J= 11.5, 4.6 Hz, 1H), 5.33 (m, 3H), 
4.21 (m, 1H), 4.07 (dd, J = 13.3, 11.9 Hz, 1H), 3.97 (ddd, J = 16.9, 11.0, 3.2 Hz, 1H), 
3.83 (d, J = 14.7 Hz, 1H), 3.70 (bs, 1H), 3.58 (d, J = 14.7 Hz, 1H), 3.35 (dd, J = 12.8, 9.2 
Hz, 1H), 3.06 (dd, J = 13.3, 6.0 Hz, 1H), 2.61-2.79 (m, 4H), 2.44 (dt, J = 13.7, 3.7 Hz, 
1H), 2.36 (m, 2H), 2.25 (m, 1H), 2.18 (m, 1H), 2.08 (d, J = 12.8 Hz, 1H), 1.84 (m, 3H), 
1.62-1.76 (m, 2H), 1.28 (m, 1H), 1.05 (m, 1H), 0.75 (m, 1H), 013 (m, 1H). 
13C NMR 
(CDCl3, 125 MHz) δ 177.6, 170.6, 169.8, 168.2, 142.7, 132.4, 130.4, 129.2, 125.7, 110.0, 
73.1, 66.2, 55.2, 51.9, 46.8, 41.2, 39.0, 33.6, 29.82, 29.77, 28.5, 27.6, 26.4, 25.0, 23.7, 
23.3. [α]
23
D = −137 (c 1.54, CHCl3). IR (film): 3013, 2947, 2862, 1694, 1667, 1553, 1499, 
1451, 1428, 1328, 1270, 1223, 1158, 1030 cm
-1. HRMS-ESI: calculated for (C26H33N2O2) 
405.2537, found 405.2542. 
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      To a solution of 2-bromopropenal diethylacetal 66 (121 mg, 0.579 mmol) in THF 
(0.50  mL)  at  -78  °C  was  added  n-BuLi  (025  mL,  2.5  M  in  hexanes,  0.625  mmol) 
dropwise. After 30 min, CuBr•SMe2 (130 mg, 0.632 mmol) was added and the mixture 
was warmed to -50 °C and stirred for 30 min at this temperature, the resultant clear 
cuprate solution was then cooled to -78 °C. 
      In a separate flask, Et2Zn (0.70 mL, 1 M in hexanes, 0.70 mmol) was added dropwise 
to a solution of CH2I2 (0.39 g, 1.5 mmol) in THF (0.50 mL) at -78 °C. The mixture was 
stirred for 30 min at -78 °C, then 30 min at 0 °C to give the Zn(CH2I)2 solution. 
      Imine 49 (72 mg, 0.453 mmol) was added to the cuprate solution at -78 °C, followed 
by immediate addition of the Zn(CH2I)2 solution prepared above. The reaction mixture 
was  stirred  for  1h  and  the  cooling  bath  temperature  raised  from  -50  to  -20  °C.  The 
solution was then warmed to rt and quenched with basic NH4Cl/NH3 solution and diluted 
with EtOAc. The organic layer was washed with basic NH4Cl/NH3 solution until the 
aqueous layer colorless. The organic layer was dried over Na2SO4 and concentrated. The 
crude product was further dried under high vacuum and used without further purification. 
An analytical pure sample could be obtained by flash column chromatography with 20-
40% EtOAc in hexanes with trace amount of Et3N. 
1H NMR (CDCl3, 500 MHz) δ 5.88 
(ddd, J = 17.1, 10.3, 6.3 Hz, 1H), 5.27 (app. d, J = 17 Hz, 1H), 5.24 (s, 1H), 5.14 (app d, 
J = 10.3 Hz, 1H), 5.05 (s, 1H), 4.69 (s, 1H), 4.01 (quint, J = 6.8 Hz, 1H), 3.57 (m, 2H), 
3.51 (d, J = 6.8 Hz, 1H), 3.43 (m, 2H), 2.37 (m, 2H), 1.19 (t, J = 7.0 Hz, 6H), 1.17 (s, 
9H). 
13C NMR (CDCl3, 100 MHz) δ 141.7, 139.5, 116.5, 116.1, 103.5, 61.81, 61.88, 57.3, 
55.7, 37.6, 22.4, 14.9. [α]
23
D = −60.0 (c 1.35, CHCl3). IR (film): 3227, 3079, 2977, 2873,  
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1644, 1475, 1444, 1417, 1390, 1364, 1329, 1117, 1062 cm
-1. HRMS-ESI: calculated for 
(C15H29NO3S+Na) 326.1760, found 326.1776. 
      The crude allylation product was mixed with 1-iodo-5-hexene (146 mg, 0.695 mmol) 
in DMF (2.0 mL) and cooled to 0 °C. NaH (130 mg, 60% dispersion in oil, 3.25 mmol) 
was added in one portion. After 2.5 h at rt, the reaction was quenched with H2O and 
extracted with diethyl ether, dried over Na2SO4 and concentrated. Purification by flash 
column chromatography with 20% EtOAc in hexanes afforded the product (91 mg, 0.236 
mmol, 52% over 2 steps). 
1H NMR (CDCl3, 500 MHz) δ 5.75 (m, 2H), 5.19 (s, 1H), 5.11 
(app d, J = 17.6 Hz, 1H), 5.10 (app d, J = 11.1 Hz, 1H), 5.00 (s, 1H), 4.96 (app d, J = 17.0 
Hz, 1H), 4.91 (app d, J = 11.1 Hz, 1H), 4.67 (s, 1H), 4.00 (bs, 1H), 3.53 (m, 2H), 3.40 (m, 
2H), 3.11 (m, 1H), 2.71 (m, 1H), 2.61 (d, J =14.1 Hz, 1H), 2.43 (m, 1H), 2.01 (m, 2H), 
1.61 (m, 1H), 1.47 (m, 1H), 1.32 (m, 2H), 1.12-1.17 (m, 15H). 
13C NMR (CDCl3, 100 
MHz) δ 142.5, 138.3, 137.8, 116.8, 115.6, 114.6, 103.6, 61.7, 60.7, 57.6, 42.8, 34.5, 33.3, 
29.5, 26.4, 23.6, 15.0. [α]
23
D = +31.7 (c 2.17, CHCl3). IR (film): 3078, 2976, 2930, 2868, 
1641,  1456,  1418,  1360,  1329,  1119,  1066  cm
-1.  HRMS-ESI:  calculated  for 
(C21H39NO3S+Na) 408.2543, found 408.2561. 
 
      To a solution of acetal 70 (91 mg, 0.236 mmol) in THF (1.0 mL) was added 10% 
oxalic acid (0.60 mL). The mixture was stirred at rt for 1h, and then quenched with 
Na2CO3 (aq) and extracted with diethyl ether. The organic extract was dried over Na2SO4 
and  concentrated.  Purification  by  flash  column  chromatography  with  diethyl  ether 
N
S
H
O
O
N
S
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70 
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afforded the aldehyde as colorless oil (69 mg, 0.221 mmol, 94%). 
1H NMR (CDCl3, 600 
MHz) δ 9.40 (s, 1H), 6.28 (s, 1H), 6.00 (s, 1H), 5.66 (m, 2H), 5.02 (d, J = 10.6 Hz, 1H), 
4.96 (d, J = 17.0 Hz, 1H), 4.91 (app d, J = 17.0 Hz, 1H), 4.86 (d, J = 10.0 Hz, 1H), 3.87 
(bs, 1H), 3.07 (m, 1H), 2.71 (m, 1H), 2.65 (m, 1H), 2.58 (m, 1H), 1.97 (m, 2H), 1.53 (m, 
1H), 1.42 (m, 1H), 1.28 (m, 2H), 1.08 (s, 9H). 
13C NMR (CDCl3, 100 MHz) δ 194.0, 
146.5, 138.1, 137.0, 136.3, 116.8, 114.6, 60.1, 57.7, 43.5, 33.1, 31.2, 29.5, 26.2, 23.4. 
[α]
23
D = +48.5 (c 2.10, CHCl3). IR (film): 3079, 2978, 2932, 2864, 1689, 1640, 1458, 
1419, 1361, 1063 cm
-1. HRMS-ESI: calculated for (C17H29NO2S+Na) 334.1811, found 
334.1807. 
 
A solution of olefin (46 mg, 0.148 mmol) in toluene (140 mL) was heated in a 110 °C oil 
bath. Hoveyda-Grubbs 2
nd generation catalyst (20 mg) in toluene (1.0 mL) was added in 4 
portions over 2 hours. After another 30 min, the solution was cooled and filtered through 
silica gel and eluted with DCM, then EtOAc to obtain product 72 (28 mg, 0.097 mmol, 
67%). Recrystallization from diethyl ether afforded analytical pure compound.  
1H NMR 
(CDCl3, 600 MHz) δ 9.53 (s, 1H), 6.39 (s, 1H), 6.13 (s, 1H), 5.66 (m, 1H), 5.21 (ddd, J = 
11.5, 6.4, 1.8 Hz, 1H), 4.34 (m, 1H), 3.46 (ddd, J = 12.8, 10.5, 1.8 Hz, 1H), 3.20 (ddd, J = 
14.2, 6.4, 1.8 Hz, 1H), 2.82 (dd, J = 13.7, 5.0 Hz, 1H), 2.74 (m, 1H), 2.59 (dd, J = 13.7, 
10.1 Hz, 1H), 2.00 (ddd, J = 17.9, 8.7, 4.6 Hz, 1H), 1.92 (m, 1H), 1.72 (m, 1H), 1.59 (m, 
1H), 1.37 (m, 1H), 1.19 (s, 9H). 
13C NMR (CDCl3, 125 MHz) δ 194.2, 147.1, 136.3, 
130.1, 129.7, 58.3, 56.0, 43.9, 32.2, 26.7, 26.5, 24.6, 23.8. [α]
23
D = −19.9 (c 0.34, CHCl3). 
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IR (film): 3053, 2984, 2928, 2861, 1691, 1445, 1421, 1362 cm
-1. HRMS-ESI: calculated 
for (C15H25NO2S+K) 322.1238, found 322.1236. 
 
A mixture of aldehyde 72 (8.8 mg, 0.031 mol) and TsOH•H2O (6.3 mg, 0.033 mmol) in 
MeOH (0.30 mL) was stirred at rt for 2h. The solvent was removed and the residue was 
dissolved in CHCl3 (0.30 mL). The solution was stirred at 40 °C for 6h and concentrated. 
The  residue  was  washed  with  diethyl  ether  and  decanted,  dried  under  high  vacuum 
afforded iminium 5-OTs (10.9 mg, 0.032 mmol, quant.). 
1H NMR (CDCl3, 400 MHz) δ 
9.46 (s, 1H), 7.70 (d, J = 7.8 Hz, 2H), 7.11 (d, J = 7.8 Hz, 2H), 6.44 (bs, 1H), 6.11 (m, 
1H), 6.01 (bs, 1H), 5.41 (m, 2H), 4.46 (m, 1H), 3.96 (m, 1H), 3.35 (m, 1H), 2.70 (m, 1H), 
2.31 (s, 3H), 2.25 (m, 2H), 2.00 (m, 2H), 1.81 (m, 1H), 1.46 (m, 1H). 
13C NMR (CDCl3, 
100 MHz) δ 172.4, 143.0, 142.9, 139.5, 139.1, 131.1, 128.6, 125.9, 125.6, 66.2, 52.8, 
33.9, 27.2, 26.4, 26.2, 21.2. [α]
23
D = −102 (c 0.80, CHCl3). IR (film): 3427, 3007, 2946, 
2864, 1621, 1496, 1445, 1215, 1182, 1123 cm
-1. HRMS-ESI: calculated for (C11H16N) 
162.1277, found 162.1244. 
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(−)-Nakadomarin A: 
1H NMR  
Natural: Kobayashi, J.; Watanabe, D.; Kawasaki, N.; Tsuda, M. J. Org. Chem. 1997, 62, 9236–9239. 
 
Influence of acid on the 
1H NMR spectrum of (−)-nakadomarin A.  
Nagata, T.; Nakagawa, M.; Nishida, A. J. Am. Chem. Soc. 2003, 125, 7484–7485. 
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(−)-Nakadomarin A:
 1H NMR  
Dixon: Jakubec, P.; Cockfield, D.; Dixon, D. J. Am. Chem. Soc. 2009, 131, 16632–16633.
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(−)-Nakadomarin A: 
13C NMR  
Natural: Kobayashi, J.; Watanabe, D.; Kawasaki, N.; Tsuda, M. J. Org. Chem. 1997, 62, 9236–9239.  
 
Dixon: Jakubec, P.; Cockfield, D.; Dixon, D. J. Am. Chem. Soc. 2009, 131, 16632–16633.
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Appendix III 
X-ray Structure Data 
   166 
(R,Z)-2-((tert-butyldimethylsilyl)oxy)-5-((2-nitrophenyl)sulfonyl)-15-oxa-5-
azabicyclo[12.2.1]heptadeca-1(16),10,14(17)-triene (19) 
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Figure 1. X-ray Structure of 19. 
 
 
   167 
X-Ray Crystallography:  A crystal mounted on a diffractometer was collected data at 
100 K.  The intensities of the reflections were collected by means of a Bruker APEX II 
CCD  diffractometer  (MoKα  radiation,  λ=0.71073  Å),  and  equipped  with  an  Oxford 
Cryosystems nitrogen flow apparatus.  The collection method involved 0.5° scans in ω at 
28° in 2θ.  Data integration down to 0.74 Å resolution was carried out using SAINT 
V7.46 A (Bruker diffractometer, 2009) with reflection spot size optimisation.  Absorption 
corrections were made with the program SADABS (Bruker diffractometer, 2009).  The 
structure  was  solved  by  the  direct  methods  procedure  and  refined  by  least-squares 
methods again F
2 using SHELXS-97 and SHELXL-97 (Sheldrick,
 2008).  Non-hydrogen 
atoms were refined anisotropically, and hydrogen atoms were allowed to ride on the 
respective atoms.  Crystal data as well as details of data collection and refinement are 
summarized in Table 1, and geometric parameters are shown in Table 2. The Ortep plots 
produced  with  SHELXL-97  program,  and  the  other  drawings  were  produced  with 
Accelrys DS Visualizer 2.0 (Accelrys, 2007). 
 
Table 1. Experimental details 
 
  cbc002 
Crystal data 
Chemical formula  C27H40N2O6SSi 
Mr  548.76 
Crystal system, space group  Orthorhombic, p212121 
Temperature (K)  100 
a, b, c (Å)  8.3473 (4), 16.1064 (7), 21.0353 (9) 
V (Å
3)  2828.1 (2) 
Z  4 
Radiation type  Mo Kα   168 
Table 1 (Continued). 
µ (mm
-1)  0.20 
Crystal size (mm)  0.32 × 0.24 × 0.18 
Data collection 
Diffractometer  CCD area detector diffractometer 
Absorption correction  Multi-scan  
SADABS 
 Tmin, Tmax  0.939, 0.965 
No.  of  measured,  independent 
and  observed  [I  >  2σ(I)] 
reflections 
108710, 7335, 7178   
Rint  0.034 
Refinement 
R[F
2 > 2σ(F
2)], wR(F
2), S  0.024,  0.065,  1.07 
No. of reflections  7335 
No. of parameters  339 
No. of restraints  0 
H-atom treatment  H-atom parameters constrained 
Δρmax, Δρmin (e Å
-3)  0.32, -0.26 
Absolute structure  Flack H D (1983), Acta Cryst. A39, 876-881 
Flack parameter  0.00 (4) 
 
Computer  programs:  APEX2  v2009.3.0  (Bruker-AXS,  2009),  SAINT  7.46A  (Bruker-AXS,  2009), 
SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Bruker SHELXTL. 
 
Table 2. Geometric parameters (Å, º) 
S1—O3  1.4333 (8)  C11—H11A  0.9900 
S1—O4  1.4379 (8)  C11—H11B  0.9900 
S1—N1  1.6236 (9)  C12—H12A  0.9900 
S1—C16  1.7881 (10)  C12—H12B  0.9900 
Si1—O2  1.6572 (8)  C13—C14  1.5293 (14) 
Si1—C23  1.8633 (13)  C13—H13A  0.9900 
Si1—C22  1.8707 (12)  C13—H13B  0.9900 
Si1—C24  1.8809 (11)  C14—C15  1.5324 (13) 
O1—C1  1.3747 (14)  C14—H14A  0.9900 
   169 
Table 2 (Continued). 
O1—C4  1.3759 (14)  C14—H14B  0.9900 
O2—C15  1.4289 (12)  C15—H15  1.0000 
O5—N2  1.2171 (14)  C16—C17  1.3939 (15) 
O6—N2  1.2260 (13)  C16—C21  1.3996 (14) 
N1—C13  1.4907 (12)  C17—C18  1.3871 (15) 
N1—C12  1.4913 (13)  C18—C19  1.3919 (15) 
N2—C17  1.4788 (13)  C18—H18  0.9500 
C1—C2  1.3529 (15)  C19—C20  1.3890 (16) 
C1—H1  0.9500  C19—H19  0.9500 
C2—C3  1.4433 (14)  C20—C21  1.3914 (15) 
C2—C15  1.5018 (15)  C20—H20  0.9500 
C3—C4  1.3577 (16)  C21—H21  0.9500 
C3—H3  0.9500  C22—H22A  0.9800 
C4—C5  1.4948 (16)  C22—H22B  0.9800 
C5—C6  1.5420 (18)  C22—H22C  0.9800 
C5—H5A  0.9900  C23—H23A  0.9800 
C5—H5B  0.9900  C23—H23B  0.9800 
C6—C7  1.5024 (18)  C23—H23C  0.9800 
C6—H6A  0.9900  C24—C26  1.5346 (17) 
C6—H6B  0.9900  C24—C25  1.5389 (15) 
C7—C8  1.3294 (17)  C24—C27  1.5426 (16) 
C7—H7  0.9500  C25—H25A  0.9800 
C8—C9  1.4992 (17)  C25—H25B  0.9800 
C8—H8  0.9500  C25—H25C  0.9800 
C9—C10  1.5339 (16)  C26—H26A  0.9800 
C9—H9A  0.9900  C26—H26B  0.9800 
C9—H9B  0.9900  C26—H26C  0.9800 
C10—C11  1.5195 (15)  C27—H27A  0.9800 
C10—H10A  0.9900  C27—H27B  0.9800 
C10—H10B  0.9900  C27—H27C  0.9800 
C11—C12  1.5186 (15)     
 
O3—S1—O4  119.72 (5)  H12A—C12—H12B  107.8 
O3—S1—N1  108.03 (5)  N1—C13—C14  112.22 (8) 
O4—S1—N1  108.27 (4)  N1—C13—H13A  109.2 
O3—S1—C16  105.10 (5)  C14—C13—H13A  109.2   170 
Table 2 (Continued). 
O4—S1—C16  106.79 (5)  N1—C13—H13B  109.2 
N1—S1—C16  108.49 (5)  C14—C13—H13B  109.2 
O2—Si1—C23  109.42 (5)  H13A—C13—H13B  107.9 
O2—Si1—C22  109.19 (5)  C13—C14—C15  112.87 (8) 
C23—Si1—C22  109.84 (6)  C13—C14—H14A  109.0 
O2—Si1—C24  105.06 (5)  C15—C14—H14A  109.0 
C23—Si1—C24  111.71 (5)  C13—C14—H14B  109.0 
C22—Si1—C24  111.47 (5)  C15—C14—H14B  109.0 
C1—O1—C4  106.67 (9)  H14A—C14—H14B  107.8 
C15—O2—Si1  121.78 (7)  O2—C15—C2  108.69 (8) 
C13—N1—C12  117.10 (8)  O2—C15—C14  109.82 (8) 
C13—N1—S1  119.03 (7)  C2—C15—C14  114.27 (9) 
C12—N1—S1  114.83 (6)  O2—C15—H15  108.0 
O5—N2—O6  125.67 (10)  C2—C15—H15  108.0 
O5—N2—C17  117.44 (9)  C14—C15—H15  108.0 
O6—N2—C17  116.76 (9)  C17—C16—C21  117.71 (9) 
C2—C1—O1  110.87 (10)  C17—C16—S1  124.47 (8) 
C2—C1—H1  124.6  C21—C16—S1  117.78 (8) 
O1—C1—H1  124.6  C18—C17—C16  122.34 (10) 
C1—C2—C3  105.72 (10)  C18—C17—N2  115.35 (9) 
C1—C2—C15  126.38 (10)  C16—C17—N2  122.31 (9) 
C3—C2—C15  127.70 (10)  C17—C18—C19  118.81 (10) 
C4—C3—C2  106.99 (9)  C17—C18—H18  120.6 
C4—C3—H3  126.5  C19—C18—H18  120.6 
C2—C3—H3  126.5  C20—C19—C18  120.23 (10) 
C3—C4—O1  109.76 (9)  C20—C19—H19  119.9 
C3—C4—C5  134.80 (11)  C18—C19—H19  119.9 
O1—C4—C5  115.43 (10)  C19—C20—C21  120.10 (10) 
C4—C5—C6  114.43 (9)  C19—C20—H20  120.0 
C4—C5—H5A  108.7  C21—C20—H20  120.0 
C6—C5—H5A  108.7  C20—C21—C16  120.76 (10) 
C4—C5—H5B  108.7  C20—C21—H21  119.6 
C6—C5—H5B  108.7  C16—C21—H21  119.6 
H5A—C5—H5B  107.6  Si1—C22—H22A  109.5 
C7—C6—C5  113.56 (11)  Si1—C22—H22B  109.5 
C7—C6—H6A  108.9  H22A—C22—H22B  109.5   171 
Table 2 (Continued). 
C5—C6—H6A  108.9  Si1—C22—H22C  109.5 
C7—C6—H6B  108.9  H22A—C22—H22C  109.5 
C5—C6—H6B  108.9  H22B—C22—H22C  109.5 
H6A—C6—H6B  107.7  Si1—C23—H23A  109.5 
C8—C7—C6  127.23 (12)  Si1—C23—H23B  109.5 
C8—C7—H7  116.4  H23A—C23—H23B  109.5 
C6—C7—H7  116.4  Si1—C23—H23C  109.5 
C7—C8—C9  126.90 (12)  H23A—C23—H23C  109.5 
C7—C8—H8  116.5  H23B—C23—H23C  109.5 
C9—C8—H8  116.5  C26—C24—C25  108.66 (10) 
C8—C9—C10  111.12 (10)  C26—C24—C27  108.96 (9) 
C8—C9—H9A  109.4  C25—C24—C27  108.97 (10) 
C10—C9—H9A  109.4  C26—C24—Si1  110.38 (8) 
C8—C9—H9B  109.4  C25—C24—Si1  110.14 (7) 
C10—C9—H9B  109.4  C27—C24—Si1  109.70 (8) 
H9A—C9—H9B  108.0  C24—C25—H25A  109.5 
C11—C10—C9  111.64 (9)  C24—C25—H25B  109.5 
C11—C10—H10A  109.3  H25A—C25—H25B  109.5 
C9—C10—H10A  109.3  C24—C25—H25C  109.5 
C11—C10—H10B  109.3  H25A—C25—H25C  109.5 
C9—C10—H10B  109.3  H25B—C25—H25C  109.5 
H10A—C10—H10B  108.0  C24—C26—H26A  109.5 
C12—C11—C10  113.80 (9)  C24—C26—H26B  109.5 
C12—C11—H11A  108.8  H26A—C26—H26B  109.5 
C10—C11—H11A  108.8  C24—C26—H26C  109.5 
C12—C11—H11B  108.8  H26A—C26—H26C  109.5 
C10—C11—H11B  108.8  H26B—C26—H26C  109.5 
H11A—C11—H11B  107.7  C24—C27—H27A  109.5 
N1—C12—C11  113.09 (8)  C24—C27—H27B  109.5 
N1—C12—H12A  109.0  H27A—C27—H27B  109.5 
C11—C12—H12A  109.0  C24—C27—H27C  109.5 
N1—C12—H12B  109.0  H27A—C27—H27C  109.5 
C11—C12—H12B  109.0  H27B—C27—H27C  109.5 
 
C23—Si1—O2—C15  65.18 (9)  C3—C2—C15—O2  -177.03 (10) 
C22—Si1—O2—C15  -55.07 (9)  C1—C2—C15—C14  -126.00 (11)   172 
Table 2 (Continued). 
C24—Si1—O2—C15  -174.74 (7)  C3—C2—C15—C14  59.93 (14) 
O3—S1—N1—C13  162.21 (8)  C13—C14—C15—O2  -50.92 (12) 
O4—S1—N1—C13  31.18 (9)  C13—C14—C15—C2  71.50 (11) 
C16—S1—N1—C13  -84.36 (8)  O3—S1—C16—C17  -145.34 (9) 
O3—S1—N1—C12  -51.61 (9)  O4—S1—C16—C17  -17.20 (10) 
O4—S1—N1—C12  177.36 (7)  N1—S1—C16—C17  99.30 (9) 
C16—S1—N1—C12  61.83 (9)  O3—S1—C16—C21  32.33 (9) 
C4—O1—C1—C2  0.35 (12)  O4—S1—C16—C21  160.48 (8) 
O1—C1—C2—C3  -0.06 (13)  N1—S1—C16—C21  -83.03 (9) 
O1—C1—C2—C15  -175.19 (9)  C21—C16—C17—C18  -0.42 (15) 
C1—C2—C3—C4  -0.25 (12)  S1—C16—C17—C18  177.25 (8) 
C15—C2—C3—C4  174.79 (10)  C21—C16—C17—N2  179.23 (9) 
C2—C3—C4—O1  0.47 (12)  S1—C16—C17—N2  -3.09 (14) 
C2—C3—C4—C5  -178.18 (12)  O5—N2—C17—C18  -77.67 (13) 
C1—O1—C4—C3  -0.51 (12)  O6—N2—C17—C18  98.40 (12) 
C1—O1—C4—C5  178.43 (10)  O5—N2—C17—C16  102.64 (12) 
C3—C4—C5—C6  -75.12 (17)  O6—N2—C17—C16  -81.28 (13) 
O1—C4—C5—C6  106.28 (12)  C16—C17—C18—C19  1.97 (16) 
C4—C5—C6—C7  68.56 (14)  N2—C17—C18—C19  -177.71 (10) 
C5—C6—C7—C8  -113.17 (15)  C17—C18—C19—C20  -1.50 (16) 
C6—C7—C8—C9  4.3 (2)  C18—C19—C20—C21  -0.46 (17) 
C7—C8—C9—C10  122.87 (14)  C19—C20—C21—C16  2.05 (16) 
C8—C9—C10—C11  -168.60 (10)  C17—C16—C21—C20  -1.60 (15) 
C9—C10—C11—C12  -168.75 (9)  S1—C16—C21—C20  -179.43 (8) 
C13—N1—C12—C11  -58.04 (12)  O2—Si1—C24—C26  54.37 (8) 
S1—N1—C12—C11  155.10 (8)  C23—Si1—C24—C26  172.91 (8) 
C10—C11—C12—N1  -51.02 (12)  C22—Si1—C24—C26  -63.78 (9) 
C12—N1—C13—C14  141.05 (9)  O2—Si1—C24—C25  -65.62 (9) 
S1—N1—C13—C14  -73.52 (10)  C23—Si1—C24—C25  52.92 (10) 
N1—C13—C14—C15  -158.29 (9)  C22—Si1—C24—C25  176.24 (9) 
Si1—O2—C15—C2  122.96 (8)  O2—Si1—C24—C27  174.44 (8) 
Si1—O2—C15—C14  -111.36 (8)  C23—Si1—C24—C27  -67.02 (9) 
C1—C2—C15—O2  -2.96 (14)  C22—Si1—C24—C27  56.29 (10) 
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Figure 2. Perspective views showing 50% probability displacement ellipsoids  
 
 
Figure  3.  Three-dimensional  supramolecular  architecture  viewed  along  the  a-axis 
direction. 
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Figure 4. X-ray structure of 40. 
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X-Ray Crystallography:  A crystal mounted on a diffractometer was collected data at 
100 K.  The intensities of the reflections were collected by means of a Bruker APEX II 
CCD  diffractometer  (MoKα  radiation,  λ=0.71073  Å),  and  equipped  with  an  Oxford 
Cryosystems nitrogen flow apparatus.  The collection method involved 0.5° scans in ω at 
28° in 2θ.  Data integration down to 0.78 Å resolution was carried out using SAINT 
V7.46 A (Bruker diffractometer, 2009) with reflection spot size optimization.  Absorption 
corrections were made with the program SADABS (Bruker diffractometer, 2009).  The 
structure  was  solved  by  the  direct  methods  procedure  and  refined  by  least-squares 
methods again F
2 using SHELXS-97 and SHELXL-97 (Sheldrick,
 2008) with OLEX 2 
interface (Dolomanov, et al., 2009).  Non-hydrogen atoms were refined anisotropically, 
and hydrogen atoms were allowed to ride on the respective atoms.  Crystal data as well as 
details  of  data  collection  and  refinement  are  summarized  in  Table  3,  and  geometric 
parameters are shown in Table 4.  The Ortep plots produced with SHELXL-97 program, 
and the other drawings were produced with Accelrys DS Visualizer 2.0 (Accelrys, 2007). 
 
Table 3. Experimental details 
  cbc003 
Crystal data 
Chemical formula  C33H42N2O5S 
Mr  578.75 
Crystal system, space group  Orthorhombic, P212121 
Temperature (K)  100 
a, b, c (Å)  8.3285 (3), 12.5911 (4), 28.403 (1) 
V (Å
3)  2978.48 (18) 
Z  4 
Radiation type  Mo Kα 
µ (mm
-1)  0.15   176 
Table 3 (Continued). 
Crystal size (mm)  0.24 × 0.18 × 0.16 
Data collection 
Diffractometer  Bruker D8 goniometer with CCD area detector diffractometer 
Absorption correction  Multi-scan  
SADABS 
 Tmin, Tmax  0.964, 0.976 
No. of measured, independent and 
observed [I > 2σ(I)] reflections 
102148, 6581, 6193   
Rint  0.048 
(sin θ/λ)max (Å
-1)  0.641 
Refinement 
R[F
2 > 2σ(F
2)], wR(F
2), S  0.042,  0.109,  1.07 
No. of reflections  6581 
No. of parameters  371 
No. of restraints  0 
H-atom treatment  H-atom parameters constrained 
Δρmax, Δρmin (e Å
-3)  0.63, -0.29 
Absolute structure  Flack H D (1983), Acta Cryst. A39, 876-881 
Flack parameter  -0.02 (7) 
 
Computer  programs:  APEX2  v2009.3.0  (Bruker-AXS,  2009),  SAINT  7.46A  (Bruker-AXS,  2009), 
SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Bruker SHELXTL (Sheldrick, 2008). 
 
Table 4. Geometric parameters (Å, º) 
C27—C28  1.374 (3)  C10—H10  0.9500 
C27—C32  1.388 (3)  C11—N2  1.331 (3) 
C27—S58  1.781 (2)  C11—O1  1.350 (2) 
C28—C29  1.387 (3)  C12—N2  1.482 (2) 
C28—H28  0.9500  C12—C13  1.520 (3) 
C29—C30  1.389 (3)  C12—H12A  0.9900 
C29—H29  0.9500  C12—H12B  0.9900 
C30—C31  1.388 (4)  C13—C14  1.510 (3) 
C30—C33  1.509 (3)  C13—H13A  0.9900 
C31—C32  1.392 (3)  C13—H13B  0.9900 
C31—H31  0.9500  C14—O1  1.457 (2)   177 
Table 4 (Continued). 
C32—H32  0.9500  C14—C16  1.504 (3) 
C33—H33A  0.9800  C14—H14  1.0000 
C33—H33B  0.9800  C15—C16  1.350 (3) 
C33—H33C  0.9800  C15—O2  1.370 (2) 
O3—S58  1.4545 (17)  C15—H15  0.9500 
O4—S58  1.4543 (16)  C16—C17  1.443 (3) 
O5—S58  1.4571 (15)  C17—C18  1.345 (3) 
C1—N1  1.465 (3)  C17—H17  0.9500 
C1—C2  1.523 (4)  C18—O2  1.378 (2) 
C1—H1A  0.9900  C18—C19  1.495 (3) 
C1—H1B  0.9900  C19—C20  1.533 (3) 
C2—C3  1.497 (5)  C19—H19A  0.9900 
C2—H2A  0.9900  C19—H19B  0.9900 
C2—H2B  0.9900  C20—C21  1.456 (4) 
C3—C4  1.535 (5)  C20—H20A  0.9900 
C3—H3A  0.9900  C20—H20B  0.9900 
C3—H3B  0.9900  C21—C22  1.350 (4) 
C4—C5  1.495 (4)  C21—H21  0.9500 
C4—H4A  0.9900  C22—C23  1.465 (4) 
C4—H4B  0.9900  C22—H22  0.9500 
C5—C6  1.312 (4)  C23—C24  1.554 (4) 
C5—H5  0.9500  C23—H23A  0.9900 
C6—C7  1.509 (3)  C23—H23B  0.9900 
C6—H6  0.9500  C24—C25  1.520 (3) 
C7—N1  1.477 (2)  C24—H24A  0.9900 
C7—C8  1.555 (3)  C24—H24B  0.9900 
C7—H7  1.0000  C25—C26  1.534 (3) 
C8—C9  1.521 (3)  C25—H25A  0.9900 
C8—H8A  0.9900  C25—H25B  0.9900 
C8—H8B  0.9900  C26—N2  1.474 (3) 
C9—C10  1.395 (3)  C26—H26A  0.9900 
C9—C11  1.403 (3)  C26—H26B  0.9900 
C10—N1  1.318 (3)     
 
C28—C27—C32  119.93 (19)  N2—C12—C13  112.90 (17) 
C28—C27—S58  119.15 (15)  N2—C12—H12A  109.0   178 
Table 4 (Continued). 
C32—C27—S58  120.92 (16)  C13—C12—H12A  109.0 
C27—C28—C29  119.8 (2)  N2—C12—H12B  109.0 
C27—C28—H28  120.1  C13—C12—H12B  109.0 
C29—C28—H28  120.1  H12A—C12—H12B  107.8 
C28—C29—C30  121.6 (2)  C14—C13—C12  109.11 (16) 
C28—C29—H29  119.2  C14—C13—H13A  109.9 
C30—C29—H29  119.2  C12—C13—H13A  109.9 
C31—C30—C29  117.8 (2)  C14—C13—H13B  109.9 
C31—C30—C33  121.6 (2)  C12—C13—H13B  109.9 
C29—C30—C33  120.6 (2)  H13A—C13—H13B  108.3 
C30—C31—C32  121.2 (2)  O1—C14—C16  110.13 (15) 
C30—C31—H31  119.4  O1—C14—C13  106.85 (16) 
C32—C31—H31  119.4  C16—C14—C13  114.71 (17) 
C27—C32—C31  119.7 (2)  O1—C14—H14  108.3 
C27—C32—H32  120.2  C16—C14—H14  108.3 
C31—C32—H32  120.2  C13—C14—H14  108.3 
C30—C33—H33A  109.5  C16—C15—O2  110.59 (17) 
C30—C33—H33B  109.5  C16—C15—H15  124.7 
H33A—C33—H33B  109.5  O2—C15—H15  124.7 
C30—C33—H33C  109.5  C15—C16—C17  106.21 (17) 
H33A—C33—H33C  109.5  C15—C16—C14  127.58 (18) 
H33B—C33—H33C  109.5  C17—C16—C14  126.21 (18) 
O4—S58—O3  113.14 (10)  C18—C17—C16  106.44 (18) 
O4—S58—O5  113.10 (10)  C18—C17—H17  126.8 
O3—S58—O5  113.11 (10)  C16—C17—H17  126.8 
O4—S58—C27  105.60 (9)  C17—C18—O2  110.41 (18) 
O3—S58—C27  105.82 (10)  C17—C18—C19  134.2 (2) 
O5—S58—C27  105.12 (9)  O2—C18—C19  115.38 (18) 
N1—C1—C2  114.06 (19)  C18—C19—C20  114.11 (19) 
N1—C1—H1A  108.7  C18—C19—H19A  108.7 
C2—C1—H1A  108.7  C20—C19—H19A  108.7 
N1—C1—H1B  108.7  C18—C19—H19B  108.7 
C2—C1—H1B  108.7  C20—C19—H19B  108.7 
H1A—C1—H1B  107.6  H19A—C19—H19B  107.6 
C3—C2—C1  116.0 (3)  C21—C20—C19  111.2 (2) 
C3—C2—H2A  108.3  C21—C20—H20A  109.4   179 
Table 4 (Continued). 
C1—C2—H2A  108.3  C19—C20—H20A  109.4 
C3—C2—H2B  108.3  C21—C20—H20B  109.4 
C1—C2—H2B  108.3  C19—C20—H20B  109.4 
H2A—C2—H2B  107.4  H20A—C20—H20B  108.0 
C2—C3—C4  115.9 (2)  C22—C21—C20  127.4 (3) 
C2—C3—H3A  108.3  C22—C21—H21  116.3 
C4—C3—H3A  108.3  C20—C21—H21  116.3 
C2—C3—H3B  108.3  C21—C22—C23  128.7 (3) 
C4—C3—H3B  108.3  C21—C22—H22  115.7 
H3A—C3—H3B  107.4  C23—C22—H22  115.7 
C5—C4—C3  111.7 (3)  C22—C23—C24  111.6 (2) 
C5—C4—H4A  109.3  C22—C23—H23A  109.3 
C3—C4—H4A  109.3  C24—C23—H23A  109.3 
C5—C4—H4B  109.3  C22—C23—H23B  109.3 
C3—C4—H4B  109.3  C24—C23—H23B  109.3 
H4A—C4—H4B  107.9  H23A—C23—H23B  108.0 
C6—C5—C4  128.9 (2)  C25—C24—C23  113.5 (2) 
C6—C5—H5  115.5  C25—C24—H24A  108.9 
C4—C5—H5  115.5  C23—C24—H24A  108.9 
C5—C6—C7  131.3 (2)  C25—C24—H24B  108.9 
C5—C6—H6  114.3  C23—C24—H24B  108.9 
C7—C6—H6  114.3  H24A—C24—H24B  107.7 
N1—C7—C6  112.92 (18)  C24—C25—C26  114.52 (18) 
N1—C7—C8  102.42 (16)  C24—C25—H25A  108.6 
C6—C7—C8  111.00 (18)  C26—C25—H25A  108.6 
N1—C7—H7  110.1  C24—C25—H25B  108.6 
C6—C7—H7  110.1  C26—C25—H25B  108.6 
C8—C7—H7  110.1  H25A—C25—H25B  107.6 
C9—C8—C7  103.02 (16)  N2—C26—C25  113.27 (17) 
C9—C8—H8A  111.2  N2—C26—H26A  108.9 
C7—C8—H8A  111.2  C25—C26—H26A  108.9 
C9—C8—H8B  111.2  N2—C26—H26B  108.9 
C7—C8—H8B  111.2  C25—C26—H26B  108.9 
H8A—C8—H8B  109.1  H26A—C26—H26B  107.7 
C10—C9—C11  119.09 (18)  C10—N1—C1  125.16 (17) 
C10—C9—C8  106.64 (17)  C10—N1—C7  111.36 (16)   180 
Table 4 (Continued). 
C11—C9—C8  133.73 (18)  C1—N1—C7  123.48 (17) 
N1—C10—C9  113.04 (18)  C11—N2—C26  121.87 (16) 
N1—C10—H10  123.5  C11—N2—C12  123.61 (17) 
C9—C10—H10  123.5  C26—N2—C12  114.43 (16) 
N2—C11—O1  119.22 (17)  C11—O1—C14  117.40 (15) 
N2—C11—C9  127.39 (18)  C15—O2—C18  106.34 (15) 
O1—C11—C9  113.37 (17)     
 
C32—C27—C28—C29  0.5 (3)  C13—C14—C16—C15  -27.6 (3) 
S58—C27—C28—C29  -179.08 (18)  O1—C14—C16—C17  32.1 (3) 
C27—C28—C29—C30  1.4 (4)  C13—C14—C16—C17  152.66 (19) 
C28—C29—C30—C31  -2.2 (4)  C15—C16—C17—C18  0.3 (2) 
C28—C29—C30—C33  176.5 (2)  C14—C16—C17—C18  -179.90 (18) 
C29—C30—C31—C32  1.3 (4)  C16—C17—C18—O2  -0.3 (2) 
C33—C30—C31—C32  -177.5 (2)  C16—C17—C18—C19  -178.9 (2) 
C28—C27—C32—C31  -1.4 (3)  C17—C18—C19—C20  -110.5 (3) 
S58—C27—C32—C31  178.16 (18)  O2—C18—C19—C20  70.8 (3) 
C30—C31—C32—C27  0.5 (4)  C18—C19—C20—C21  68.1 (3) 
C28—C27—S58—O4  76.95 (19)  C19—C20—C21—C22  -110.7 (3) 
C32—C27—S58—O4  -102.60 (19)  C20—C21—C22—C23  0.7 (5) 
C28—C27—S58—O3  -162.83 (17)  C21—C22—C23—C24  104.0 (3) 
C32—C27—S58—O3  17.6 (2)  C22—C23—C24—C25  60.0 (3) 
C28—C27—S58—O5  -42.9 (2)  C23—C24—C25—C26  177.72 (18) 
C32—C27—S58—O5  137.57 (18)  C24—C25—C26—N2  57.4 (2) 
N1—C1—C2—C3  -63.1 (3)  C9—C10—N1—C1  174.11 (19) 
C1—C2—C3—C4  57.0 (4)  C9—C10—N1—C7  -5.9 (2) 
C2—C3—C4—C5  49.3 (4)  C2—C1—N1—C10  126.6 (2) 
C3—C4—C5—C6  -77.3 (4)  C2—C1—N1—C7  -53.4 (3) 
C4—C5—C6—C7  -3.6 (5)  C6—C7—N1—C10  -103.9 (2) 
C5—C6—C7—N1  8.6 (4)  C8—C7—N1—C10  15.5 (2) 
C5—C6—C7—C8  -105.7 (3)  C6—C7—N1—C1  76.0 (2) 
N1—C7—C8—C9  -18.1 (2)  C8—C7—N1—C1  -164.53 (18) 
C6—C7—C8—C9  102.7 (2)  O1—C11—N2—C26  -171.06 (17) 
C7—C8—C9—C10  15.7 (2)  C9—C11—N2—C26  10.2 (3) 
C7—C8—C9—C11  -173.1 (2)  O1—C11—N2—C12  5.5 (3) 
C11—C9—C10—N1  -179.60 (17)  C9—C11—N2—C12  -173.22 (19)   181 
Table 4 (Continued). 
C8—C9—C10—N1  -6.9 (2)  C25—C26—N2—C11  70.7 (2) 
C10—C9—C11—N2  -175.89 (19)  C25—C26—N2—C12  -106.1 (2) 
C8—C9—C11—N2  13.8 (4)  C13—C12—N2—C11  1.6 (3) 
C10—C9—C11—O1  5.3 (3)  C13—C12—N2—C26  178.34 (17) 
C8—C9—C11—O1  -165.0 (2)  N2—C11—O1—C14  24.1 (2) 
N2—C12—C13—C14  -34.7 (2)  C9—C11—O1—C14  -157.02 (16) 
C12—C13—C14—O1  60.1 (2)  C16—C14—O1—C11  67.9 (2) 
C12—C13—C14—C16  -62.2 (2)  C13—C14—O1—C11  -57.3 (2) 
O2—C15—C16—C17  -0.2 (2)  C16—C15—O2—C18  0.1 (2) 
O2—C15—C16—C14  179.98 (17)  C17—C18—O2—C15  0.1 (2) 
O1—C14—C16—C15  -148.13 (19)  C19—C18—O2—C15  179.07 (18) 
 
  Figure 5. Perspective views showing 50% probability displacement.	 ﾠ
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Figure  6.  Three-dimensional  supramolecular  architecture  viewed  along  the  a-axis 
direction. 
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Figure 7. X-ray structure of (−)-nakadomarin A•2HCl. 
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X-Ray Crystallography:  A crystal mounted on a diffractometer was collected data at 
100 K.  The intensities of the reflections were collected by means of a Bruker APEX II 
DUO CCD diffractometer (CuKα radiation, λ=1.54178 Å), and equipped with an Oxford 
Cryosystems nitrogen flow apparatus.  The collection method involved 1.0° scans in ω at 
30°, 55°, 80° and 115° in 2θ.  Data integration down to 0.84 Å resolution was carried out 
using  SAINT  V7.46  A  (Bruker  diffractometer,  2009)  with  reflection  spot  size 
optimisation.  Absorption corrections were made with the program SADABS (Bruker 
diffractometer, 2009).  The structure was solved by the direct methods procedure and 
refined  by  least-squares  methods  again  F
2  using  SHELXS-97  and  SHELXL-97 
(Sheldrick,
 2008).    Non-hydrogen  atoms  were  refined  anisotropically,  and  hydrogen 
atoms were allowed to ride on the respective atoms. Crystal data as well as details of data 
collection  and  refinement  are  summarized  in  Table  5,  and  geometric  parameters  are 
shown in Table 6. The Ortep plots produced with SHELXL-97 program, and the other 
drawings were produced with Accelrys DS Visualizer 2.0 (Accelrys, 2007). 
 
Table 5. Experimental details 
 
  cbc004 
Crystal data 
Chemical formula  C58H92Cl4N4O4 
Mr  1051.25 
Crystal system, space group  Triclinic, P1 
Temperature (K)  100 
a, b, c (Å)  9.1145 (2), 10.5842 (3), 19.4857 (6) 
α, β, γ (°)  86.220 (2), 78.251 (2), 64.761 (2) 
V (Å
3)  1664.24 (8) 
Z  1   185 
Table 5 (Continued). 
Radiation type  Cu Kα 
µ (mm
-1)  1.93 
Crystal size (mm)  0.14 × 0.08 × 0.06 
Data collection 
Diffractometer  Bruker D8 goniometer with CCD area detector diffractometer 
Absorption correction  Multi-scan  
SADABS 
 Tmin, Tmax  0.774, 0.893 
No. of measured, independent and 
observed [I > 2σ(I)] reflections 
28211, 9146, 8461   
Rint  0.054 
(sin θ/λ)max (Å
-1)  0.596 
Refinement 
R[F
2 > 2σ(F
2)], wR(F
2), S  0.112,  0.286,  1.09 
No. of reflections  9146 
No. of parameters  704 
No. of restraints  93 
H-atom treatment  H atoms treated by a mixture of independent and constrained refinement 
Δρmax, Δρmin (e Å
-3)  0.91, -0.40 
Absolute structure  Flack H D (1983), Acta Cryst. A39, 876-881 
Flack parameter  0.09 (3) 
 
Computer  programs:  APEX2  v2009.3.0  (Bruker-AXS,  2009),  SAINT  7.46A  (Bruker-AXS,  2009), 
SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Bruker SHELXTL (Sheldrick, 2008). 
       
Table 6. Geometric parameters (Å, º) 
C3—N1  1.508 (14)  C33A—N3  1.51 (2) 
C3—C4  1.512 (18)  C34A—C35  1.63 (3) 
C4—C5  1.570 (18)  C35—C36  1.56 (2) 
C2—C1  1.469 (14)  C36—C37  1.448 (16) 
C2—N1  1.534 (12)  C37—C38  1.315 (16) 
C2—C11  1.570 (14)  C38—C39  1.546 (14) 
C1—C16  1.339 (14)  C39—N3  1.483 (13) 
C1—O1  1.366 (12)  C39—C40  1.524 (15) 
C5—C6  1.593 (19)  C40—C41  1.500 (13)   186 
Table 6 (Continued). 
C6—C7  1.500 (17)  C41—C42  1.510 (14) 
C7—C8  1.315 (15)  C41—C45  1.584 (14) 
C8—C9  1.545 (14)  C42—N4  1.511 (13) 
C9—C10  1.428 (13)  C43—C44  1.524 (16) 
C9—N1  1.535 (13)  C43—N4  1.549 (13) 
C10—C11  1.547 (13)  C44—C45  1.462 (16) 
C11—C12  1.501 (13)  C45—C46  1.557 (15) 
C11—C15  1.555 (13)  C46—C47  1.398 (14) 
C12—N2  1.481 (11)  C47—C48  1.324 (16) 
C13—C14  1.501 (15)  C48—O2  1.394 (13) 
C13—N2  1.549 (13)  C48—C49  1.508 (15) 
C14—C15  1.560 (15)  C49—C50  1.553 (16) 
C15—C16  1.491 (14)  C50—C51  1.487 (18) 
C16—C17  1.435 (13)  C51—C52  1.311 (16) 
C17—C18  1.353 (15)  C52—C53  1.559 (17) 
C18—O1  1.367 (12)  C53—C54  1.493 (17) 
C18—C19  1.446 (14)  C54—C55  1.540 (17) 
C19—C20  1.506 (16)  C55—C56  1.523 (15) 
C20—C21  1.517 (18)  C56—N4  1.470 (14) 
C21—C22  1.374 (15)  C5S—C4S  1.31 (3) 
C22—C23  1.457 (17)  C5S—C6S  1.36 (3) 
C23—C24  1.547 (16)  C5S—O2S  1.37 (2) 
C24—C25  1.538 (16)  C5T—C4T  1.35 (3) 
C25—C26  1.520 (14)  C5T—O2T  1.37 (2) 
C26—N2  1.477 (13)  C5T—C6T  1.37 (3) 
C31—C46  1.353 (15)  C2S—O1S  1.40 (4) 
C31—O2  1.374 (12)  C2S—C1S  1.49 (3) 
C31—C32  1.464 (13)  C2S—C3S  1.50 (3) 
C32—N3  1.549 (12)  C2T—C1T  1.34 (3) 
C32—C41  1.558 (15)  C2T—C3T  1.37 (3) 
C33—C34  1.47 (2)  C2T—O1T  1.38 (2) 
C33—N3  1.512 (14)  C2P—C1P  1.32 (3) 
C34—C35  1.61 (2)  C2P—C3P  1.36 (3) 
C33A—C34A  1.48 (3)  C2P—O1P  1.37 (2) 
 
N1—C3—C4  112.9 (11)  C36—C35—C34A  102.1 (18)   187 
Table 6 (Continued). 
C3—C4—C5  113.3 (13)  C34—C35—C34A  47.4 (17) 
C1—C2—N1  114.5 (8)  C37—C36—C35  110.5 (11) 
C1—C2—C11  100.9 (8)  C38—C37—C36  127.7 (10) 
N1—C2—C11  105.5 (7)  C37—C38—C39  122.5 (10) 
C16—C1—O1  113.0 (9)  N3—C39—C40  102.0 (8) 
C16—C1—C2  116.2 (9)  N3—C39—C38  111.6 (9) 
O1—C1—C2  130.7 (9)  C40—C39—C38  114.8 (9) 
C4—C5—C6  114.7 (10)  C41—C40—C39  104.4 (8) 
C7—C6—C5  109.3 (10)  C40—C41—C42  109.6 (8) 
C8—C7—C6  126.5 (10)  C40—C41—C32  103.8 (8) 
C7—C8—C9  124.7 (10)  C42—C41—C32  113.4 (8) 
C10—C9—N1  103.2 (8)  C40—C41—C45  112.9 (8) 
C10—C9—C8  117.4 (9)  C42—C41—C45  109.7 (9) 
N1—C9—C8  111.2 (8)  C32—C41—C45  107.3 (7) 
C9—C10—C11  106.7 (8)  C41—C42—N4  116.8 (8) 
C12—C11—C10  110.8 (7)  C44—C43—N4  110.3 (8) 
C12—C11—C15  110.7 (8)  C45—C44—C43  113.6 (10) 
C10—C11—C15  113.2 (8)  C44—C45—C46  113.5 (9) 
C12—C11—C2  113.2 (8)  C44—C45—C41  111.8 (9) 
C10—C11—C2  101.7 (8)  C46—C45—C41  102.3 (8) 
C15—C11—C2  106.8 (7)  C31—C46—C47  106.4 (10) 
N2—C12—C11  117.5 (8)  C31—C46—C45  109.2 (9) 
C14—C13—N2  112.5 (8)  C47—C46—C45  144.0 (11) 
C13—C14—C15  111.9 (9)  C48—C47—C46  107.7 (10) 
C16—C15—C11  103.5 (8)  C47—C48—O2  110.8 (9) 
C16—C15—C14  113.5 (8)  C47—C48—C49  133.9 (11) 
C11—C15—C14  111.5 (8)  O2—C48—C49  114.8 (10) 
C1—C16—C17  104.8 (10)  C48—C49—C50  113.2 (9) 
C1—C16—C15  110.5 (9)  C51—C50—C49  110.7 (11) 
C17—C16—C15  144.2 (10)  C52—C51—C50  129.9 (13) 
C18—C17—C16  106.5 (10)  C51—C52—C53  125.9 (12) 
C17—C18—O1  111.1 (9)  C54—C53—C52  114.2 (11) 
C17—C18—C19  134.2 (11)  C53—C54—C55  115.3 (10) 
O1—C18—C19  114.5 (10)  C56—C55—C54  110.3 (10) 
C18—C19—C20  113.5 (9)  N4—C56—C55  114.0 (9) 
C19—C20—C21  112.6 (11)  C39—N3—C33  114.3 (10)   188 
Table 6 (Continued). 
C22—C21—C20  123.3 (13)  C39—N3—C33A  121 (2) 
C21—C22—C23  129.9 (12)  C33—N3—C33A  22.1 (16) 
C22—C23—C24  113.3 (11)  C39—N3—C32  106.1 (8) 
C25—C24—C23  115.7 (9)  C33—N3—C32  111.3 (9) 
C26—C25—C24  111.9 (10)  C33A—N3—C32  123 (3) 
N2—C26—C25  112.4 (9)  C56—N4—C42  116.0 (8) 
C3—N1—C2  113.5 (8)  C56—N4—C43  110.5 (8) 
C3—N1—C9  116.5 (8)  C42—N4—C43  112.2 (8) 
C2—N1—C9  105.7 (7)  C31—O2—C48  104.2 (8) 
C26—N2—C12  115.3 (8)  C4S—C5S—C6S  112 (3) 
C26—N2—C13  113.1 (8)  C4S—C5S—O2S  107 (2) 
C12—N2—C13  111.7 (8)  C6S—C5S—O2S  116 (2) 
C1—O1—C18  104.5 (8)  C4T—C5T—O2T  106 (2) 
C46—C31—O2  110.8 (9)  C4T—C5T—C6T  114 (2) 
C46—C31—C32  116.8 (10)  O2T—C5T—C6T  112 (2) 
O2—C31—C32  131.9 (10)  O1S—C2S—C1S  109 (2) 
C31—C32—N3  113.7 (8)  O1S—C2S—C3S  107 (3) 
C31—C32—C41  102.7 (8)  C1S—C2S—C3S  108 (3) 
N3—C32—C41  104.8 (8)  C1T—C2T—C3T  113 (3) 
C34—C33—N3  110.8 (12)  C1T—C2T—O1T  106 (3) 
C33—C34—C35  113.6 (14)  C3T—C2T—O1T  113 (3) 
C34A—C33A—N3  119 (3)  C1P—C2P—C3P  110 (2) 
C33A—C34A—C35  110 (3)  C1P—C2P—O1P  108 (2) 
C36—C35—C34  113.6 (11)  C3P—C2P—O1P  112 (2) 
 
N1—C3—C4—C5  107.9 (13)  C33—C34—C35—C34A  25 (2) 
N1—C2—C1—C16  103.4 (10)  C33A—C34A—C35—C36  91 (3) 
C11—C2—C1—C16  -9.4 (11)  C33A—C34A—C35—C34  -20.3 (17) 
N1—C2—C1—O1  -82.4 (12)  C34—C35—C36—C37  -45.3 (16) 
C11—C2—C1—O1  164.7 (9)  C34A—C35—C36—C37  -93.8 (18) 
C3—C4—C5—C6  -59.4 (16)  C35—C36—C37—C38  86.3 (17) 
C4—C5—C6—C7  -45.3 (14)  C36—C37—C38—C39  4 (2) 
C5—C6—C7—C8  85.5 (14)  C37—C38—C39—N3  -87.2 (13) 
C6—C7—C8—C9  7 (2)  C37—C38—C39—C40  157.4 (12) 
C7—C8—C9—C10  155.8 (12)  N3—C39—C40—C41  44.3 (9) 
C7—C8—C9—N1  -85.7 (13)  C38—C39—C40—C41  165.1 (9)   189 
Table 6 (Continued). 
N1—C9—C10—C11  42.6 (10)  C39—C40—C41—C42  -156.5 (9) 
C8—C9—C10—C11  165.3 (9)  C39—C40—C41—C32  -35.0 (9) 
C9—C10—C11—C12  -155.9 (9)  C39—C40—C41—C45  80.9 (10) 
C9—C10—C11—C15  79.0 (11)  C31—C32—C41—C40  132.0 (8) 
C9—C10—C11—C2  -35.3 (10)  N3—C32—C41—C40  13.0 (9) 
C1—C2—C11—C12  -108.3 (8)  C31—C32—C41—C42  -109.1 (9) 
N1—C2—C11—C12  132.2 (8)  N3—C32—C41—C42  131.9 (8) 
C1—C2—C11—C10  132.7 (8)  C31—C32—C41—C45  12.3 (10) 
N1—C2—C11—C10  13.3 (9)  N3—C32—C41—C45  -106.8 (8) 
C1—C2—C11—C15  13.8 (9)  C40—C41—C42—N4  -168.7 (9) 
N1—C2—C11—C15  -105.7 (8)  C32—C41—C42—N4  75.8 (11) 
C10—C11—C12—N2  -169.9 (9)  C45—C41—C42—N4  -44.2 (12) 
C15—C11—C12—N2  -43.4 (12)  N4—C43—C44—C45  -53.4 (12) 
C2—C11—C12—N2  76.5 (11)  C43—C44—C45—C46  -54.8 (13) 
N2—C13—C14—C15  -48.2 (12)  C43—C44—C45—C41  60.3 (12) 
C12—C11—C15—C16  109.9 (9)  C40—C41—C45—C44  111.9 (11) 
C10—C11—C15—C16  -124.9 (8)  C42—C41—C45—C44  -10.7 (12) 
C2—C11—C15—C16  -13.8 (9)  C32—C41—C45—C44  -134.3 (9) 
C12—C11—C15—C14  -12.4 (12)  C40—C41—C45—C46  -126.2 (9) 
C10—C11—C15—C14  112.7 (10)  C42—C41—C45—C46  111.2 (9) 
C2—C11—C15—C14  -136.1 (8)  C32—C41—C45—C46  -12.4 (10) 
C13—C14—C15—C16  -58.1 (12)  O2—C31—C46—C47  1.2 (12) 
C13—C14—C15—C11  58.3 (11)  C32—C31—C46—C47  174.2 (9) 
O1—C1—C16—C17  -0.6 (11)  O2—C31—C46—C45  -173.3 (8) 
C2—C1—C16—C17  174.6 (8)  C32—C31—C46—C45  -0.3 (13) 
O1—C1—C16—C15  -174.4 (7)  C44—C45—C46—C31  128.7 (10) 
C2—C1—C16—C15  0.8 (12)  C41—C45—C46—C31  8.1 (11) 
C11—C15—C16—C1  8.4 (10)  C44—C45—C46—C47  -42 (2) 
C14—C15—C16—C1  129.4 (9)  C41—C45—C46—C47  -162.9 (14) 
C11—C15—C16—C17  -161.4 (12)  C31—C46—C47—C48  -0.4 (13) 
C14—C15—C16—C17  -40.3 (17)  C45—C46—C47—C48  170.7 (14) 
C1—C16—C17—C18  -0.7 (10)  C46—C47—C48—O2  -0.5 (13) 
C15—C16—C17—C18  169.4 (12)  C46—C47—C48—C49  -171.1 (12) 
C16—C17—C18—O1  1.8 (11)  C47—C48—C49—C50  112.1 (15) 
C16—C17—C18—C19  -175.1 (10)  O2—C48—C49—C50  -58.3 (15) 
C17—C18—C19—C20  112.3 (14)  C48—C49—C50—C51  -68.6 (14)   190 
Table 6 (Continued). 
O1—C18—C19—C20  -64.4 (14)  C49—C50—C51—C52  126.1 (13) 
C18—C19—C20—C21  -67.6 (15)  C50—C51—C52—C53  -3 (2) 
C19—C20—C21—C22  126.4 (12)  C51—C52—C53—C54  -156.9 (12) 
C20—C21—C22—C23  -4.9 (19)  C52—C53—C54—C55  57.7 (15) 
C21—C22—C23—C24  -153.0 (12)  C53—C54—C55—C56  63.2 (14) 
C22—C23—C24—C25  60.9 (14)  C54—C55—C56—N4  176.9 (9) 
C23—C24—C25—C26  60.6 (14)  C40—C39—N3—C33  -158.3 (9) 
C24—C25—C26—N2  177.6 (9)  C38—C39—N3—C33  78.6 (11) 
C4—C3—N1—C2  161.9 (10)  C40—C39—N3—C33A  178 (2) 
C4—C3—N1—C9  -74.9 (13)  C38—C39—N3—C33A  55 (2) 
C1—C2—N1—C3  29.7 (12)  C40—C39—N3—C32  -35.3 (9) 
C11—C2—N1—C3  139.7 (9)  C38—C39—N3—C32  -158.4 (8) 
C1—C2—N1—C9  -99.3 (10)  C34—C33—N3—C39  -78.1 (16) 
C11—C2—N1—C9  10.8 (9)  C34—C33—N3—C33A  36 (7) 
C10—C9—N1—C3  -160.0 (9)  C34—C33—N3—C32  161.7 (12) 
C8—C9—N1—C3  73.3 (11)  C34A—C33A—N3—C39  40 (5) 
C10—C9—N1—C2  -32.9 (9)  C34A—C33A—N3—C33  -37 (4) 
C8—C9—N1—C2  -159.6 (8)  C34A—C33A—N3—C32  -101 (5) 
C25—C26—N2—C12  -165.4 (8)  C31—C32—N3—C39  -97.2 (10) 
C25—C26—N2—C13  64.3 (11)  C41—C32—N3—C39  14.2 (9) 
C11—C12—N2—C26  -76.8 (11)  C31—C32—N3—C33  27.7 (14) 
C11—C12—N2—C13  54.1 (12)  C41—C32—N3—C33  139.1 (10) 
C14—C13—N2—C26  126.8 (9)  C31—C32—N3—C33A  49 (2) 
C14—C13—N2—C12  -5.2 (12)  C41—C32—N3—C33A  160.4 (19) 
C16—C1—O1—C18  1.6 (10)  C55—C56—N4—C42  -165.9 (9) 
C2—C1—O1—C18  -172.7 (9)  C55—C56—N4—C43  64.9 (11) 
C17—C18—O1—C1  -2.1 (10)  C41—C42—N4—C56  -77.3 (12) 
C19—C18—O1—C1  175.4 (8)  C41—C42—N4—C43  51.0 (12) 
C46—C31—C32—N3  104.9 (11)  C44—C43—N4—C56  129.5 (9) 
O2—C31—C32—N3  -83.9 (13)  C44—C43—N4—C42  -1.7 (12) 
C46—C31—C32—C41  -7.7 (12)  C46—C31—O2—C48  -1.5 (11) 
O2—C31—C32—C41  163.4 (11)  C32—C31—O2—C48  -173.0 (11) 
N3—C33—C34—C35  108.3 (16)  C47—C48—O2—C31  1.2 (12) 
N3—C33A—C34A—C35  -100 (5)  C49—C48—O2—C31  173.8 (10) 
C33—C34—C35—C36  -60.2 (17)     
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Table 7. Hydrogen-bond parameters 
D—H···A  D—H (Å)  H···A (Å)  D···A (Å)  D—H···A (°) 
N1—H1···Cl3
i  0.93  2.15  3.048 (9)  163.2 
N2—H2A···Cl2  0.93  2.05  2.975 (8)  174.8 
N3—H3AA···Cl4
ii  0.93  2.15  3.049 (9)  161.6 
N4—H4···Cl1
iii  0.93  2.05  2.977 (9)  174.7 
O1S—H1S···Cl3
i  0.85  2.36  3.21 (2)  179.4 
O1P—H1P···O1S  0.84  1.93  2.27 (3)  103.1 
O2T—H2T···Cl4  0.85  2.32  3.171 (19)  179.5 
 
Symmetry code(s):  (i) x-1, y, z; (ii) x+1, y-1, z; (iii) x+1, y, z.   
      	 ﾠ
Figure 8. Perspective views showing 50% probability displacement.   192 
 
Figure  9.  Three-dimensional  supramolecular  architecture  viewed  along  the  a-axis 
direction. 
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